An Investigation Into The Biological Responses Induced Following Oral Exposure To Silver nanoparticles by Murphy, Anna
Technological University Dublin 
ARROW@TU Dublin 
Doctoral Science 
2015-10 
An Investigation Into The Biological Responses Induced Following 
Oral Exposure To Silver nanoparticles 
Anna Murphy 
Technological University Dublin, anna.murphy3@tudublin.ie 
Follow this and additional works at: https://arrow.tudublin.ie/sciendoc 
 Part of the Biology Commons 
Recommended Citation 
Murphy, A. (2015) An investigation into the biological responses induced following oral exposure to silver 
nanoparticles. Doctoral Thesis. Technological University Dublin. doi:10.21427/D73K5W 
This Theses, Ph.D is brought to you for free and open 
access by the Science at ARROW@TU Dublin. It has been 
accepted for inclusion in Doctoral by an authorized 
administrator of ARROW@TU Dublin. For more 
information, please contact 
yvonne.desmond@tudublin.ie, arrow.admin@tudublin.ie, 
brian.widdis@tudublin.ie. 
This work is licensed under a Creative Commons 
Attribution-Noncommercial-Share Alike 3.0 License 
 An investigation into the biological responses 
induced following oral exposure to silver 
nanoparticles 
 
Anna Murphy BSc (Hons) 
 
A thesis submitted to Dublin Institute of Technology  
For the degree of Doctor of Philosophy 
 
School of Physics 
Dublin Institute of Technology 
Kevin Street, Dublin 8 
 
October 2015
i 
 
 
Abstract 
This study aims to investigate the biological responses induced by silver nanoparticles 
(AgNP) following oral exposure. The commonality of AgNP in consumer goods 
highlights the need for a thorough investigation into the interaction with and subsequent 
responses evoked in living systems following exposure.  Firstly, the potential interaction 
with and effect of biofluid components, namely cholic acid (CA), deoxycholic acid 
(DCA) and ursodeoxycholic acid (UDCA), on AgNP toxicity was investigated. Two 
cell lines corresponding to organs related to the biofluid components, HepG-2 a 
hepatocellular carcinoma derived from liver tissue and Hep2 an epithelial cell line, were 
employed. Physicochemical and cytotoxic screening was performed and the ability of 
biofluid components to modify AgNP cytotoxicity was explored. No alteration to the 
physicochemical characteristics of AgNP by biofluid components was observed; 
however their addition resulted in altered AgNP toxicity. Greater reactive oxygen 
species (ROS) induction was noted in the presence of CA and DCA. UDCA 
demonstrated no modification of toxicity in HepG-2 cells however significant 
modification was observed in Hep2 cells. It was concluded that biofluid components 
can modify AgNP toxicity but is dependent on the biofluid component itself and the 
location where it acts. 
As inhalation is the most common route of nanoparticle entry and given the close 
proximity to the GI tract, the tendency of cross exposure between the two is prevalent. 
As such the next line of investigation involved the potential toxicity of AgNP to A549 
alveolar epithelial carcinoma cells and the influence of a major component of lung 
surfactant dipalmitoylphosphatidylcholine (DPPC) on toxicity. This follow up 
investigation revealed that exposure generated low levels of oxidative stress and a 
reduction in cell viability. While the presence of DPPC caused no influence on viability 
studies its presence increased ROS formation and significantly modified the 
inflammatory response generated by AgNP exposure. These findings suggest a possible 
interaction between AgNP and DPPC causing particles to become more reactive thus 
increasing oxidative insult and inflammatory response within A549 cells. 
The final investigation in this report was on the biological effects of AgNP on the innate 
immune response of circulating white blood cells. This study determined the ability of 
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AgNP to induce an inflammatory response in THP-1 monocytes by measuring AgNP 
stimulated gene expression of the pro-inflammatory cytokines interleukin-1 (IL-1), 
interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α). A further study on 
monocytes extracted from a cohort of blood samples, was carried out to compare the 
inflammatory response to THP-1 monocytes. Finally ELISAs were performed on 
supernatants of THP-1 monocyte cultures to test for the activation of pro-IL-1β a key 
mediator of the inflammasome complex. The findings clearly demonstrate AgNP can 
significantly up-regulate pro-inflammatory cytokine gene expression in THP-1 and 
primary human blood monocytes, with IL-1β release by inflammasome involvement 
indicating AgNP can result in an immunologically active state.  
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Chapter 1 
Introduction and Overview 
 
1.1 Introduction to Nanotechnology 
The origins of modern nanotechnology begin with the physicist Richard P. Feynmen 
and his lecture in 1959 entitled “There’s Plenty of Room at the Bottom”. In the lecture 
Feynmen described that it was not the laws of physics which prohibited the 
manipulation of atoms or molecules but the methods and tools available at that time 
(Feynmen 1959). Despite Feynmens conjecturing,  it was not until 1974 that Norio 
Taniguchi first used the term nanotechnology stating that “Nanotechnology mainly 
consists of the processing, separation, consolidation and deformation of materials by 
one atom or one molecule” (Taniguchi 1974). From that time the definition of 
nanotechnology has been expanded and changed. In October 2011, the European 
Commission published a report which defined a nanomaterial as; 
“A natural, incidental or manufactured material containing particles, in an 
unbound state or as an aggregate or as an agglomerate, and where for 50% or 
more of the particles in the number size distribution, one or more external 
dimensions is in the range 1-100nm 
In specific cases and where warranted by concerns for the environment, health, 
safety or competitiveness the number size distribution threshold may be replaced 
by a threshold between 1-50% 
By derogation from the above, fullerenes, graphene flakes and single wall 
carbon nanotubes with one or more external dimensions below 1nm should be 
considered as nanomaterials.” 
This recommendation of a definition for a nanomaterial was to be used for materials that 
require special provisions such as risk assessment (European Commission, 2011).  
While this definition aimed to encompass a general nanomaterial definition, there are 
numerous definitions detailing the parameters of what classifies a nanomaterial within 
certain sectors such as cosmetics, food and biocides. This in itself presents a lot of 
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confusion regarding the definition of a nanomaterial as the context in which the 
nanomaterial is presented must be taken into account (European Commission, 2009; 
2011; 2012). 
This EU Commission definition has generated a lot of controversy and was considered 
too broad by some industries, too narrow by others and used inappropriate thresholds. 
As a result this definition is currently under review as to whether the size number 
distribution threshold of 50% should be increased or decreased. This review is due to 
conclude in 2016 following consultation with stakeholders regarding its findings 
towards the end of 2015 (European Commission, 2015). 
 
1.2 Potential of Nanotechnology  
Nanotechnology has often been described as a new frontier of this century with many 
different applications in various fields including textiles, electronics, medicine, 
cosmetics and food, demonstrated graphically in figure 1.1 (Sozer & Kokini, 2008; 
Bouwmeester et al, 2009). Between March 2006 and February 2008 the number of 
consumer products containing nanoparticles had tripled with more than a thousand 
commercial products identified (Powell et al, 2010). It was discovered during this time 
that over 200 manufactures marketed their products as “nano-products” and of these 9% 
were food and beverage while health and fitness accounted for 60% (Sozer & Kokini, 
2008). A recent report stated that the global nanotechnology market was worth an 
estimated $26 billion in 2014 and is predicted to reach approximately $64.2 billion by 
2019 (McWilliams, 2014). The inventory of consumer products currently on the market 
in 2015 using nanotechnology has increased substantially to 1,628 a 24% increase from 
2010. This inventory allows the public to browse the products currently available and 
also provides details on the companies behind these nano-products. Of the 1600+ 
products listed, 117 accounts for food and beverage based products with health and 
fitness making up the largest number of products at 907. Silver proves to be the most 
popular nanomaterial of choice with 483 of the 1628 products are listed as containing 
nano-silver (Nanotechproject, 2013). This exponential growth in nano-based products 
and increased consumer exposure will only continue to grow and highlights the need not 
only for strict regulation but also for a complete risk assessment on the impact of 
exposure. This work will examine the biological effects of exposure to nanoparticles on 
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humans, ultimately contributing to an on-going project into the development of a 
complete and detailed risk assessment of the potential harm resulting from exposure to 
nanoparticles. While there are a number of different routes of entry, this project will 
focus on the oral route of exposure and thus will focus on the applications of 
nanotechnology where oral exposure to nanoparticles is a requirement or a concern. 
 
 
Figure 1.1 Applications of Nanotechnology and some examples of the nano-enabled 
products available  
 
1.3 Application of nanotechnology in areas of industry where oral exposure is 
essential or a concern 
The applications for nanotechnologies are numerous and the likelihood of exposure to 
humans is becoming increasingly significant. Their inclusion into a variety of everyday 
products only increases the incidence of contact and raises questions regarding potential 
hazards of exposure. While their inclusion can provide various benefits there is the 
potential to produce undesirable biological effects. Oral exposure provides one of the 
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easiest routes of nanoparticle entry be it through food additives, drug delivery 
(ingestion) or products such as deodorants, fabrics and bedding (inhalation), and 
highlights this route as one of the most common entry points and one in which any risk 
assessment regarding nanoparticle safety must be focused (Sekhon, 2010; Boisseau & 
Loubaton, 2011; Cerkez et al, 2012). 
 
1.3.1 Application of Nanotechnology in the Food Industry 
Nanotechnology is nothing new to the food industry with certain well established 
products employing a form of nanotechnology to reduce fat content of for example 
mayonnaise by emulsifying fat droplets in nano-sized water droplets without effecting 
taste. More recent uses of nanoparticles include food supplements, additives, novel 
foods, flavourings and packaging (Smolkova et al, 2015). The presence of nanoparticles 
in food can be unintentional as well as intentional with nanoparticles used in all aspects 
of the food industry from use as pesticides or fertilizers to veterinary drugs. The 
presence of nanoparticles in food packaging as a means of detecting food spoilage or 
monitoring temperature and moisture, present another route of unintentional 
nanoparticle presence in food through leaching. Nanoparticles such as titanium dioxide 
(TiO2) are added to powdered food as anticaking agents in products such as powdered 
milk and sugar as well as its use as a white colouring for confectionary and white 
coloured sauces and dressings (Lomar et al, 2002; Smolkova et al, 2015). Silver 
nanoparticles (AgNP) are used as antibacterial agents in food products and can be used 
as a detection method for food spoilage known as “e-noses”. Another aspect is the use 
of AgNP in gels to coat food such as vegetables preventing water loss and their 
incorporation into cellulose pads to prevent microbial growth when placed in contact 
with meat products including beef (Tung et al, 2014; Smolkova et al, 2015). 
One of the most important aspects of nanotechnology in food is the ability to allow 
delivery of certain labile bioactive compounds such as antioxidants and vitamins. The 
encapsulation of such compounds in solid lipid nanoparticles can potentially increase 
their bioavailability and stability, and protect from degradation by various enzymes and 
acids in the GI tract. This application has the potential to improve overall health and can 
be applied to pharmaceuticals as well as natural bioactive compounds (McClements, 
2013; Weiss et al, 2008; Yao et al, 2015).  
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A recent extensive research of nanotechnology in the food sector by the European Food 
Safety Authority (EFSA) revealed 633 nanotechnology applications with product 
names, related suppliers and described the physio-chemical characteristics of 
nanomaterials in the food, agriculture and feed sectors. 55 types of nanomaterials were 
identified and the most common applications were found to be in food additives or food 
contact materials (Peters et al, 2014).  
 
1.3.2 Application of Nanotechnology in Drug Delivery 
Nanotechnology is well established in drug delivery as an intelligent method of delivery 
maximising the targeted control of compounds while minimizing side effects. The 
application of nanotechnology in drug delivery aims to improve bioavailability of drug 
compounds, prolong their residence time in the body and allow for targeted delivery to 
affected sites while sparing healthy cells.  Engineering polymeric nanoparticles is a 
growing area of drug delivery research and shows promise as a method of targeted drug 
release. These polymers can be produced to be biocompatible and are often 
biodegradable, allowing intelligent controlled release of a drug product while producing 
non-toxic by-products following degradation that are then easily eliminated from the 
body (York et al, 2008). Dendrimers are also a popular choice for drug delivery with 
drug molecules either encapsulated within the dendrimer or covalently attached to the 
surface. A number of characteristics including easy manipulation of size and attached 
functional groups, high penetration of cell membranes and a lack of immunogenicity 
make them a popular delivery vehicle (Yang et al, 2009; Siewiera & Labieniec-Watala, 
2012; Safari & Zarneger, 2015). 
 
Oral delivery of chemotherapeutic drugs is a growing area of interest in order to 
maintain a constant high level of exposure of chemotherapeutics to cancer cells while 
also improving patient comfort. This could provide a breakthrough in the available 
cancer treatments given intravenously which result in peaks above the maximum 
tolerable concentration and fast excretion from the circulation, thus limiting the 
therapeutic effects and resulting in serious side effects typically associated with current 
cancer treatment (O’Neill & Twelves, 2002; Feng et al, 2011; Jia et al, 2013; Mei et al, 
2013). Dendrimers have been highlighted for potential oral delivery due to their ability 
to permeate intestinal epithelium enhancing drug absorption (Wiwattanapatapee et al, 
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2000). Polymeric micelles are another means of delivery providing increased solubility 
of drugs and improving oral bioavailability (Gaucher et al, 2010).  Liposomes have also 
been highlighted as a possible carrier due to their potential protection of encapsulated 
drugs from intestinal degradation while increasing absorption (Moutardier et al, 2003; 
Mei et al, 2015). This method of cancer treatment provides many challenges in its 
design with numerous factors to be considered both physiologically and the particular 
properties required of the carrier. The treatment of cancer through oral drug delivery 
may not be too far off and highlights how the application of nanotechnology can be 
used to improve the treatment of diseases such as cancer and improve the quality of life 
of those affected. 
 
1.4 Concerns of Nanotechnology  
Everyday consumer products containing nanomaterials are becoming more widely 
available and easily accessible. As a result it is important to consider various questions 
raised regarding the health and environmental risks associated with these products. 
Together with potential risks, the concerns of the public must be addressed regarding 
these products. In the past not acknowledging the public view has led to problems with 
the introduction of new technologies, in particular regarding the introduction of 
genetically modified (GM) products (Gaskell et al, 1999).With the continued growth of 
nano-based products, it is important to take into account the public concerns at the 
beginning of product development in order to avoid a backlash similar to that observed 
with the introduction of GM products. Studies have been carried out in order to gauge 
public perception of nanotechnology and have concluded that general knowledge on this 
topic is very limited with many not understanding the term nanotechnology and what it 
implies. A study into the general public’s perception on new food technologies 
including nanotechnology highlighted that consumer acceptance of a new technology 
cannot be assumed, and that consumers reactions to new technologies and the likelihood 
of acceptance varies with each individual and each technology. The main observations 
from this study indicated that stakeholders must carefully consider the methods 
involved in introducing new technologies well in advance of market launch and that 
transparency is paramount in building consumer confidence and acceptance of new 
technologies (Henchion, 2012). This study has highlighted that there is still clearly a 
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need for a detailed and complete risk assessment into the applications of 
nanotechnology, particularly nano-silver to build consumer confidence in the area.   
The need for proper and strict regulation guidelines and testing are only now coming to 
the forefront with the exponential growth in the industry over the past couple of years. 
In April 2015 the US Environmental Protection Agency (EPA) was forced to stop the 
sale of two nano-silver based products for use in hospitals as sterile agents due to 
unsubstantiated claims made by the company that these products “can swiftly eradicate 
all micro-organisms and keep surfaces free of colonization for up to a full year” (Nano 
Defence Solutions Inc). Under new federal law filed by the Center for Food Safety any 
product that contains a pesticide as an active ingredient must be registered with the EPA 
and determined to be risk free when used as per the labels instructions. The EPA now 
acknowledge nano-silver antimicrobial products should be regulated as new pesticides 
and that products must be regulated and safety tested by independent experts in order to 
safeguard the public from unregulated nano-products on the market (Center for Food 
Safety, 2015). 
 
1.4 Nanosilver  
Bulk silver is a white and brilliant metallic element that has been utilized for thousands 
of years due to its antimicrobial activity, high thermal and electrical conductivity and its 
low contact resistance (Nordberg et al, 1988).  Usage of silver in its bulk form has a 
long history dating back thousands of years. Its use for the preservation of food and 
purification of water in ancient times has been well documented with large silver 
vessels used for the storage of wine and water. During World War I silver was used to 
treat wounded soldiers and prevent infection prior to the discovery of antibiotics 
(Russell & Hugo, 1994; Chen & Schluesener, 2008). Although it has well described 
healing and preservative properties, prolonged exposure to silver has been associated 
with irreversible pigmentation of the skin known as argyria (Rosenman et al, 1972; 
Marshall & Schneider, 1977; Gulbranson et al, 2000; White et al, 2003). Apart from 
this condition silver was believed to be relatively non-toxic and in the advent of 
nanotechnology, manufacture of silver on a nano-scale has become a rapidly expanding 
area of development. 
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Nanosilver is probably one of the most highly used nanomaterials on the market today 
with applications ranging from antibacterial textiles and medical devices to food 
packaging, cosmetics, water treatment and electronics. Compared to bulk silver, 
nanosilver displays different physicochemical properties and can exhibit different 
biological activities (Zhai et al, 2006; Dawy et al, 2012; Greulich et al, 2009). Probably 
the most important property of nanosilver and the one that makes it so appealing is its 
antimicrobial activity. Its ability to inhibit microbial growth has made its use in the 
medical sector invaluable with dressings, bandages and catheters to name a few 
embedded or coated with nanosilver to prevent infection and sepsis (Cheng et al, 2004). 
This antimicrobial property has now been applied to everyday consumer products from 
laundry detergents and water purificants to paints and even clothing. It has been 
reported that the antimicrobial effect of AgNP result from their ability to interfere with 
membrane permeability and redox-cycling in the cytosol of bacteria by attaching to the 
cell membrane, causing accumulation of intracellular radicals and if small enough, 
eventually entering the cell causing DNA damage (Liang et al, 2010). Staying within 
the medical sector nanosilver also has uses diagnostically. In the area of bio-imaging 
and bio-sensing the plasmonic properties of nanosilver are used to improve diagnostic 
mechanisms. The attachment of nanosilver to biosensors reduces the interference of the 
buffer solution it is suspended in and produces greater resolution. For bio-imaging 
compared to the fluorescent dyes commonly used, nanosilver can be detected by 
numerous microscopy techniques and can be used to monitor dynamic biological events 
for extended periods of time due to its photostable property (Sotiriou & Pratsinis, 2011).  
 
1.5 This Thesis 
This study focuses on AgNP, commonly used across a variety of industries due to their 
antimicrobial properties. The reason being that while there are benefits which have led 
to growth and innovation within the area of nanotechnology, there is still a lack of 
regulation and a gap in the knowledge regarding the fate of AgNP following exposure, 
the interaction with biological entities and how this can ultimately affect the responses 
produced. It is important to establish the interaction with and potential toxic effect on 
biological systems in order to produce a complete and detailed risk assessment, not to 
hinder the development of the industry but to provide knowledge so that further 
innovation utilizing AgNP can be carried out in an informed, regulated and safe manner. 
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This study is part of an on-going Science Foundation of Ireland (SFI) funded project 
with the overall aim to develop a risk assessment for oral exposure to silver 
nanoparticles from food products. From the work performed over the last four years it is 
hoped that the knowledge gained can actively contribute to this risk assessment and 
provide insight into the effects of nanoparticle exposure on living systems, furthering 
the understanding of the toxic profile of AgNP. 
Specifically this thesis aims to establish nanoparticle interaction with biological entities, 
namely biofluids, associated with the GI tract and the lung, two organ systems affected 
by oral exposure and how this interaction may affect the response produced. This study 
does not end here, as nanoparticles do not remain in initial exposure sites, but have the 
ability to translocate through the body moving to different biological compartments 
eventually reaching circulatory system. The final part of this investigation is to 
determine the immunological significance of AgNP on circulating white blood cells and 
whether their presence can induce an innate immune response. An overview of the 
thesis is summarized in figure 1.2, and highlights the thought process of the thesis 
design, following the route of AgNP from initial oral exposure to eventual absorption 
into the bloodstream. 
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Figure 1.2 Summary diagram of thesis outline highlighting the main focus points 
following the potential route taken by AgNP following oral exposure. Arrows indicate 
areas of interest throughout the study 
 
Before any toxicity studies can be performed it is first essential to carry out full 
physicochemical characterisation of the tested AgNP. This will provide important 
information and give insight into how AgNP will interact with different cells of the 
body following internalisation. This characterisation will be presented in chapter 4. 
Investigations in to how AgNP interact with various biofluid components present in the 
body, such as bile acids and lung surfactant will be assessed. Their ability to modify the 
toxic profile of AgNP in the liver, larynx and lung all areas associated with oral 
exposure will be presented in chapters 5 and 6. In doing so this study aims to mimic real 
life exposure scenarios and determine the influence of certain biological entities, in this 
case components of biofluids, on the biological response induced following AgNP 
exposure. Following this an investigation into the effects induced by AgNP exposure 
following absorption into the circulatory system will be investigated. The potential 
effect of AgNP on the innate immune response of circulating white blood cells will be 
explored. First a monocyte cell line was used to determine pro-inflammatory cytokine 
gene expression induced by AgNP exposure, indicative of an inflammatory response. A 
further study on human monocytes extracted from a cohort of human blood samples was 
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carried out to compare the AgNP response with that observed in the monocyte cell line, 
all detailed in chapter 7. 
The key research questions that are considered over the PhD are as follows: 
 What are the physicochemical characteristics of AgNP and does the addition of 
biofluid components alter them? 
 Are AgNP toxic to cells associated with oral exposure and does the addition of 
biofluid components modify the observed toxicity? 
 Can AgNP exposure result in up-regulation of pro-inflammatory cytokine gene 
expression in THP-1 monocytes? 
 Can AgNP exposure result in up-regulation of pro-inflammatory cytokine gene 
expression in primary human monocytes and how does this response compare to 
the response in THP-1 monocytes? 
 Does AgNP exposure result in cleavage and activation of pro-IL-1β, indicating a 
role for the inflammasome complex in AgNP response in circulating blood 
cells? 
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Chapter 2 
“Nanotoxicology” 
 
2.1 Introduction 
The previous chapter highlighted the potential of nanotechnology and its benefits as a 
technology across a wide range of industries, including medical, cosmetics and food 
with a focus on AgNP. Although it continues to be marketed as an advantageous 
technology improving the quality of products in the areas of health, food, technology 
and agriculture a number of concerns are being raised as to the impact of this 
technology on the environment and human health. The rapid growth of this industry and 
apparent lack of regulation has led people to question the possible harm associated with 
this technology. This chapter will discuss some of the issues associated with 
nanomaterial and nanoparticle exposure, the various routes of exposure and the risk 
associated with exposure to AgNP. It should be noted however that the benefits of 
nanotechnology greatly outweigh the negatives and so any risk assessment must be 
balanced so as not to stifle innovation and development. 
 
2.2 Nanoparticle interactions with Biological Systems 
The relationship between nanoparticles and biological systems is complex, with a 
variety of factors including physicochemical characteristics of the particle and the 
position within the body as well as the variety of proteins and biological entities present 
influencing the types of interactions and responses produced.  
These intermolecular forces apart from dictating the biological response evoked by 
nanoparticle exposure are fundamental to life itself. Intermolecular interactions are 
required for the basic functioning of cells. Proteins, a fundamental components of cells, 
are formed by the formation of peptide bonds which link a number of amino acids 
together resulting in the production of a protein. Protein folding is important in 
determining function and occurs through several types of weak molecular interactions; 
hydrogen bonds, ionic bonds and van der Waals forces. Although weak, a large number 
of these bonds form allowing protein folding to occur and form a stable conformation. 
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A fourth force is also involved. Clustering of the non-polar hydrophobic side chains of 
the polypeptide towards the inside of the molecule will allow these side chains to avoid 
the aqueous cell environment thus further affecting protein shape (Alberts et al, 2002). 
In addition to protein formation and folding, intermolecular forces are required to allow 
proteins to carry out functions including binding specifically to ligands in order to carry 
out specific functions, for example antibody binding to specific bacterium marking it for 
destruction and removal from the body.  
In addition to proteins, attractive forces are essential to DNA structure with hydrogen 
bonding between base pairs producing the distinctive double helical shape of the DNA 
molecule (Guerra et al, 2000). Haemoglobin is a complex protein structure made up of 
multiple protein subunits that requires the formation of covalent bonds such as 
disulphide bridges and hydrogen bonds to maintain stability following folding (Cooper, 
2000; Berg et al, 2002). From the basic formation of the cell to construction of proteins 
to the reversible binding of oxygen to heme for transportation around the body, 
molecular interactions are essential for living systems and form the basis of life itself. 
While it is clear that intermolecular forces are vital to life, forming the basis of cellular 
structure and function, it is important to consider the interaction between nanoparticles, 
cells and other biomolecules. As intermolecular interactions are fundamental to living 
organisms and dictate various processes, the same focus should be put on nanoparticle-
biomolecule interactions as these may also dictate biological outcome following 
exposure. 
The interaction between nanoparticles and various biomolecules including proteins has 
become an important topic in understanding the behaviour of nanoparticles following 
exposure. Not only is the type of biomolecule or location within the body a factor, but 
also the physicochemical characteristics of the nanoparticle can dictate the type of 
response induced (Lynch et al, 2009; Ehrenberg et al, 2009). Following entry into living 
systems a dynamic layer of biomolecules adsorb onto the nanoparticle surface and this 
coating is what cells “see” and interact with. Nanoparticles may become coated with 
proteins, lipids, sugars and other molecules impacting not only the properties of the 
nanoparticle itself but also the adsorbed biomolecules (Cukalevski et al, 2011; Bailes et 
al, 2012; Lesniak et al, 2012). Biological interactions have been shown to vary as a 
nanoparticle moves from one biological environment to another, subsequently changing 
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the composition of the surface coating with evidence suggesting the same nanoparticles 
can elicit different responses based on the particular composition of the surface coating 
(Maiorano et al,2010; Lundqvist et al, 2011). With the variety of biomolecules present 
and the number of additional factors involved in nanoparticle-biomolecule interactions, 
it is becoming apparent that a need for mapping the surface coatings of nanoparticles in 
the relevant biological and cellular compartments, in order to understand the various 
interactions and possibly predict the responses produced is required (Lynch et al, 2007; 
Byrne et al, 2013). 
It is safe to say that with the literature available nanoparticles will not exist as non-
interacting entities within biological systems but will quickly become associated with a 
layer of biomolecules following entry and this surface coating will vary depending on a 
number of factors relating to the nanoparticle itself, the biological location and types of 
biomolecules encountered. It is this interaction that provides vital information into 
predicting nanoparticle behaviour and biological outcome, both of which must be 
addressed in toxicological research. 
 
2.3 Exposure Routes 
When considering the risks associated with contact to nanoparticles and nanomaterials 
one of the aspects to be identified first is exposure routes to the body. There are three 
main routes of entry that must be considered;  
1. Skin 
2. Inhalation 
3. Oral Exposure 
 
2.3.1 Skin 
Dermal exposure to nanoparticles is becoming increasingly common particularly in the 
area of drug delivery where nanoparticle formulations have been incorporated into 
topical creams and lotions. The skin represents the main protection barrier of the body 
and provides first line defence against infection and environmental hazards. The barrier 
function of the skin is provided by the stratum corneum which is composed of highly 
differentiated keratinocytes. These keratinocytes contain a natural moisturising factor 
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which keeps the skin hydrated and are held together by a lipid lamellae layer preventing 
water loss and providing barrier permeability (Cork et al, 2009). While it has been 
previously demonstrated that titanium dioxide (TiO2) and zinc oxide (ZnO) 
nanoparticles do not penetrate the skin, it has been noted that metallic nanoparticles of 
10nm and less could penetrate the skin and deposit in the deepest layers of the stratum 
corneum (Baroli et al, 2007; Pflucker et al, 2001; Shulz et al, 2002; Cross et al, 2007). 
In relation to the penetration of AgNP into the skin, it was demonstrated that particles of 
30nm and less can penetrate the skin eventually reaching the deepest layers of the 
stratum corneum and that in damaged skin this permeation is increased (Larese et al, 
2009). It was suggested that a certain amount of particles dissolve and diffuse through 
the skin as elemental silver, this hypothesis is similar to a mechanism observed for 
nickel penetration where stratum corneum diffusible compounds are formed by the 
oxidation and solubilisation of particles on the skin surface and enter by an intracellular 
route (Hostynek et al, 2001). 
 
2.3.2 Inhalation 
Nanoparticle exposure via inhalation is probably the most common entry point for 
nanoparticles and because of this, targeted and controlled drug delivery via the lungs 
has become a popular area for development. Inhalation provides an easy entry route for 
engineered nanoparticles in nano-carrier systems for drug delivery, allowing an easy 
route for targeted, controlled and non-invasive delivery. Liposomes in particular have 
been the nano-carrier of choice in the development of improved and intelligent drug 
delivery systems (Varez-Lorenzo et al, 2009; Shum et al, 2001). A number of 
investigations into the mechanisms of nanoparticle uptake in the lung have provided 
information into the methods required for the formulation of potential carriers to induce 
uptake and the various access points. Entry may occur via a transcellular mechanism 
mediated by specific receptors, paracellular uptake or through mucus penetration with 
the characteristics of the nanoparticle often dictating the route of entry as well as the 
biological response induced (Prakash & Matalon, 2014). A summary of these potential 
entry methods are highlighted in figure 2.1. While inhalation provides an alternative 
method of pharmaceutical delivery, improving both the treatment and comfort of 
patients, it can be a double edged sword providing an easy access route for undesirable 
nanoparticles. A number of studies have been undertaken to explore lung entry of 
21 
 
various nanoparticles and their subsequent distribution around the body. Cerium oxide 
(CeO2) nanoparticles have been shown to cause acute toxicity in the lungs following 
exposure. It was postulated that this could lead to chronic inflammation days after the 
exposure period, with particles deposited in the lungs as they penetrate through the 
alveolar wall into the systemic circulation (Srinivas et al, 2010; He et al, 2010). AgNP 
exposure in the lung has also been shown to induce cytotoxicity along with other 
nanometals including ZnO and TiO2. The induced toxicity may result in knock-on 
effects including excessive secretion of certain biological agents causing dysfunction in 
the cytokine network, thus reducing the efficiency of the respiratory immune system 
(Liu et al, 2013).  
 
 
Figure 2.1 Potential routes of absorption of nanoparticles following inhalation and the 
response induced, dependent on both nanoparticle characteristics and host factors. ASM 
Airway Smooth Muscle, ROS Reactive Oxygen Species (Prakash & Matalon, 2014) 
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2.3.3 Oral exposure 
Oral exposure is the main exposure route associated with this study. Indeed the 
probability of nanoparticle exposure via ingestion is high with the advent of 
nanoparticle use in drug delivery and also their incorporation into food products, to 
increase the health benefits and assist in adequate nutrient delivery. In terms of drug 
delivery the oral route is the easiest and most acceptable to patients but due to the 
various obstacles associated with delivery such as degradation by stomach acid and 
elimination by the first-pass effect, the stability and final concentration of the drug 
reaching the systemic circulation comes into question. Nanoparticle systems offer a 
solution to the problems associated with ingestion of pharmaceuticals. An example of 
nanoparticle use in oral drug delivery is the use of chitosan nanoparticles. These 
nanoparticles are biocompatible, non-toxic, have muco-adhesive properties and can 
open tight junctions in the intestinal tract facilitating their residence time in the 
gastrointestinal (GI) tract and transport across the gastric epithelium. When loaded with 
insulin chitosan nanoparticles have been shown to increase the bioavailability and 
absorption of insulin therefore reducing blood glucose levels in in vivo diabetic rat 
models (Chen et al, 2013; Lin et al, 2007). 
As well as ingestion of nanoparticles due to drug delivery, nanoparticles are used in 
food products to prolong shelf-life and also to increase the nutritional value of foodstuff 
by increasing the bioavailability of nutrients. 
 
2.3.3.1 Ingestion 
Throughout evolution humans have ingested various nano and microparticles including 
nutrients such as ferritin, thus demonstrating how the GI tract has adapted to facilitate 
nanoparticle uptake. This naturally occurring nanoparticle, ingested both in meat and 
plant based food, appears to be only partially digested in the GI tract and it has been 
suggested that it may be endocytosed and utilised by epithelial cells in the gut as a 
source of dietary iron. This process highlights that nanoparticle uptake in the gut can 
occur and that in some cases it may be beneficial (Powell et al, 2010). Once food is 
partially digested by chewing in the oral cavity, dissolution begins in the stomach due to 
acidic conditions and the release of various enzymes. Following release from the 
stomach the food is then exposed to bile salts which will emulsify any fats and 
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hydrophobic compounds present (Acosta, 2009). Although there are a number of 
digestion processes nanoparticles will be exposed to, their sub-cellular size can 
dramatically increase their residence time in the gut. They can achieve this because of 
the large surface area available to interact with biological entities and their size can 
contribute to a decreased rate of clearance by intestinal mechanisms. Nanoparticles can 
efficiently deliver bioactive compounds to various targets in the body because they can 
pass through fine capillaries, penetrate deep tissues, cross the epithelial lining 
fenestration and are usually taken up efficiently by cells (Chen et al, 2006). Along the 
inner surface of the small intestine microvilli coat the surface of epithelial cells. These 
structures are fundamental for nutrient absorption and the layer of mucin covering the 
surface of the microvilli represents a key component involved in nanoparticle uptake 
(Acosta, 2009).   
The GI tract has been noted as a major area of AgNP deposition coupled with 
pathological responses. A number of studies have demonstrated damaged microvilli and 
intestinal glands, abnormal pigmentation and an increase in intestinal goblet cells 
following oral administration of AgNP in rats (Hadrup & Lam, 2014; Shahare & 
Yashpal, 2013; Jeong et al, 2010; Kim et al, 2010). The liver in particular is an 
important site of nanoparticle deposition following ingestion with reports of high 
concentrations of AgNP reported in mice 24 hours after exposure. Inhalation also 
provides a route to the liver. Mucocilliary clearance of nanoparticles can result in entry 
to the GI tract and deposition in the liver. Accumulation of AgNP can lead to liver 
toxicity including bile duct hyperplasia and inflammation (Kim et al, 2008; Nemmar et 
al, 2002). The liver has also been identified as a one of the main pathways involved in 
nanoparticle excretion. Hepato-biliary secretion is believed to be a main route of 
intestinal secretion of nanoparticles with evidence of gold and polystyrene nanoparticle 
excretion by this route. Accumulation of nanoparticles within bile canaliculi is 
suggestive of the important role of bile in the intestinal secretion and elimination of 
nanoparticles in faeces (Zhao et al, 2014; Johnston et al, 2010; Semmler-Behnke et al, 
2008).  
There are four main pathways by which nanoparticles can cross the gastrointestinal 
mucosa; transcellular uptake by enterocytes, M-cell uptake, persorption and paracellular 
uptake. The primary function of enterocytes is to absorb and transport nutrients 
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systemically, but data has shown that these cells can also take up particulate material 
(Acosta, 2009).  
 
1) Transcellular uptake 
The transcellular transport of particulate material across enterocytes is known as 
transcytosis. This process begins at the apical cell membrane whereby an endocytic 
process transports particles through the enterocytes or the M-cells in Peyers patches and 
releases them at the basolateral side of the epithelium (Des Rieux et al, 2006; Magnuson 
& Bouwmeester, 2011). There are two methods of transcytosis, one involves the direct 
diffusion of particles through the enterocyte, this is a passive mechanism and the other 
requires specific receptors for the transport of particles. This active process uses 
receptors to capture nanoparticles with specific surface chemistry and internalise them 
(Acosta, 2009; Des Rieux et al, 2006).  
 
2)  M-cell uptake 
Although enterocytes represent 90-95% of the epithelial cells in the intestine it is 
through M-cells that is the most common route of uptake for nanoparticles (Powell et al, 
2010). M-cells are a specialised, differentiated group of epithelial cells located in the 
Peyer’s patches of the lower intestine (Powell et al, 2010; Acosta, 2009). They can 
transport material intact from the lumen to adjacent mononuclear cells and their location 
is thought to be at important immune inductive sites (Powell et al, 2010). M-cells 
primary function is to sample potential antigens in the intestine and this role provides a 
mechanism of continued pathogen and antigen surveillance (Powell et al, 2010; Acosta, 
2009). Although M-cells are more permeable than enterocytes it would seem that these 
cells are an ideal entry point for nanoparticle absorption, however M-cells represent less 
than 1% of the total intestine area making delivery of particles more difficult. To 
overcome this issue there are currently developments to incorporate specific ligands on 
nanoparticles for M-cell delivery. Due to their antigen monitoring role, M-cells have 
developed specific receptors to capture various antigens and pathogens coated with 
glycoproteins and it is this principle that is being explored as a possible method for the 
targeted delivery of nanoparticles (Acosta, 2009).   
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3)  Paracellular uptake 
Another route for nanoparticle uptake in the intestine is through the interstitial space 
between epithelial cells known as paracellular uptake. However due to the space 
between the cells ranging from 0.3-1nm, the paracellular route is considered the least 
effective of the four mechanisms. For the majority of nanoparticles the space between 
the epithelial cells is just too small to permeate (Acosta, 2009). Although the tight 
junctions between epithelial cells are extremely efficient at preventing even the smallest 
nanoparticles to permeate, there are a number of physiological conditions that can affect 
the integrity of these junctions (Acosta, 2009; Des Rieux et al, 2006).  Various 
situations including disease, calcium chelators and epithelial cell metabolism can affect 
tight junctions allowing the influx of very small nanoparticles (Acosta, 2009). In 
addition to physiological conditions a number of synthetic peptides can also modulate 
the influx of nanoparticles through tight junctions. One such peptide is an E-cadherin-
derived peptide that expands tight junctions between the endothelium by acting on the 
aqueous filled pores of the paracellular pathways causing expansion (Magnuson & 
Bouwmeester, 2011). 
 
4) Persorption 
Finally the route of persorption or passage through “gaps” has also been described as a 
mechanism of nanoparticle uptake. This occurs when enterocytes are shed into the gut 
lumen from the villous tip leaving a hole in the epithelium through which nanoparticles 
as well as large particles including starch can be translocated (Acosta, 2009). A 
summary of all methods of nanoparticle transport across the GI tract is illustrated in 
figure 2.2. 
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Figure 2.2 Summary diagram of methods of nanoparticle transport in the GI tract 
 
Nanoparticles can be modified to protect from metabolism and local degradation. As a 
result they can enter intact into the blood and lymphoid circulation from the 
gastrointestinal epithelium and from here be further distributed to other tissues in the 
body. Once in the blood nanoparticles can interact with blood components which may 
influence their distribution and subsequent excretion. There are a number of organs 
where nanoparticles have been identified including the liver and spleen. It has been 
revealed that the smaller the nanoparticle the more diverse the distribution within the 
body with some nanoparticles identified in the bone marrow and brain (Bouwmeester et 
al, 2009).  
The method of nanoparticle uptake is influenced by a number of characteristics of the 
specific nanoparticle. Absorption depends not only on the physicochemical properties of 
the nanoparticle but on the properties associated with the GI tract. Whether a particle is 
absorbed or not depends on its initial contact with enterocytes, its ability to access and 
diffuse through mucus, cellular trafficking and post-translocation events (Medina et al, 
2007). The transcellular uptake of nanoparticles can be influenced by specific particle 
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characteristics such as particle size, surface charge, attachment of ligands or coating 
with surfactants, shape, physical and chemical stability (Magnuson & Bouwmeester, 
2011). Different properties of particles can affect not only if they are absorbed but the 
rate at which they are so. One important factor appears to be charge and studies have 
shown that anionic nanoparticles can reach the epithelial surface and diffuse across the 
mucus layer whereas cationic particles become trapped in negatively charged mucus 
(Magnuson & Bouwmeester, 2011). Size also appears to be a key factor as it has been 
shown that the smaller the particle diameter the faster particles diffuse through the GI 
tract and reach the colonic enterocytes (Medina et al, 2007).   
 
2.4 GI Tract Defences 
As mentioned, oral exposure is the main focus of this report and can include inhalation 
as well as ingestion. While separate these systems function only millimetres apart and it 
is possible a certain amount of nanomaterial will enter the lung during ingestion in the 
oral cavity where both the oesophagus and trachea begin. While this report will include 
data on nanoparticle toxicity exposure to the lungs it is mainly toxicity due to ingestion 
and the effects on the GI tract that will be investigated. 
On a daily basis the GI tract is exposed to numerous potentially harmful agents, and 
with a total surface area in the range of 200m
2
, without an adequate defence system 
harmful pathogens and toxic agents would gain easy access to associated organs and the 
systemic circulation. While protective mechanisms must be in place for prevention from 
infiltration of unwanted agents, a balance must be maintained between the defences 
keeping potentially harmful agents out and normal functions such as exchange of 
nutrients and ions. As a result the GI tract has a number of defence mechanisms in place 
that constantly monitor the substances within the intestine. These include commensal 
gut microflora, the epithelial surface of the intestine, intestinal macrophages and 
mucosal B cells all of which provide the GI tract with a multi-layered defence system 
(Schenk & Mueller, 2008). 
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2.4.1 Commensal Gut Microflora 
The microflora that are resident in the gut provide a number benefits including 
facilitating the digestion of nutrients such as cellulose. The most important function by 
far is that these bacteria occupy ‘space’ within the intestine that would otherwise 
become occupied by other unwanted disease causing pathogens. While in some 
instances such as in immunocompromised patients the commensal bacteria may become 
pathogenic, in the normal healthy individual the relationship is mutually beneficial with 
microflora providing a barrier defence by maintaining the epithelial villi (Hooper et al, 
2001; Schenk & Mueller, 2008). 
 
2.4.2 The Epithelial Surface 
Within the intestinal epithelium are specialised cells known as goblet cells. Their 
primary function is to secrete mucus onto the surface of the epithelium which adds to 
the physical barrier (Mueller & Macpherson, 2006). This complex mix of glycoproteins 
ensures commensal bacteria remain in the intestinal lumen and do not penetrate the 
epithelium. Another group of cells called Paneth cells, secret antibacterial enzymes such 
as lysozyme upon exposure to invading pathogens, another component preventing 
access to the intestinal mucosa (Ayabe et al, 2000). 
 
2.4.3 Intestinal Macrophages 
Bacteria that bypass the aforementioned intestinal barriers and gain access to the 
mucosa can be phagocytosed and destroyed by intestinal macrophages. These 
macrophages are also involved in maintaining tissue homeostasis by phagocytosing 
dead cells and do not display potent inflammatory cytokine production. This feature 
prevents an overstimulation of the immune system to commensal bacteria if they gain 
access to the mucosa (Sansonetti & Braesco, 2001; Smith et al, 2001; Schenk & 
Mueller, 2008). 
 
2.4.4 Mucosal B cell System 
B cells are antibody producing lymphocytes and mucosal B cells provide an active 
defence by terminally differentiating into plasma cells that secrete only IgA antibody. 
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Once secreted this IgA enters the intestinal lumen and can bind to invading pathogens 
reducing their motility and adhesive properties (Kallies et al, 2004; Kaetzel et al, 1991; 
Schenk & Mueller, 2008). 
 
2.5 Lung Defences 
The lung serves as a massive surface area between the external environment and the 
host and as such requires a multilayered defence system to protect from invading 
pathogens that are constantly inhaled. There are two types of defence mechanism found 
in the lung, the initial mechanical response mechanism and the innate immune response. 
The first line of defence involves non-specific receptors that line the lung involved in 
mucociliary clearance, cough reflex and the ciliary beat removing invading pathogens. 
While this initial line of defence is important it has now been discovered that a more 
sophisticated innate immune defence is present providing a key role in removal of 
potentially harmful pathogens. Pulmonary epithelial cells produce a variety of small 
molecules that are involved in innate immunity. Two of these secreted components SP-
A and SP-D have been shown to play an important role in host defence (Zaas & 
Schwartz, 2005; LeVine & Whitsett, 2001). 
 
2.5.1 Surfactant protein A (SP-A) 
SP-A is a surfactant associated protein that is expressed by alveolar type II cells and 
binds dipalmitoylphosphatidylcholine (DPPC). Its key role in host defence is enhancing 
microbial phagocytosis by macrophages. It acts an opsonin that stimulates uptake of a 
variety of pathogens by alveolar macrophages. As wells as enhanced macrophage 
uptake, SP-A can also induce calcium dependant neutrophil uptake of certain pathogens 
including E. coli (LeVine & Whitsett, 2001).  
 
2.5.2 Surfactant protein D (SP-D) 
SP-D is expressed in pulmonary tissue but is also found in other tissues in the body. 
Like SP-A, it is expressed by alveolar type II cells and binds phosphatidylinositol in 
pulmonary surfactant. SP-D has been shown to bind and aggregate bacteria enhancing 
their phagocytosis by alveolar macrophages. In addition to bacteria, SP-D can also bind 
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and aggregate certain viral and fungal surfaces including influenza A and Aspergillus 
(LeVine & Whitsett, 2001). 
 
2.6 Role of Biofluids 
A biofluid is any fluid originating from within the body that can be excreted, secreted, 
obtained by a needle or can develop due to a pathological process and ranges from 
blood to bile and breast milk to cyst fluid (Medicinenet). There are numerous biofluids 
in the body including saliva, blood, urine, stomach acid and bile to name a few. Each 
biological fluid has its own important individual role within the body. Some of those 
functions include: 
 Blood: oxygen transport 
 Saliva: breakdown of starch by amylase and aids in chewing 
 Urine: excretion of waste metabolites and excess water 
 Stomach Acid: aids in further digestion and breakdown of food via enzymes 
 Bile: hydrolyses fat 
In addition to the vital physiological role biofluids perform within the body, they have 
also been shown to aid in nanoparticle processing including isolating particles from 
larger agglomerates, particle coating and modification of surface chemistry (Herzog et 
al, 2009). In this study components of two major biofluids found in the body will be 
investigated,  ursodeoxycholic acid (UDCA), cholic acid (CA) and deoxycholic acid 
(DCA) that form part of total bile and dipalmitoylphosphatidylcholine (DPPC) a 
component of lung surfactant.  
 
2.6.1 Dipalmitoylphosphatydilcholine (DPPC) 
Pulmonary surfactant is composed of a variety of complex phospholipids, lipids and 
surfactant specific proteins. DPPC is the most abundant phospholipid, comprising 70-
80% of total surfactant. Pulmonary surfactant is synthesized by type II pneumocytes and 
any deficiency of this fluid can result in serious respiratory disorders such as Acute 
Respiratory Distress Syndrome (ARDS). The overall function is to reduce surface 
tension at the liquid-air interface at the bronchoalveolar surface (Kumar & Bohidar, 
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2010; Serrano & Perez-Gil, 2006). During inspiration, surfactant lowers surface tension 
to near equilibrium, minimizing the work of breathing. During exhalation, surface 
tension values are reduced, stabilizing the lungs at low air volume and preventing 
pulmonary oedema (Bakshi et al, 2008). In order to perform these functions all of the 
components of lung surfactant are required to work in synergy. 
 
2.6.2 Bile Acids 
Bile acids are steroidal detergents synthesized from cholesterol by hepatocytes which 
drain into the bile duct, hepatic duct and finally into the gall bladder for storage. During 
digestion and in response to several enzymes, bile is released into the duodenum where 
its principle function is lipid digestion. On average 0.4-0.8L of bile is produced each 
day with over 95% reabsorbed in the intestine and returned to the gall bladder. Bile 
acids themselves are amphiphatic molecules with an unusual structure in that they do 
not have a well-defined head and tail group and exist as flat rigid molecules. They can 
be divided into two groups (1) primary bile acids, synthesized in the liver from 
cholesterol and (2) secondary bile acids, formed following bacterial hydrolysis of the 
amide backbone of conjugated bile acids in the large intestine. Bile acids provide a 
crucial function in digestion by solubilising and transporting fat soluble nutrients across 
the intestinal mucosa. Bile acids adsorb onto the surface of digested lipids and remove 
any bound proteins from the surface allowing easy lipid lipolysis by lipid enzymes 
(Kumar & Bohidar, 2010; Maldonado-Valderrama et al, 2011; Holm et al, 2013). For 
this study three bile acids were investigated; 
1. Ursodeoxycholic Acid (UDCA) 
2. Cholic Acid (CA) 
3. Deoxycholic Acid (DCA) 
 
1. Ursodeoxycholic Acid (UDCA) 
UDCA is a secondary bile acid produced from primary bile acids metabolized by gut 
bacteria, comprising 3% of total bile acids (Perez & Briz, 2009). Despite its low 
abundance it is an extremely interesting bile acid as it has been shown to have direct 
antioxidant properties against hydroxyl radicals and can also prevent the retention of 
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certain toxic hydrophobic bile acids. UDCA also has a number of therapeutic 
applications including dissolving gall stones and as an alternative therapy for hepatitis C 
patients in place of interferon therapy (Arisawa et al, 2009; Lapeena et al, 2002). 
 
2. Cholic Acid (CA) 
Cholic acid, along with chenodeoxycholic acid (CDCA), is one of the major primary 
bile acids in the liver and is synthesized from cholesterol. Cholic acid constitutes about 
30-40% of bile acids and together with CDCA makes up almost 80% of the bile acid 
component of total bile (Debruyne et al, 2001). Formation of these bile acids is 
important in cholesterol homeostasis. The specific enzyme for cholic acid synthesis is 
12α-hydoxylase which is important in determining the ratio of cholic acid to CDCA. 
Tight regulation of this synthesis is required as it is believed that a change in the ratio of 
these two bile acids may result in gallstone formation due to a reduction in the 
conversion of cholesterol to bile acids (Del Castillo-Olivares & Gil, 2000). 
 
3. Deoxycholic Acid (DCA) 
Deoxycholic acid (DCA) is a secondary bile acid resulting from the anaerobic 
dehydroxylation of unabsorbed cholic acid by bacteria residing in the gut. This process 
occurs in the colon on any cholic acid that has not been absorbed in the ileum. DCA 
constitutes roughly 10-40% of bile acids in total bile (Marcus & Heaton, 1988). DCA 
has been noted to promote colonic epithelium proliferation and this proliferation is 
related to serum DCA levels (Deschner et al, 1981; Ochsenkuhn et al, 1999). This bile 
acid along with others including cholic acid has been implicated in colorectal 
malignancies. It has been observed that bile acids can stimulate the growth of malignant 
cells and promote their invasion. Certain conjugated bile acids have also been 
implicated in breast cysts as elevated levels of these bile acids were observed in cyst 
fluid. This may indicate a potential role of glycine conjugated bile acids including 
cholic acid, CDCA and DCA in breast malignancies. However other bile acids are also 
being exploited as therapies for cancer treatment. UDCA is the most promising with 
investigations into a targeted therapy for colorectal cancer (Debruyne et al, 2001). 
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2.7 The Immune System 
An intact and functioning immune system is vital in the protection against harmful 
external stimuli. Inflammation is the process by which cells of both the innate and 
adaptive immune system are activated in order to remove an invading agent and repair 
any damage caused. The controlled and rapid initiation and effective resolution of 
inflammation is vital to maintain normal homeostasis.  
The innate immune response is the first line of active defence and comprises a number 
of phagocytic cells, including macrophages, neutrophils, and the complement system. 
Monocytes in particular are the primary cell type involve in the initial immune response 
to external stimuli, recognising distinct patterns (PAMPs) on the surface of pathogens 
such as lipopolysaccharide (LPS) via receptors on the cell surface, toll-like receptors 
(TLRs) (Palm & Medzhitov, 2009; Beutler, 2009; Oberbarnscheidt et al, 2011) . 
Recognition of these patterns is vital in the detection of an infection but also in 
determining the type of infection. The response to these PAMPs involves the release of 
a variety of pro-inflammatory cytokines including interleukin-1 (IL-1), interleukin-6 
(IL-6) and tumour necrosis factor alpha (TNF-α). Monocytes are one of the main 
mediators of the initial inflammatory response with an important role in phagocytosis of 
foreign material at entry sites (Beutler, 2009; Oberbarnscheidt et al, 2011). Their 
production of inflammatory mediators including IL-1, IL-6 and TNF-α, are vital to the 
initial immune response. These cytokines have profound effects on associated cells and 
the local microenvironment such as leukocyte migration, endothelial adhesion increased 
neutrophil activation and antibody secretion all contributing to the inflammatory 
response (Rehman et al, 2012; Medzhitov & Janeway Jr, 2000; Kawai & Akira, 2007). 
IL-1β is of particular interest due to its central role in the inflammatory process. IL-1β 
exerts a number of effects including influencing immune cells such as macrophages and 
endothelial cells and also producing systemic effects. Cleavage to its mature form is 
essential for directing the host response to injury or infection. 
 
2.7.1 Interleukin-1 (IL-1) 
The IL-1 family comprises eleven members of which most are pro-inflammatory but 
some can have anti-inflammatory functions. IL-18 and IL-1β are the most fully 
characterised and have an unusual property in that they are initially expressed as 
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inactive pre-cursors that require additional processing to become biologically active 
(Monteleone et al, 2015; Chen & Schroder, 2013).  IL-1β in particular is the focus of 
many studies due to its highly active state and its secretion from immune cells. Its 
functions range from recruitment of immune cells to induction of fever (Dinarello, 
1996).  It has been shown that IL-1β is involved in certain pathologies, is not required 
for normal homeostasis and that a deficiency in this cytokine can have a protective 
effect (Joosten et al, 2013; Dinarello, 2011).  
Monocytes are the main source of IL-1 which is pivotal in co-ordinating the early 
immune response. This cytokine is the most potent fever inducing molecule and as such 
is tightly regulated. Over-expression or dysregulation of IL-1 can cause auto 
inflammatory disorders and contributes to the progression of septic shock (Goldback-
Mansky & Kastner, 2009; Dinarello, 2009; Dinarello, 1996).  IL-1 has been implicated 
in a number of acute and chronic inflammatory disorders and as a result IL-1β has been 
isolated as a therapeutic target for the treatment of certain disorders including 
rheumatoid arthritis and autoinflammatory syndromes that are characterized by local 
and systemic inflammation, recurrent fevers and fatigue (Dinarello, 2011; Dinarello, 
2013). 
 
2.7.2 Interleukin-6 (IL-6) 
IL-6 is a well-defined multi-functional cytokine involved in the proliferation and 
differentiation of cells involved in inflammation. IL-6 activation occurs through binding 
to its receptor which can be either membrane bound or soluble (Scheller et al, 2014). 
IL-6 has demonstrated a variety of functions in addition to its contribution to the 
inflammatory process, including liver regeneration, bone remodelling and metabolism 
(Spooren et al, 2011). It has also been shown to have anti-inflammatory properties with 
an important role in regulating the levels of other pro-inflammatory cytokines 
suggesting a role in the prevention of dysregulation of certain cytokines (Xing et al, 
1998; Spooren et al, 2011). The opposing effects exhibited by IL-6 are attributed to the 
two receptor types with the soluble receptor responsible for the pro-inflammatory 
effects and binding to the membrane bound form accounts for the anti-inflammatory 
effects (Wolf et al, 2014). 
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IL-6 along with other cytokines including TNF-α, can stimulate the release of 
chemokines to attract neutrophils to the site of inflammation and can contribute to the 
overall systemic reaction in response to inflammation (Scheller et al, 2011; Gruys et al, 
2005). IL-6 induction forms part of the normal initial inflammatory response resulting 
from a disruption to the body’s normal homeostasis but its overexpression has been 
implicated in a number of pathologies. These can range from autoimmune diseases 
including thyroiditis, rheumatoid arthritis to cancer (Feghali & Wright, 1997). 
Expression of this cytokine has been shown to be a contributing factor in the 
progression of cancers such as colitis associated colon cancer and Kaposi sarcoma. An 
increase in levels of circulating IL-6 has also been implicated in the development of 
Hodgkin’s lymphoma (Lin & Karin, 2007; Scheller et al, 2011).  
 
2.7.3 Tumour Necrosis Factor Alpha (TNF-α) 
TNF-α is a multi-functional molecule which plays a vital role in acute inflammation and 
has been described as a very potent cytokine. Along with other pro-inflammatory 
cytokines it is important not only in the initiation, but also in the maintenance of 
inflammation (Nathan, 2002). Released by a number of cells upon stimulation, mainly 
macrophages, TNF-α can mediate a number of responses directly such as fever and 
tissue damage, release of acute phase proteins from the liver in addition to cell 
proliferation, differentiation and apoptosis (Nathan, 2002; Hehlgans & Pfeffer, 2005).  
This cytokine can also exert its effects indirectly by downstream signalling leading to 
the activation of other inflammatory factors, such as IL-6, augmenting the inflammatory 
response by activation of the cytokine cascade as well as acting as a key factor in 
monocyte adhesion to the endothelium by up-regulation of several adhesion molecules 
including ICAM-1 (Feghali & Wright, 1997; Warren, 1990; Ende et al, 2014).   
In addition to the beneficial role of TNF-α in the inflammatory process and 
homeostasis, this cytokine can produce damaging effects to the host. TNF-α has 
systemic endotoxic activity that when produced in large quantities, contributes to fever 
and shock (Feghali & Wright, 1997; Beutler & Caerami, 1988). Dysregulation can lead 
to a chronic inflammatory state and can result in a number of pathological conditions. 
Some of the conditions TNF-α has been implicated in include rheumatoid arthritis and 
inflammatory bowel conditions (Hehlgans & Pfeffer, 2005). As a result, blocking of 
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TNF-α has been and continues to be investigated as a potential therapy for certain 
inflammatory disorders (Wong et al, 2008). 
 
2.7.4 The Inflammasome 
Induction of IL-1β is particularly interesting as maturation to its fully functioning form 
is tightly regulated by the inflammasome. The inflammasome is a complex of multiple 
proteins found in the cytoplasm and requires a number of danger signals such as tissue 
stress in order to trigger inflammatory caspases. Initial signalling in the innate immune 
response via TLRs leads to the transcription of pro-IL-1β but for complete activation a 
second signal detected by intracellular sensor molecules is required to activate the 
inflammasome, resulting in caspase-1 mediated cleavage to the mature form. The 
“sensing” of both signals in a two-step activation process is essential in controlling the 
cleavage of cytokines like IL-1β and IL-18 to produce an effective and controlled 
inflammatory response against infective agents (Martinon et al, 2002; Latz et al, 2013; 
Terlizzi et al, 2014; Schroder & Tschopp, 2010; Gross et al, 2011).  
It is now widely accepted that in order to produce the mature active form of IL-1β, gene 
expression of this cytokine alone is not sufficient and requires involvement of the 
inflammasome. The inflammasome is an important platform allowing for caspase-1 
mediated maturation of IL-1β. While a variety of stimuli can induce gene expression of 
IL-1β, in order to exert its immunological effects the pro-form must be cleaved by 
caspase-1 in order to produce the mature molecule. The most prominently investigated 
inflammasome is NLRP3 as it is the most fully characterised, diverse and clinically 
significant of all inflammasomes and can be activated by exposure to pathogens and 
other environmental irritants (Schroder & Tschopp, 2010). Caspase-1 activity which is 
vital for pro-IL-1β cleavage to the bioactive form is tightly regulated by the NLRP3 
inflammasome (Latz et al, 2013; Schroder & Tschopp, 2010). In addition to proteolytic 
processing of pro-IL-1β, caspase-1 is also required for a form of cell death known as 
pyroptosis. This results in rapid pore formation in the plasma membrane of cells leading 
to osmotic cell lysis (Satoh et al, 2013). Cleavage to the bioactive form is essential in 
order for IL-1β to perform its immunological effects which range from co-ordinating 
early immune response through cell activation to systemic responses such as regulation 
of appetite, temperature and sleep (Dinarello, 2009; Chen et al, 2011; Kasza, 2013; 
37 
 
Yang et al, 2012). Inflammasome activation can also play a role in adaptive immunity 
as cytokines resulting from its activation are involved in further signalling including 
differentiation of T cells into the various subtypes (Chen et al, 2011).  
 
2.8 Nanotoxicity 
Toxicity can be defined as the degree to which a substance can harm living organisms. 
The area of toxicology studies the interaction and effects of such substances on living 
organisms (Timbrell, 1998). As the interaction between living organisms, the 
environment and various nanoparticles becomes more common it is now important to 
focus not only on the benefits provided by these nanoparticles but to also establish any 
risk associated with exposure. Based on the basic definitions of toxicity, nanotoxicology 
can be described as the study of the toxic effects of nanoparticles on living organisms 
and the environment (Donaldson et al, 2004; Paur et al, 2011; Arora et al, 2012). The 
area of nanotoxicology aims to provide answers to some of the concerns raised about 
the safety of nanoparticle exposure and to provide clear, conclusive data regarding the 
relationship between nanoparticles including their concentrationmetrics and 
physicochemical characteristics, and biological systems. The mechanism by which 
nanoparticles mediate their toxicity is also an important factor to be considered (Paur et 
al, 2011; Suh et al, 2009; Lewinski et al, 2008; Donaldson et al, 2004). AgNP are 
becoming of particular interest in nanotoxicology as although they provide a number of 
benefits including antibacterial properties it is now apparent that on an ultra-small scale, 
they can induce toxicity following internalisation and migrate to various organs around 
the body (Sung et al, 2008; DeVasConCellos et al, 2012; Antony et al, 2015). 
 
2.8.1 Nanoparticle Toxicity in the G. I Tract 
In this report the focus is on entry and resulting toxicity following oral exposure to 
AgNP with a focus on the GI tract, including the lungs, and subsequent entry into the 
blood stream. Next to inhalation ingestion of nanoparticles is probably one of the most 
common routes of exposure. While toxicity in the lungs following inhalation of AgNP 
has been well documented, toxicity brought about by ingestion and the subsequent 
effects induced are still not fully understood (Gaillet & Rouanet, 2015). It has been well 
documented that prolonged exposure via ingestion to silver results in systemic argyria 
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but a full cytotoxic profile of AgNP effects on the GI tract is still required (Gulbranson 
et al, 2000; White et al, 2003). 
With a total surface area in the range of 200m
2 
(although this size has recently been 
diputed indicating a smaller surface area in the range of roughly 32m
2
), required for 
optimum nutrient exchange and absorption, the GI tract provides one of the largest 
surfaces within the body that any internalised nanoparticle will come into contact with 
(Powell et al, 2010; Helander & Fändriks, 2014). As discussed previously the GI tract 
has been exposed to naturally occurring nanoparticles throughout evolution and has the 
capacity to absorb and internalize materials on the nanoscale via a number of uptake 
mechanisms (Powell et al, 2010; Acosta, 2009; Des Rieux et al, 2006). This theory can 
also be applied to manmade or engineered nanoparticles. Following absorption it is 
possible for AgNP to be transported to various organs in the body including the liver 
and eventually enter the circulation (Shahare et al, 2013; Bergin & Witzmann, 2013). 
The liver in particular operates closely with the GI tract during digestion and is 
important in the detoxification of various harmful substances. A number of studies have 
reported liver toxicity in response to AgNP exposure and also highlighted it as a major 
site of particle accumulation (Hussain et al, 2005; Takenaka et al, 2001; Hadrup & 
Lam, 2014; Kim et al, 2008; Sardari et al, 2012).  When evaluating the toxicity of 
AgNP on the GI tract it must be taken into account the variety of substances the 
particles will have contact with. These substances range from the commensal gut 
microflora that reside in the intestine to the various biological fluids involved in the 
digestive process such as bile and stomach acid, to partially digested food, all which 
may influence the particles physicochemical profile and resulting biological response 
(Walczyk et al, 2010; Mahmoudi et al, 2011). 
 
2.8.2 Nanoparticle Toxicity and the Immune System 
The immune system is a vital component of the body’s defence against foreign elements 
such as pathogens and particulates (Chaplin, 2010). Understanding this complex and 
sophisticated system is important when investigating nanoparticle toxicity in order to 
develop a complete profile of the interaction of nanoparticles with immune cells and the 
resulting response induced (Zolnik et al, 2010; Farerra & Fadeel, 2015). Several studies 
have focused on investigating the immune-modulatory effects of nanoparticles both in 
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pristine form and following their interaction with biological proteins leading to 
alterations in the responses induced. These studies have looked at two aspects of 
nanoparticle interaction with the immune system: beneficial and harmful (Paino & 
Zucolotto, 2015; Barkhordari et al, 2014; Tian et al, 2007; Xu et al, 2013).  
Nanoparticles have been shown to initiate inflammation and a subsequent immune 
response. For instance carbon nanotubes (CNTs) can affect the phagocytic function of 
macrophages leading to an impaired ability to clear an invading pathogen. CNTs may 
also impair dendritic cell function, which are vital in stimulating T and B cell responses 
thus linking the innate and adaptive responses. This impairment results in 
immunosuppression reducing the body’s defence against infection (Dumortier, 2013; 
Laverney et al, 2013). AgNP have been noted as potent triggers of an inflammatory 
response resulting from interaction with immune cells including macrophages 
producing cytokine release and immune cell recruitment with ROS generation often 
acting as a contributing factor (Kim & Choi, 2012; Park et al, 2011; Lim et al, 2012; 
Martinez-Gutierrez et al, 2012). One of these AgNP mediated responses involves IL-1β 
release, a potent cytokine involved in innate immunity which is involved in widespread 
systemic effects through activation of the inflammasome (Simard et al, 2015; Yang et 
al, 2012). The involvement of AgNP in its release highlights the immunological 
significance of these nanoparticles and may have pathological consequences or 
contribute to already existing diseases (Birrell & Eltom, 2011; Yang et al, 2012).  
As previously mentioned nanoparticle immune system interactions can be manipulated 
to provide desirable immune-modulatory effects. An investigation into engineered 
nanoparticles has highlighted their potential use as antigen-presenting cells and carriers 
of immunostimulatory molecules for vaccination purposes (Zolnik et al, 2010; Farrera 
& Fadeel, 2015). Nanomaterials are also being investigated as potential adjuvants. 
Adjuvants are important components of vaccines enhancing immunogenicity of a 
particular antigen thus increasing a protective immune response. AgNP have been 
targeted as a potential adjuvant with a study demonstrating significant adjuvant effects 
when tested with bovine serum albumin (BSA) and ovalbumin (OVA) in mice. 
Increased levels of specific antibodies along with leukocyte recruitment highlighted the 
potential biomedical application of AgNP as an adjuvant (Xu et al, 2013). While these 
initial findings look promising AgNP use as an adjuvant is a long way off considering 
their toxicity. 
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The two sided argument for nanoparticle interaction with the immune system leaves a 
lot of questions still unanswered as to the variety of responses induced by exposure, the 
role of physicochemical transformation upon entry has on responses induced and also 
where to find a balance between the desirable and harmful effects of nanoparticles both 
natural and engineered on the immune system. 
 
2.9 Summary 
Nanotechnology has a wide variety of applications in consumer products and as a result 
the potential contact with living systems cannot be avoided. This has resulted in 
concerns being raised about the potential risk nanoparticle exposure has on the health of 
humans and also its environmental impact. AgNP in particular have been highly 
regarded for their benefits but it is only now coming to light the health risks they pose. 
As such a more in depth analysis of their toxic potential is required including looking at 
their interaction with various components of biological systems and the resulting 
responses produced following oral exposure. This includes assessing interactions with 
components of biofluids such as bile and lung surfactant to establish if this can 
influence the biological response provoked by AgNP as well as the consequences of 
AgNP entry into the circulation. From the literature reviewed and the evidence provided 
on the toxicity of AgNP exposure, this study aims to investigate the modification of 
AgNP physicochemical characteristics and toxicity by biofluid components. In addition 
an investigation into the induction of an innate immune response following particle 
absorption into the blood will be undertaken. Hopefully this study can provide a more 
realistic and detailed investigation into the toxicological effects of AgNP and contribute 
to the on-going development of a complete risk assessment detailing the potential risk 
posed by exposure to AgNP.  
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Chapter 3 
General Experimental 
3.1 Introduction 
This chapter will introduce and outline the various techniques used in characterising and 
determining the cytotoxic effect of AgNP. Full characterisation of nanoparticles is 
crucial in assessing the size, shape, stability and other properties of particles prior to 
cytotoxicity testing. It is these properties which will ultimately affect how AgNP will 
interact with cells and other biological entities upon entering the body and determine 
their cytotoxic profile. The AgNP in question are PVP coated particles purchased from 
Sigma-Aldrich, Dublin (Catalogue No: 758329). Together with the physicochemical 
characterisation, the methods used for cytotoxic, inflammatory and immunological 
evaluation will also be discussed in this chapter. 
 
3.2 Test materials and reagents 
Polyvinylpyrrolidone (PVP) coated silver (Ag) nanopowder of < 100nm Catalogue No: 
758329, was purchased from Sigma-Aldrich Ltd (Dublin, Ireland). 3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) Catalogue No: M5655 
and 2’, 7’- dichlorofluorescin diacetate (DCFH-DA) Catalogue No: D6883 as well as 
cell culture media, supplements, trypsin solution, lipopolysaccharide (catalogue No: 
L4391), polymyxin B (catalogue No: P0972),  Tri-reagent (catalogue No: T9424), 1-
Bromo-3chloropropane (catalogue No: B9673), 2-propanol (Catalogue No: I9516), 
ethanol (Catalogue No: E7023), PCR primers, adenosine 5’-triphosphate disodium salt 
hydrate (ATP) (Catalogue No: A6419) and Ac-YVAD-CMK an inhibitor of the 
inflammasome were all purchased from Sigma-Aldrich Ltd (Ireland). Alamar blue (AB) 
was purchased from Biosciences (Dublin, Ireland). UDCA (Catalogue No: U5127), CA 
(Catalogue No: C1129), DCA (Catalogue No: D2510) and DPPC were purchased from 
Sigma-Aldrich (Dublin, Ireland). Reverse transcription qScript™ kit (Catalogue No: 
95047) was purchased from Quanta Bioscience (Maryland, USA). Two step reverse 
transcription of DNA was performed using LightCycler® 480 SYBR Green I Master kit 
(Catalogue No: 04 887 352 001) purchased from Roche (Sussex, UK). 
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3.3 Characterisation of nanoparticles 
Prior to the cytotoxicity testing, pristine AgNP and AgNP in various dispersions were 
characterised. The suspensions of AgNP were prepared in deionised water (dH2O), 
DMEM and RPMI media using a bath-sonicator for 20 minutes (Degussa-Ney 
ULTRAsonik 57X 50/60 Hz, California, USA) prior to size and zeta potential analysis. 
 
3.3.1 Scanning Electron Microscopy (SEM) 
Scanning electron microscopy (SEM) generates a number of signals at the surface of 
specimens using a focused beam of high-energy electrons. Signals received from the 
electron-sample interaction reveal information regarding the external morphology, 
chemical composition, crystalline structure and orientation of the sample. A 2-
dimentional image of the sample is generated by data collected over a selected area of 
the sample surface. Using conventional SEM techniques an area of 1cm to 5 microns 
can be imaged. 
Scanning electron microscopy was employed to estimate nanoparticle size from the 
images produced by this technique. A Hitachi SU 6600 FESEM instrument was used to 
obtain images of the AgNP. First the SEM was calibrated with Au on Carbon standard 
provided by Agar Scientific (Essex, UK). Samples were prepared by dispersing particles 
in ethanol by sonication 750 watts Ultrasonic Processor tip (Branson Ultrasonics, Ultra 
sonic processor VCX-750W) at 40% amplitude for a total of 45 seconds. Samples were 
spin coated onto pure silicon wafers which had been thoroughly cleaned by sonication 
in acetone for 30 minutes followed by boiling in propanol for 30 minutes. Silicon 
wafers were then left to air dry in a dust free environment and the nanoparticle sample 
was then spin coated onto wafers 24 hours prior to measurement. 
 
3.3.2 Dynamic Light Scattering (DLS) 
Dynamic light scattering (DLS) is a technique employed for measuring the 
hydrodynamic radius of particles. Particles are illuminated by a laser which scatters 
light due to Brownian motion. Smaller particles are moved further and more rapidly 
producing greater fluctuations of light.The intensity of this light scatter is fluctuated at a 
rate dependant on the size of a particle. Analysis of these fluctuations or scatter pattern 
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yields information on the hydrodynamic radius of the particle using the Stokes-Einstein 
equation (equation 3.1): 
 
 
 
Equation 3.1 Stokes-Einstein equation 
 
D is the diffusion constant  
kB is Boltzmanns constant  
T is absolute temperature  
η is the viscosity of the medium  
r is the radius of a spherical particle 
 
DLS and zeta potential measurements were performed with the aid of a Malvern 
ZetaSizer Nano ZS (Malvern Instruments, Worcestershire, UK) operating with version 
5.10 of the systems Dispersion Technology Software (DTS Nano). For size 
measurement DTS0012 disposable sizing cuvettes were used. The samples were 
equilibrated at 25°C for 2 minutes before each measurement.  
 
3.3.3 Zeta Potential Analysis 
Zeta potential is a measure of particle stability. The liquid layer surrounding a particle 
consists of two parts an inner region where ions are tightly bound and an outer region 
where they are less firmly bound. Within the outer layer is a boundary known as the 
slipping plane where ions and particles form a stable entity and the potential at this 
boundary is the zeta potential. 
Zeta potential measurements were performed with the aid of a Malvern ZetaSizer Nano 
ZS (Malvern Instruments, Worcestershire, UK) operating with version 5.10 of the 
systems Dispersion Technology Software (DTS Nano). For zeta potential analysis, 
DTS1060T clear disposable zeta cells were used and measurements were performed 
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with the automatic model setting, using a voltage of five to minimize artefacts and 
charring of media proteins during analysis.  
 
3.3.4 BET Analysis 
The specific surface area of AgNP was established with a Micrometrics GEMINI BET. 
BET sample holders were filled with a known mass of powdered nanoparticles and 
measured. The sample was degassed for two hours at room temperature with nitrogen 
gas prior to analysis. Nitrogen gas was used as the absorptive gas and a multipoint 
method was used in the estimation of specific surface area. 
 
3.4 Cell culture 
HepG-2 cells (ATCC: HB-8065) an immortalized hepatocellular carcinoma cell line, 
Hep2 (ATCC: CCL-23) a cell line of laryngeal origin, A549 (ATCC: CCL-185) an 
immortalized carcinogenic alveolar cell line and the human monocyte cell line THP-1 
(ATCC: TIB202) were employed this study. HepG-2 cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) with 2mM L-glutamine, sodium pyruvate and 
supplemented with 10% foetal bovine serum (FBS) at 37°C in humidified 5% CO2. 
Hep2 cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 45 
IU/ml penicillin and 45 IU/ml streptomycin at 37°C in humidified 5% CO2. A549 cells 
were cultured in RPMI-1640 medium supplemented with 10% foetal bovine serum 
(FBS), 2mM L-glutamine and 45 IU/ml penicillin and 45 IU/ml streptomycin at 37°C in 
humidified 5% CO2. The THP-1 cell line was cultured in RPMI 1640 (Sigma-Aldrich, 
Ireland) supplemented with 12.5% foetal bovine serum and 2mM L-glutamine. Cells 
were incubated at 37°C in humidified 5% CO2.  All cell culture media including FBS 
other reagents and supplements are from Gibco purchased through Biosciences (Dublin, 
Ireland). 
 
3.5 Cytotoxic evaluation 
The AB and MTT assays were performed for assessment of cytotoxicity of AgNP to the 
cell lines. The test used a range of eight concentrations of AgNP (3.91-500µg/ml) in 
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which effects were likely to occur, this in turn allowed inhibitory concentration (IC50) to 
be calculated. In all cases results were compared to an unexposed control (cells in 
culture media only), eliminating any dependence of the cell line exposures on well type, 
seeding efficiency and numbers, exposure times and volumes. A stock suspension of 
AgNP was prepared aseptically from which different concentrations of nanoparticles 
were prepared in the respective HepG-2, Hep2, A549 and THP-1 cell media followed 
by sonication (Branson Ultrasonics, Ultra sonic processor VCX-750W, maximum 
amplification 40%). As a positive control 10% DMSO was prepared in the respective 
media. For cytotoxic analysis of nanoparticles in the presence of biofluid components, a 
range finding experiment was performed to determine concentration of interest for the 
definitive experiment. A stock solution of this test concentration was prepared for each 
biofluid component, UDCA, CA and DCA, and the surfactant DPPC in the appropriate 
cell media. A concentrationfinding experiment for each bile acid was performed in the 
respective cell lines to determine a working concentration for cytotoxic studies. The 
working concentration was noted to have no cytotoxic effect when exposed to cells 
alone. Based on the concentrationfinding experiments and previous studies, 
concentrations of 50µM, 1mM and 0.125mM were prepared for UDCA, CA and DCA 
respectively and a concentration of 2.2 x 10
-7
M UDCA was prepared for Hep2 cell line 
(Arisawa et al, 2009). Using this solution of each biofluid component and DPPC, a 
stock dispersion of AgNP was prepared aseptically from which a range of nanoparticle 
concentrations was prepared. For cytotoxic analysis of nanoparticles in the presence of 
DPPC a concentration of 0.25µg/ml was chosen based on previous studies (Herzog et 
al, 2009). A stock solution of this test concentration (0.25µg/ml) was prepared for 
DPPC in RPMI-1640. For all assays and exposure scenarios fresh nanoparticle 
suspensions were prepared for each experiment. 
 
3.5.1 Alamar Blue assay 
The alamar blue assay is a cell viability assay that measures the proliferation of cells. 
Growing cells maintain a reducing environment in their cytosol that causes the REDOX 
indicator contained in the AB dye to be converted from the non-fluorescent resazurin, to 
the fluorescent resorufin dye. The fluorescence is measured and relates to the quantity 
of proliferating cells present. 
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For the AB assay, cells were seeded in 96 well microtitre plates (Nunc, Denmark) at a 
density of 1 x 10⁵, 5 x 104, 4 x 104 and 3 x 104 cells per ml for 24, 48, 72 and 96 hour 
exposures respectively in 100µl of cell culture media containing 10% FBS. At least 
three independent experiments were conducted with six replicate wells employed per 
concentration per plate in each independent experiment. After 24 hours of cell 
attachment, plates were washed with 100µl per well PBS and treated with increasing 
concentrations of AgNP prepared in media for 24, 48, 72 and 96 hours. All incubations 
were performed at 37°C in a 5% CO2 humidified incubator. The assay was performed 
according to manufacturer’s instructions. Briefly, control media and test exposures were 
removed, cells were rinsed with 100µl PBS and 100µl of AB solution (5% [v/v] 
solution of AB) prepared in fresh media with no added supplements were added to each 
well. After 3 hour incubation AB fluorescence was measured at excitation and emission 
wavelength of 531nm and 595nm respectively in TECAN GENios (Grodig, Austria). 
Wells containing AB solution and media only were used as blanks. For this assay the 
mean fluorescence units for six replicate cultures were calculated for each exposure 
treatment. Acellular studies were performed with test particles and the AB dye to 
confirm no interference of the particle with dye conversion (Gupta Mukherjee et al, 
2012). 
 
3.5.2 MTT assay 
The MTT assay is used to measure the mitochondrial integrity of cells. Viable cells 
depend on an intact mitochondrial respiratory chain. When cells are alive the yellow 
tetrazolium salt (MTT) is cleaved to a purple formazan dye by succinate dehydrogenase 
a component if the mitochondrial respiratory chain. Cells are then solubilised with an 
organic solvent and the absorbance is measured. 
As with the AB assay a parallel set of three plates were set up for the MTT assay, 
seeded and exposed as previously described. After the same exposure times as AB 
assay, 24, 48, 72 and 96 hours, test medium was removed. Cells were washed with 
100µl PBS and 100µl of freshly prepared MTT solution (5mg/ml MTT in media 
{without supplements}) was added to each well. After 3 hour incubation the solution 
was removed, cells were rinsed 100µl PBS and 100µl MTT fixative (DMSO) was added 
to each well. Plates were shaken at 240rpm for 10 minutes. Following this step the 
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supernatant was removed and transferred to a new 96 well plate for analysis as it has 
been observed that sedimentation of AgNP on the bottom of wells interferes with 
absorbance readings, producing higher values. Absorbance was read at 595nm in 
TECAN GENios (Grodig, Austria). Acellular studies were performed with test particles 
and the MTT dye to confirm no interference of the particle with dye reduction (Gupta 
Mukherjee et al, 2012). 
 
3.5.3 Reactive Oxygen Species (ROS) studies 
The ROS assay uses a cell permeable fluorogenic probe, dichlorodihydrofluorescin 
diacetate (DCFH-DA) to detect intracellular reactive oxygen species. DCFH-DA is 
diffused into cells and deacetylated by cellular esterases to the non-fluorescent DCFH. 
DCFH is then rapidly oxidised to the fluorescent DCF by ROS. The fluorescence is 
measured and is directly proportional to the levels of ROS in cells. 
Intracellular oxidative stress was quantified using a 2’, 7’-dichlorofluorescin diacetate 
(DCFH-DA) plate assay to detect intracellular hydroperoxides and probe for a wide 
range of ROS. Confluent cells were trypsinized and seeded at a density of 1 x10⁵ cells 
per ml prepared in media, onto 96 well black bottomed plates (Nunc, Denmark) and 
allowed to attach for 24 hours. Six independent experiments were performed with six 
replicate wells for negative control, positive control and test concentrations on each 
plate. A working stock of 20µM DCFH-DA in PBS was prepared and all test 
concentrations, positive and unexposed negative controls were prepared in this working 
stock and exposed to cells. The negative control consisted of 20µM DCFH-DA in PBS 
only, the positive control was 5µM hydrogen peroxide (H2O2) prepared in DCFH-
DA/PBS working stock and the AgNP test concentrations (3.91-500µg/ml) together 
with the AgNP-biofluid component test concentrations were prepared in the DCFH-
DA/PBS working stock. Prior to cellular testing, acellular studies were performed with 
the test particles and the DCF dye at all test scenarios to confirm no reduction of the dye 
due to AgNP interference. No reduction of DCFH-DA by AgNP was noted (Gupta 
Mukherjee et al, 2012). 
After 24 hours of attachment, the media was removed and wells were washed with PBS, 
100µl per well. Cells were then treated with 100µl of positive control, negative control 
and test concentrations and plates were incubated for 15min, 30 min, 1hr, 2hr, 3hr, 4hr, 
61 
 
5hr and 6hr. The rate of intracellular ROS production was monitored at each time point 
by the emission of DCFH-DA at 529nm by excitation at 504nm at the various time 
points (plates were re-incubated after each time point reading). Readings were 
performed on a TECAN GENios plate reader (Grodig, Austria). 
 
3.5.4 Confocal Microscopy 
The confocal microscope enables visualisation deep within living tissues and cells. It 
uses point illumination and a spatial pinhole to eliminate out of focus light allowing 
only light within the focal plane to be detected. This allows for increased contrast and 
the ability to produce 3-dimensional structures from the images obtained. 
Confluent cells were trypsinized and at a concentration of 1 x 10
5
 cells per ml, 100µl of 
cell suspension were seeded onto 35mm glass bottom dishes (MatTek Corporation, 
Ashland, MA, USA). Glass dishes were incubated for 1 hour. Following incubation 1ml 
of cell culture media was added to cell suspensions. Dishes were re-incubated and 
allowed to attach for 24 hours. A working stock of 10µM CM-H2DCFDA (Molecular 
Probes- Invitrogen, California, USA) was prepared in DMSO.  A stock suspension of 
AgNP was prepared aseptically, from which different concentrations of nanoparticles 
could be prepared, was prepared in cell media followed by bath-sonication (Degussa-
Ney ULTRAsonik 57X, California, USA).  As a positive control, 10% DMSO was 
prepared in the respective cell culture media. The negative control consisted of cell 
culture media only. 
After 24 hours of attachment, media was removed and glass dishes were washed with 
PBS 1ml per dish.  Cells were treated with 100µl of CM-H2DCFDA and incubated for 
30 minutes. After incubation, dishes were washed in PBS 1ml per dish. 1ml test 
concentrations, negative and positive controls were added to dishes and incubated for 1 
hour. After incubation dishes were washed in PBS 1ml per dish and imaged 
immediately. Images were taken on a Zeiss 510 LSM confocal microscope with an 
external argon ion laser source of 488nm excitation and using a bandpass filter of 505-
530nm to detect the fluorescent DCF dye. 
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3.5.5 Clonogenic assay 
The clonogenic assay, standardised by Franken et al (2006), was initially developed in 
1956 by Puck and Marcus. The assay was performed in six well plates (Nunc, Denmark) 
each seeded with 1ml of cell suspension in media, 400 cells per ml, and 1ml of media 
alone. Cells were allowed to attach for 12 hours to ensure there were single cells at the 
bottom of each well at the time of exposure. After the attachment period, wells were 
washed with PBS 2ml per well and then treated with increasing concentrations of AgNP 
(3.91-500µg/ml) prepared in RPMI or AgNP prepared in RPMI with DPPC, 2ml per 
well. Plates were then incubated for 10 days, 37°C 5% CO2 in a humidified incubator 
(Herzog et al, 2007; Casey et al, 2008). Two replicate wells on each plate were used for 
controls. This was performed for each test concentration. Following incubation, test 
exposures and controls were removed and wells washed with 2ml per well PBS. Finally 
cells were fixed and stained with 20% carbol fuschin in dH2O (BDH, Poole, UK) and 
colonies were manually counted. For all assays 10% DMSO prepared in supplemented 
media was used for positive control. 
 
3.6 Inflammatory Studies 
3.6.1 IL-8 & TNF-α  
Release of inflammatory markers Interleukin 8 (IL-8) and tumour necrosis factor alpha 
(TNF-α) were studied using Human ELISA Max™ deluxe sets for IL-8 and TNF-α of 
BioLegend Inc. (San Diego, California). Supernatant samples were collected prior to 
inflammatory studies. Sample collection was performed in six well plates (Nunc, 
Denmark) each seeded with 1ml of cell suspension in RPMI, 5 x 10
4
 cells per ml. Plates 
were incubated at 37°C for 24 hours. After incubation cells were treated with 1ml of 
increasing concentrations of AgNP (3.91-500µg/ml). Plates were incubated and cell 
supernatant collected at designated time intervals, 1 through 6 hours. After sample 
collection inflammatory studies were performed as per manufactures instructions. All 
reagents and standards were prepared as per instructions and all reagents were brought 
to room temperature prior to use. In brief, one day prior to running ELISA 100µl of 
capture antibody (IL-8/TNF-α) was added to each well of a Nunc Maxisorp™ 96 
microwell plate. Plates were sealed and incubated for 16-18 hours at 4°C. Following 
capture antibody attachment, plates were washed 4 times with at least 300µl wash 
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buffer per well with residual buffer removed by firmly tapping plate on absorbent paper. 
To block non-specific binding 200µl assay diluent A was added to each well. Plates 
were sealed and incubated at room temperature for 1 hour with shaking at 200rpm. 
Following incubation, plates were washed as per instructions and 50µl of samples and 
standards were added to wells. Plates were sealed and incubated at room temperature for 
2 hours with shaking.  Following incubation plates were washed in wash buffer and 
100µl detection antibody solution was added to each well, plates were then sealed and 
incubated at room temperature for 1 hour with shaking. Plates were washed in wash 
buffer and 100µl of Avidin-HRP solution was added to each well. Plates were sealed 
and incubated for 30 minutes at room temperature with shaking. Following incubation, 
plates were washed in wash buffer and 100µl TMB substrate solution C was added to 
each well with incubation in the dark for 15 minutes. After incubation, 100µl stop 
solution was added to each well and absorbance was read at 450nm and 570nm within 
30 minutes using a SpectraMax® M3 Microplate reader (Molecular Devices, California, 
USA). 
 
3.7 Pro-inflammatory Cytokine Gene Expression Analysis 
3.7.1 Cell Line Treatment with AgNP 
The human monocyte cell line THP-1 was cultured in RPMI 1640 (Sigma-Aldrich, 
Ireland) supplemented with 12.5% foetal bovine serum and 2mM L-glutamine. Cells 
were incubated at 37°C in humidified 5% CO2. For exposures, cells at density of 1 x 10
5
 
cells per ml in 10mls cell culture media were seeded in T25 flasks (Corning Life 
Sciences) and incubated overnight at 37°C in humidified 5% CO2. Designated flasks 
were then exposed to either two concentrations of AgNP (50 and 100µg/ml), LPS 
(1µg/ml) or a combination of AgNP and LPS. AgNP and LPS and a combination of 
AgNP and LPS in cell culture media were added to assigned flasks making a final 
volume of 20mls per flask. Flasks were incubated for 1, 6, 8 or 24 hours. Following 
exposures cell suspensions were centrifuged at 1200rpm for 10 minutes at 4°C. 
Supernatants were removed and stored for further analysis and cells were re-suspended 
in 1ml PBS ready for RNA extraction. 
AgNP exposure doses for later gene expression studies were chosen based on Inhibitory 
Concentration (IC50) of THP-1 cells exposed to increasing concentrations of AgNP (1.9-
64 
 
250µg/ml) as determined by the alamar blue (AB) cytotoxicity assay. Cells were seeded 
in 96 well microtitre plates (Nunc, Denmark) at a density of 1 x 10⁵ cells/ml for 24 hour 
exposure in 50µl cell culture media, after which designated flasks were exposed to 50µl 
of increasing concentrations of AgNP. At least three independent experiments were 
conducted with six replicate wells employed per concentration per plate in each 
independent experiment. Plates were treated with increasing concentrations of AgNP 
prepared in media for 24 hours. This time point was chosen as gene studies require 
shorter exposure times in order to detect gene expression. Following incubation the 
assay was performed according to manufacturer’s instructions. Briefly, 50µl AB 
solution was added to wells (total volume 150µl) and incubated for 3 hour. Following 
incubation AB fluorescence was measured at excitation and emission wavelength of 
531nm and 595nm respectively using a SpectraMax® M3 Microplate reader (Molecular 
Devices, California, USA). Wells containing AB solution and media only were used as 
blanks with 10% DMSO used as a positive control. For this assay the mean fluorescence 
units for six replicate cultures were calculated for each exposure treatment. IC50 values 
were calculated from the average response of three independent experiments fitted to a 
sigmoidal curve and a four parameter logistic model used to calculate IC50 with a 
(p<0.05).  
In an experiment to establish possible endotoxin contamination of AgNP, THP-1 cells 
were incubated with polymyxin B (20µg/ml) for 1 hour prior to AgNP exposure. Cells 
at density of 1 x 10
5
 cells per ml in 10mls cell culture media were seeded in two sets of 
four (eight total) T25 flasks (Corning Life Sciences) and incubated overnight at 37°C in 
humidified 5% CO2. One set of flasks were incubated with 20µg/ml polymyxin B for 1 
hour prior to exposure. Designated flasks were then exposed to either AgNP (50 µg/ml), 
LPS (1µg/ml) or a combination of AgNP and LPS. AgNP and LPS and a combination 
of AgNP and LPS in cell culture media were added to assigned flasks making a final 
volume of 20mls per flask. Flasks were incubated for 8 hours. Following exposures, cell 
suspensions were centrifuged at 1200rpm for 10 minutes at 4°C. Supernatants were 
removed and cells were re-suspended in 1ml PBS ready for RNA extraction and 
subsequent gene expression analysis. The presence of polymyxin B prevented LPS 
induced gene expression but did not inhibit AgNP induced gene expression. Endotoxin 
was not detected in AgNP used in this study. 
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For IL-1β ELISA studies, THP-1 cells (n=5) were plated alone or stimulated with LPS 
(10ng/ml) for 4 hours and exposed to ATP (5mM) for 1 hour or AgNP (50 and 
100µg/ml) for 6 hours at 37°C. In some cases cells were pre-treated with Ac-YVAD-
CMK (20µM) for 1 hour prior to ATP and AgNP exposures.   
 
3.7.2 Primary Monocyte Isolation and Treatment with AgNP 
20mls of whole blood were taken from 20 normal healthy donors after acquiring 
internal ethical approval via a review board and individual donor consent in heparinized 
vacutainers and all samples were processed immediately. Monocytes were extracted by 
positive selection process using CD14 Dynabeads® from Invitrogen by Life 
Technologies (Dublin, Ireland). Prior to use beads were washed and re-suspended as per 
manufacturer instructions. For the isolation process 500µl beads per 20mls whole blood 
were utilized and the procedure was performed as per instructions. Briefly, whole blood 
samples were diluted 1:2 in monocyte isolation buffer and centrifuged at 600g for 10 
minutes at room temperature. Following centrifugation the upper layer was discarded 
and the blood re-suspended to the original volume in monocyte isolation buffer. Blood 
was transferred to 15ml tubes and 500µl Dynabeads® were added to each sample. 
Tubes were incubated for 20 minutes at 2-8°C with gentle tilting. Following incubation, 
tubes were placed in the DynaMag™ 15 magnet (Invitrogen by Life Technologies, 
Dublin, Ireland) for 2 minutes. For positive monocyte selection, the supernatant was 
carefully removed and discarded from the tubes which remained in the magnet and had 
attached monocytes in the tube. 15ml isolation buffer was added to tubes with gentle 
mixing to wash monocytes from the tubes. This wash step was repeated twice more to 
obtain a high purity of extracted monocyte cells. The pellet was then re-suspended in 
RPMI-1640 cell culture medium. 
Cells were counted on a Beckman Z™ Series COULTER COUNTER® (Brea, 
California, USA) and were seeded at a concentration of 4 x 10
4
 cells per ml (500µl total 
volume) in a 24 well plate (Nunc, Roskilde, Denmark), and incubated at 37°C with 5% 
CO2 overnight. Cells were then exposed to AgNP concentration of 50µg/ml (IC50 
concentration). Plates were incubated for 8 hours at 37°C with 5% CO2. 
Experimentation was limited on the extracted monocytes as only as small number of 
monocytes was harvested per donor blood sample. Therefore all optimisation 
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experiments incorporating concentration, time and the effects of LPS stimulation were 
carried out on THP-1 cells prior to these experiments. 
Following incubation cells were removed from the base of the 24 well plates using a 
cell scraper (Sarstedt, Numbrecht, Germany), suspended in cell culture media, and spun 
in a pre-cooled microfuge at 3000g for 5 minutes at 4°C. Cell pellets were re-suspended 
in 1ml PBS for subsequent RNA extraction. 
 
3.7.3 Gene Expression Analysis 
The ability of AgNP exposure to induce pro-inflammatory cytokine gene expression 
was evaluated using RT-PCR. THP-1 cells and monocytes from a human cohort (n=20) 
were cultured in vitro and exposed to AgNP as described in the previous section. Once 
cells were centrifuged and the pellet re-suspended, total RNA was isolated using the 
Tri-reagent protocol developed by Chomczynski & Sacchi (1987). Briefly, the pellet 
was re-suspended in a pre-cooled microfuge at 3000g for 5 minutes at 4°C. The 
supernatant was removed and 1ml of Tri-reagent added. Samples were allowed to stand 
at room temperature for 5 minutes then 0.2ml of 1-Bromo-3chloropropane per ml of 
Tri-reagent was added. Samples were mixed for 15 seconds and allowed to stand for 2 
minutes at room temperature before centrifugation at 12000g for 15 minutes at 4°C. The 
aqueous phase (colourless upper liquid) was transferred to a fresh tube. 0.5ml of 
isopropanol per ml of Tri-reagent was added to each tube, and incubated at room 
temperature for 5 minutes. Tubes were centrifuged at 12000g for 10 minutes at 4°C, the 
supernatant was removed and the pellet was washed with 1ml ethanol. The RNA pellet 
was re-suspended in 30µl of DEPC H2O. First strand cDNA was synthesized using 
qScript™ kit Quanta Bioscience (Maryland, USA), according to manufactures 
instructions. Briefly, reverse-transcription master mix was prepared; 15µl of master mix 
was pipetted into individual tubes followed by 5µl each RNA sample. Tubes were 
mixed gently and contents were collected by brief centrifugation. Tubes were placed in 
a Thermocycler following the protocol and the run was initiated. 
The resulting cDNA was amplified using quantitative real time PCR using 
LightCycler® 480 SYBR Green I Master from Roche Life Science (Sussex, UK). 
Samples were analysed on LightCycler® 480 white 96 well plates from Roche Life 
Science (Sussex, UK).  
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Table 1 Table of forward and reverse primer sequences for housekeeping gene actin, 
and for target genes IL-1, IL-6 and TNF-α 
Gene  Forward Sequence Reverse Sequence 
Actin 5’-ACTCTTCCAGCCTTCCTTCC 5’-GTTGGCGTACAGGTCTTTGC 
IL-1 5’-GGGCCACACATCTACTAGGC 5’-TGGGTATCTCAGGCATCTCC 
IL-6 5’-
GATGCAATAACCACCCCTGACCC 
5’-
CAATCTGAGGTGCCCATGCTAC 
TNF-
α 
5’-AAGAGAATTGGGGGCTTAGG 5’-CAGGGATCAAAGCTGTAGGC 
 
Cycling conditions were the same for all primers and as follows: 95°C for 5 minutes, 
followed by 45 cycles of 95°C for 10 seconds, 60°C for 10 seconds and 72°C for 10 
seconds, followed by 1 cycle of melting curve of 95°C for 5 seconds, 65°C for 1 minute 
then cooling at 4°C. PCR was performed on a Roche LightCycler®480 system (Sussex, 
UK). CT data results were obtained directly from the LC480 program (using SYBR 
green fluorescence) and used to determine the pro-inflammatory gene expression levels 
following AgNP exposure. The delta delta (ΔΔ) CT method of relative quantification 
was applied in the analysis of RT-PCR gene expression data (Livak & Schmittegen, 
2001). 
 
3.7.4 Human IL-1β ELISA 
Release of Human IL-1β was studied using a Human IL-1β ELISA Max™ Deluxe set 
from BioLegend Inc. (San Diego, CA, USA). THP-1 cells were plated in 24 well plates 
(Nunc, Roskilde, Denmark) 2 x 10
5
 cells per well in 200µl of 10% FBS 1640 RPMI 
medium. AgNP in cell culture media were added to each well making a final volume of 
400µl per well. Cell culture supernatant was collected after 6 hours and stored at -80°C. 
ELISA carried out as per manufacturer instructions. Briefly, one day prior to 
investigation 96 well plates were coated with diluted Capture Antibody solution, 100µl 
per well. Plates were sealed and incubated overnight between 2 and 8°C. The following 
day plates were washed 4 times with wash solution as per instructions and 200µl 1X 
Assay Diluent A was added to each well in order to block plates. Plates were sealed and 
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incubated at room temperature for 1 hour with shaking. After incubation plates were 
washed 4 times and 50µl of Assay Buffer D was added to wells that would contain 
sample or standard. 50µl of sample or standard was added to the appropriate wells and 
plates were sealed and incubated at room temperature for 2 hours with shaking. 
Following incubation, plates were washed 4 times and 100µl of diluted Detection 
Antibody solution was added to each well. Plates were sealed and incubated at room 
temperature for 1 hour with shaking. After incubation plates were washed 4 times and 
100µl of diluted Avidin-HRP solution was added to each well. Plates were sealed and 
incubated at room temperature for 30 minutes with shaking. Following incubation plates 
were washed 5 times with soaking for 30 to 60 seconds per wash. 100µl of Substrate 
Solution was added to each well and plates were incubated in the dark for 20 minutes. 
After incubation 100µl of Stop Solution was added to each well to stop the reaction. 
Absorbance was measured immediately at 450nm and 570nm using a SpectraMax® M3 
Microplate reader (Molecular Devices, California, USA). 
 
3.8 Statistical analysis 
At least three independent experiments were performed for each cytotoxicity endpoint. 
Results for each assay were expressed as a percentage of unexposed control ± standard 
deviation with control values set as 100%. Statistically significant differences between 
samples and their respective controls were calculated using the statistical analysis 
package InStat (GraphPad Software Inc, San Diego, California). Statistically significant 
differences were set at p<0.05. Normality of data was confirmed with Q-Q percentile 
plots and Kolmogorov-Smirnov tests. Equality of variances was evaluated using Levène 
tests. One-way analysis of variances (ANOVA) followed by Dunnett’s multiple 
comparison tests were carried out for normally distributed samples with homogeneous 
variances. Non-parametric tests, namely Kruskal-Wallis followed by Mann-Whitney-u-
tests were applied to samples without normal distribution and/or inhomogeneous 
variances. Cytotoxicity data (where appropriate) was fitted to a sigmoidal curve and a 
four parameter logistic model used to calculate the Inhibitory Concentration (IC50) 
values. The IC50 value refers to a concentration of a compound where a 50% effect is 
observed, in this case a reduction in cell viability. IC50 values were reported as ±95% 
confidence intervals. IC50 values were estimated using XLfit3™, a curve fitting add on 
for Microsoft® Excel (ID Business Solutions, UK).  
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For real-time PCR experiments, relative quantification analysis directly from the LC480 
program (from the real-time PCR experiments using SYBR green fluorescence) was 
used to determine the pro-inflammatory gene expression levels following AgNP 
exposure. The reference gene (Actin) normalises sample to sample differences and was 
important to determine the changes in expression of different genes, according to 
concentrationand time.  
The quantitative endpoint for real-time PCR is the threshold cycle (CT). It is defined as 
“The PCR cycle at which the fluorescent signal of the reporter dye crosses an arbitrarily 
placed threshold” (Schmittegen & Livak, 2008). A mathematical model widely used in 
the analysis of RT-PCR data is the delta delta (ΔΔ) CT method (Livak & Schmittegen, 
2001). This was applied to the raw CT data to give a ratio of target gene to the control 
gene to demonstrate gene expression changes. Mean-fold changes are calculated from 
mean normalised values of raw CT data between samples. The ΔΔCT mathematical 
model normalises sample to sample differences. The aim was to determine the effect of 
AgNP on the pro-inflammatory cytokine gene expression. This method enabled the 
measurement of gene expression changes of target genes normalised to Actin 
(housekeeper gene) monitored at AgNP exposure (50 and 100µg/ml) at 1, 6, 8 and 24 
hours relative to the expression without AgNP exposure (control). The value of the 
mean-fold change of gene expression without AgNP (control) was 1. The mean-fold 
changes in gene expression of each target gene were plotted by Microsoft Excel, and the 
graphs present either up-regulation or down-regulation of samples determined by 
whether they reach above or below the control sample value of 1. 
Statistically significant differences between samples and their respective controls were 
calculated using the statistical analysis package InStat. Statistically significant 
differences were set at p<0.05. Normality of data was confirmed with Q-Q percentile 
plots and Kolmogorov-Smirnov tests. Equality of variances was evaluated using Levène 
tests. One-way analysis of variances (ANOVA) followed by Dunnett’s multiple 
comparison tests were carried out for normally distributed samples with homogeneous 
variances. Non-parametric tests, namely Kruskal-Wallis followed by Mann-Whitney-u-
tests were applied to samples without normal distribution and/or inhomogeneous 
variances.  
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3.9 Chapter Summary 
This chapter has highlighted the various techniques employed to characterise the 
physical and chemical properties of AgNP and also the various assays used to determine 
the toxic effect (if any) of these particles on the chosen cell lines. The following 
chapters will discuss the results obtained using the techniques described here. 
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Chapter 4 
Physicochemical Characterisation of Silver Nanoparticles 
Adapted from “Potential of biofluid components to modify silver nanoparticle 
toxicity” and “The surfactant dipalmitoylphophatidylcholine modifies acute 
responses in alveolar carcinoma cells in response to low concentrationsilver 
nanoparticle exposure” 
 
4.1 Introduction 
Nano-metals, in particular silver nanoparticles (AgNP) have shown remarkable 
antimicrobial properties and as a result have been applied to various consumer products 
(Sozer & Kokini, 2009; Sotiriou & Pratsinis, 2011; Chen & Schluesener, 2008). The 
widespread contact with AgNP has raised concerns over their possible toxicity upon 
entering the body. Paramount to their proposed toxicity is their physicochemical 
characteristics including, size, shape and also their interaction with cell culture media 
and its various protein components. This chapter will explore the interaction of AgNP 
with biofluid components, ursodeoxycholic acid (UDCA), cholic acid (CA), and 
deoxycholic acid (DCA), three components of bile and dipalmitoylphosphatidylcholine 
(DPPC) a major component of human lung surfactant. These biofluid components were 
selected to correspond to the exposure route investigated in this report. Bile plays a 
central role in lipid digestion and absorption of nutrients while lung surfactant is 
essential for the normal breathing process (Maldonado-Valderrama et al, 2011; Seranno 
& Peres-Gil, 2006). The various biofluids play important roles within the body and it is 
essential that we establish how AgNP will interact with them, as inevitably they will 
come into contact with one another upon exposure. Before toxicity testing was 
performed the AgNP were fully characterised using Scanning Electron Microscopy 
(SEM), Dynamic Light Scattering (DLS) particle size analysis and zeta potential 
analysis. Where possible, measurements were performed on AgNP as purchased and on 
test suspensions of the same. The ability of the aforementioned biofluid components to 
alter particle size, aggregation and particle stability was monitored and discussed. The 
importance of establishing physicochemical characteristics of nanoparticles has been 
highlighted as a critical component when performing toxicity testing. As nanoparticle 
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characteristics will most likely change in cell culture media and biological systems from 
the pristine powder, performing a full physicochemical profile will provide insight into 
the toxic mechanisms of nanoparticles. Failure to adequately characterise nanoparticles 
will make any toxicological data insignificant, of limited value and will not be 
comparable to other studies with a similar nanomaterial (Warheit, 2008). In light of this 
observation a full physicochemical profile of AgNP will follow, first focusing on 
particle size and any alterations from the pristine powder when in suspensions of cell 
culture media and in the presence of biofluid components. 
 
4.2 Particle Size 
The methods of particle characterisation employed to determine the relative size of 
AgNP as purchased and in various suspensions were SEM and DLS. Figure 4.1 (a) and 
(b) shows SEM analysis of a dilute sample of AgNP. This sizing method was performed 
on pristine particles as purchased from Sigma-Aldrich (Catalogue No: 758329). SEM 
revealed spherical particles with a size of 50-70nm. This method reflects the physical 
particle diameter of the pristine particles as purchased. In a study published by Gupta 
Mukherjee et al (2012), SEM analysis determined a diameter of <50nm for the same 
Sigma-Aldrich AgNP employing the same preparation method for SEM analysis as this 
study. While this method of particle sizing provides useful information on the pristine 
AgNP, it does not represent how particles will be presented to biological systems upon 
entering the body and how the various biofluids they come into contact with may affect 
them. While SEM analysis provides a fast analysis of nanoparticles with a simple 
sample preparation, analysis of biological samples by this method requires fixation and 
any change in nanoparticle size due to interaction with biological material cannot be 
monitored by this method. DLS analysis will allow monitoring of the system AgNP are 
suspended in and provide data on particle hydrodynamic radius and any change that 
occurs due to the presence of certain biological material, in this case protein 
components of cell culture media, biofluid components and the surfactant DPPC. 
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Figure 4.1 (a) and (b) SEM micrograph at scale bar of 500nm image pristine AgNP (a) 
at a magnification of x80,000 and (b) at a magnification of x70,000 dispersed in ethanol 
to a concentration of 1.56µg/ml by sonication using Ultrasonic Processor tip 
 
4.3 DLS Analysis of AgNP with Biofluid Components UDCA, CA and DCA 
DLS size measurements were performed on pristine AgNP suspended in dH2O and cell 
culture media with and without the addition of the tested biofluid components to the 
media. A concentration of AgNP was chosen for DLS analysis of 15.6µg/ml 
representing a concentrationat which a toxic effect was observed, as will be discussed in 
chapters 5 and 6. DLS data from this study is illustrated in figure 4.2 (a)-(d). When 
suspended in a biological media the various proteins within that media can associate 
(a) 
(b) 
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with any nanoparticles present and it is postulated that this protein coating can 
determine the response of biological systems rather than the particles themselves 
(Lynch et al, 2007). It can be assumed that any protein association that occurs in the 
nanoparticle dispersions presented here may impact the hydrodynamic radius of 
particles and cause possible agglomeration. 
From DLS analysis, AgNP size in dH2O was determined to be 34nm ±SD 3.5nm. A 
shift in hydrodynamic radius was observed in preparations of AgNP in RPMI. 
Dispersed in RPMI alone there are two clear peaks observed one representing RPMI 
itself and the other at approximately 40nm representing AgNP. Upon addition of UDCA 
to the dispersion no effect on the hydrodynamic radius was noted. The two peaks were 
still observed with only a slight increase in size distribution. This variation may be 
explained by a shift in the plane of shear upon addition of UDCA as UV-Vis 
spectroscopic analysis demonstrated no significant interaction of AgNP with the cell 
culture media components. In the presence of DMEM there was a shift in the 
distribution of AgNP compared to their dispersion in dH2O. The first peak remained 
relatively unchanged apart from a reduced number of particles falling within this size 
range. The second wider peak demonstrated the greatest change with the majority of 
particles falling within this size range which has shifted to below 100nm. However 
upon addition of UDCA, CA and DCA (figure 4.2 (b) – (d)) significant changes were 
noted with only one peak between 1-10nm observed which was attributed to DMEM. 
UDCA, CA and DCA have a large size distribution (greater than 200nm) and may result 
in the formation of large agglomerates with nanoparticles, causing them to precipitate 
out at an elevated rate preventing their detection by DLS analysis resulting in the 
detection of DMEM only. A possible reason may be due to masking of particles in 
larger agglomerates caused by the presence of CA and DCA or potentially the particles 
may have fallen out of solution at a faster rate following addition of these biofluid 
components preventing their detection. Further investigation is required into why these 
particular dispersions of AgNP and biofluid components cannot be detected by DLS 
analysis and how this will ultimately affect their toxicological testing. This may result 
in altered toxic responses due to association of biofluid components with particles. This 
will be discussed in more detail in chapters 5 and 6. 
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Figure 4.2 (a) – (d) Dynamic Light Scattering size (nm) particle number (count) 
distribution plot of AgNP (15.6µg/ml) dispersed in media, dH2O and in the presence of 
(a) UDCA (RPMI), (b) UDCA (DMEM), (c) CA and (d) DCA. Data presented is the 
average of three individual experiments 
 
4.4 DLS Analysis of AgNP with DPPC 
Figure 4.3 demonstrates DLS measurements on AgNP suspended in dH2O, in RPMI cell 
culture media and in the presence of DPPC. A representative concentration of AgNP 
(15.6µg/ml) that produces a biological effect was chosen. Two peaks were demonstrated 
in analysis of AgNP alone with the greatest number of particles falling in the range of 
34nm ±3.5. The broader peak can be attributed to particle agglomeration. A slight shift 
in hydrodynamic radius was observed in preparations of AgNP in RPMI. Dispersed in 
RPMI alone two clear peaks were observed one representing RPMI itself and the other 
at approximately 40nm representing AgNP. The addition of DPPC caused little change 
in hydrodynamic radius but produced a larger peak at the 20-40nm range suggesting 
possible isolation of particles from larger agglomerates with its addition to the system.  
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Figure 4.3 Dynamic Light Scattering size (nm) particle number distribution plot of 
AgNP (15.6µg/ml) dispersed in media, dH2O and in the presence of DPPC. Data 
presented is the average of three individual experiments 
 
4.5 UV-Vis Spectroscopy 
UV-Vis absorption spectroscopy was performed to identify the features of the cell 
culture media RPMI and DMEM and of AgNP dispersed in the culture media. This 
method was employed to explore if AgNP interact with cell growth medium and its 
various constituents. The UV-Vis spectrum of cell culture media consists of a number 
of features at 360, 410 and 560nm. There is also a feature at 270nm that is not 
illustrated. The feature at 410nm is the 10% foetal bovine serum (FBS) that is added to 
culture media which also displays another feature at 270nm, the feature at 360nm is 
riboflavin, a vitamin present in the medium and finally the feature at 560nm can be 
attributed to the phenol red indicator.  
The UV-Vis absorption analysis of the different preparations of AgNP in cell culture 
media and with the addition of biofluid components demonstrated no changes to the 
spectra. The lack of alteration suggests that secondary toxicity caused by nutrient 
depletion would be unlikely. Data are presented in Appendix A4.4.1 (a) and (b). 
While DPPC appeared to have no influence on particle size the data indicate an 
influence on particle agglomeration. As such UV-vis absorption was performed to 
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determine any interaction between the various components of the different suspensions. 
No interaction between components was demonstrated indicating that a secondary 
toxicity due to depletion of nutrients would be unlikely. Data are presented in Appendix 
A4.4.2. 
 
4.6 Stability and Surface area 
Zeta potential analysis, illustrated in Tables 4.1 and 4.2, was performed using the same 
sample preparations as for sizing analysis. Typically values above 30mV or below -
30mV indicate stability of the overall system. Zeta potential analysis of AgNP dispersed 
in dH2O (Table 4.1) showed instability of particles at all test concentrations which is 
unexpected as the particles purchased are PVP coated. When the particles were 
dispersed in the test media differences were noted and the AgNP in RPMI demonstrated 
stable results, whereas interestingly dispersion of AgNP in DMEM was revealed to be 
unstable. Upon the addition of the bile components CA, DCA and UDCA however, the 
system was also found to be unstable. The large values noted when particles were 
dispersed in RPMI and RPMI with UDCA would suggest a tendency to repel each other 
and as such reduce the likelihood of agglomeration. The lower values for AgNP in 
DMEM and DMEM with UDCA, CA and DCA suggest reduced repulsive forces 
between particles increasing the potential to agglomerate (Xia et al, 2006). This may 
result in particle precipitation out of solution as observed in DLS analysis. However it 
can be assumed from the data that the addition of biofluid components does not modify 
the overall stability of the system compared to the values noted for dispersions of AgNP 
in cell culture media alone. 
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Table 4.1 Table of Zeta Potential results for three concentrations of AgNP 3.91, 15.6 
and 62.5µg/ml dispersed in different cell culture media and in the presence of different 
biofluid components. Data expressed as average value ±SD of three individual 
experiments. 
 
 
62.5µg/ml 15.6µg/ml 3.9µg/ml 
AgNP Only -15.5 ±1.2mV -31.2 ± 0.9mV -22.1 ± 6.6mV 
AgNP RPMI -473.7 
±50.8mV 
-380 ± 
121.1mV 
-221 ± 
117.2mV 
AgNP DMEM -7.9  ± 5.1mV 1.9 ± 3.4mV -11.2 ± 7.2mV 
AgNP 1mM CA-DMEM -7.1 ± 6.9mV -2.6 ± 3.4mV -27.6 ± 5mV 
AgNP 0.125mM  DCA-
DMEM 
-4.9 ± 9.8mV -12.1 ± 5mV -5.5 ± 8.9mV 
AgNP 50µM UDCA-DMEM -6.6 ± 2.3mV -8.1 ± 6.4mV -6 ± 5mV 
 
Zeta potential analysis was also performed on AgNP suspensions with DPPC as 
illustrated in Table 4.2. When suspended in cell culture media and in the presence of 
DPPC the system was stable. The addition of DPPC was noted to have no impact on the 
overall stability. 
 
Table 4.2 Table of Zeta Potential results for three concentrations of AgNP 3.91, 15.6 
and 62.5µg/ml dispersed in RPMI and in the presence of DPPC. Data expressed as 
average value ±SD of three individual experiments. 
 62.5 µg/ml 15.6 µg/ml 3.9µg/ml 
AgNP Only -15.5 ± 1.2mV -31.2 ± 0.9mV -22.1 ± 6.6mV 
AgNP RPMI -473.7 ± 50.8mV -380 ± 121.1mV -221 ± 117.2mV 
AgNP 0.25 µg/ml DPPC-RPMI -454 ± 175.6mV -485 ± 106.5mV -440.3 ± 434.5mV 
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BET analysis was also employed to determine surface area of AgNP powder as 
purchased and yielded a surface area of 2.3 ± 0.1 m
2
/g. 
 
4.7 Discussion 
The physicochemical characteristics of AgNP play an important role in how they will 
interact with biological systems. The size, associated surface area, shape and chemical 
composition have all been shown to be of great importance to nanoparticle toxicity. Size 
influences surface area which leads to greater cell contact, while shape can also 
influence interactions for example, truncated triangular nanoparticles show increased 
toxicity compared to spherical nanoparticles and it is believed that cylindrical particles 
can cross the cell membrane easier than other shapes due to their ability to harness the 
clatherin machinery (Renwick et al, 2004; Rai et al, 2009; Kam et al, 2004).  
It is now well established that upon entry into the body nanoparticles almost 
immediately become coated in protein and that this adsorbed layer or “corona” is 
important in biological responses to nanoparticle exposure (Gray, 2004; Lynch & 
Dawson, 2008). While there will be adsorption of the proteins of biofluid components, 
DPPC and cell culture media onto the nanoparticle surface, it can be assumed that these 
proteins will associate and dissociate from AgNP at different rates depending on a 
factors such as concentration and affinity (Lynch et al, 2007).    
Proteins tend to agglomerate upon dispersion in an aqueous solution and may coat 
AgNP trapping them within agglomerates increasing the rate at which they fall out of 
solution. A number of studies have investigated this dispersion to determine how this 
affects overall toxicity. It is known that nanoparticles once suspended in cell culture 
media can precipitate out of solution and agglomerate at different rates. As such this 
raises a number of questions relating to dosimetry and the effect of agglomerate 
formation on the end result of nanoparticle exposure.  As well as influencing the results 
of toxicity it can also influence exposure times as agglomerate formation and 
precipitation may increase the time taken for delivery of the full concentrationto cells. 
Further investigation is required to develop a method of including dosimetric 
parameters into toxicological testing so that accurate results for in vitro assays can be 
obtained that are comparable to animal models (Cohen et al, 2014; Cohen et al, 2013; 
Kroll et al, 2009; Teeguarden et al, 2007).   
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Zeta potential analysis was also performed and a change in values would indicate 
interaction of nanoparticles with biofluid components, the surfactant DPPC and cell 
culture media, suggesting indirect toxicity caused by their interaction (Casey et al, 
2007; Casey et al, 2008). No change on overall stability was noted following biofluid 
component or DPPC addition. The overall particle stability also influences size and 
agglomerative state. Larger unstable zeta potential values were noted for AgNP 
dispersions in RPMI with UDCA addition. These large values suggest particles will 
repel each other reducing the potential to agglomerate. The lower values noted for 
AgNP dispersions in DMEM with UDCA, CA, DCA suggest low repulsive forces and 
thus a tendency to agglomerate. This may explain the lack of particle size data due to 
particle precipitation out of solution potentially caused by agglomeration. The 
dispersant is an important factor in particle stability thus effecting size and possible 
agglomeration (Xia et al, 2006). 
A recent study demonstrated that AgNP exposed to synthetic stomach fluid led to 
transformations in particles including particle aggregation, changes in particle 
morphology and the release of silver ions (Mwilu et al, 2013).  It was suggested that 
alterations to AgNP size and surface properties due to exposure to synthetic stomach 
acid may impact their transformation through the gastrointestinal tract and may in turn 
influence AgNP interaction with the cells they encounter. The binding of proteins be it 
from cell culture media, biofluid components or other surfactants can aid in the binding 
of particles to cell surfaces, their trafficking through biological systems and the 
resulting effects. Very recently in a study by Wang et al (2013), the protein surface 
coating or “corona” was identified as providing a Trojan horse effect to nanoparticles. 
Initial entry of nanoparticles into the cell did not cause immediate toxicity it was only 
when the nanoparticles were transported to the lysosome and the surface coating was 
degraded in the acidic environment, that toxicity was observed. At this point, much later 
after initial exposure, loss of lysosomal integrity and release of its contents was noted 
followed by cell death via apoptosis (Wang et al, 2013). These findings can be related 
to the work undertaken in this study as biofluid components and the surfactant DPPC 
are protein entities and will ultimately form part of the protein corona and may 
contribute to particle interactions with living systems and any related toxicity which 
will be further discussed in chapters 5 and 6. 
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This reiterates the importance of performing realistic exposure scenarios in 
toxicological testing to determine nanoparticle interactions in biological systems. These 
results highlight the importance of establishing the physicochemical characteristics of 
AgNP in a variety of biological suspensions, as their interaction with these biofluids 
influence their interactions with cellular components and biological systems and will 
ultimately determine their distribution throughout the body and the signalling pathways 
and end responses they induce. 
 
4.8 Chapter Summary 
This chapter has illustrated the physicochemical characteristics of AgNP both as 
purchased and with the addition of biofluid components and the surfactant DPPC. The 
ability of the tested biofluid components and DPPC to influence AgNP size, aggregative 
state and stability were discussed. By gaining an understanding of these characteristics 
and how AgNP interact with biofluid systems within the body, may help in our 
understanding of how this contact may modify interaction with biological systems and 
any associated toxicity. The presence of biofluid components and surfactants may 
change how AgNP interact with biological systems, their distribution within the body, 
how a cell “sees” the particle and ultimately the response that results from particle-cell 
interaction. 
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Chapter 5 
Adapted from “Potential of biofluid components to modify silver nanoparticle 
toxicity” 
 
5.1 Introduction 
Nanotechnology has been described as a new frontier in science and technology with 
many different applications in fields including textiles, electronics, medicine, cosmetics 
and food (Sozar & Kokini, 2009; Bouwmeester et al, 2009). Silver nanoparticles 
(AgNP) in particular are becoming the material of choice for incorporation into 
consumer goods mainly due to their antimicrobial properties (Choi et al, 2008).  
When considering nanoparticle exposure it is important to take into account not only the 
route of entry to the body but also the various biological systems, biofluids and 
surfactants they will encounter. Indeed as a result of the potential interaction with 
various components of biofluids, nanoparticles may be affected, ultimately changing 
how they interact with cells and the responses they evoke. 
With the ever increasing use of nanoparticles in food products and with pending EU 
legislation enforcing that all forms of engineered nanoparticles present in food must be 
stated on food packaging ie. “nano-labelling” it is now more crucial than ever that the 
interaction between nanoparticles and living systems is thoroughly investigated (Nano 
and other Emerging Technologies Blog, 2013). In particular, the potential toxic effect of 
nanoparticles to the gastrointestinal (GI) tract and their interactions with various 
biofluids associated with this system must be determined. 
The GI tract has been noted as a major area of AgNP deposition coupled with 
pathological responses. A number of studies have demonstrated damaged microvilli and 
intestinal glands, abnormal pigmentation and an increase in intestinal goblet cells 
following oral administration of AgNP in rats (Hadrup & Lam, 2014; Shahare & 
Yashpal, 2013; Jeong et al, 2010; Kim et al, 2010). The liver in particular is an 
important site of nanoparticle deposition following ingestion with reports of high 
concentrations of AgNP reported in mice 24 hours after exposure. Inhalation also 
provides a route to the liver. Mucocilliary clearance of nanoparticles can result in entry 
to the GI tract and deposition in the liver. Accumulation of AgNP can lead to liver 
87 
 
toxicity including bile duct hyperplasia and inflammation (Kim et al, 2008; Nemmar et 
al, 2002). The liver has also been identified as a one of the main pathways involved in 
nanoparticle excretion. Hepato-biliary secretion is believed to be a main route of 
intestinal secretion of nanoparticles with evidence of gold and polystyrene nanoparticle 
excretion by this route. Accumulation of nanoparticles within bile canaliculi is 
suggestive of the important role of bile in the intestinal secretion and elimination of 
nanoparticles in faeces (Zhao et al, 2014; Johnston et al, 2010; Semmler-Behnke et al, 
2008).  
A biofluid is any fluid originating from within the body that can be excreted, secreted, 
obtained by a needle or can develop due to a pathological process and ranges from 
blood to bile and breast milk to cyst fluid (Medicinenet). It has been shown that certain 
biofluids and surfactants can aid the processing of nanoparticles and can isolate 
nanoparticles from larger agglomerates by coating the particle or modifying its surface 
chemistry (Herzog et al, 2009). Interactions with various surfactants can result in 
adsorption of a variety of different molecules and proteins onto the surface of 
nanoparticles. As a result, many studies have shown that this “coating” can affect how a 
nanoparticle interacts with the biological environment. These affects range from 
changes in the particle itself such as ion release and changes in morphology to the 
responses it induces and where it is trafficked within the body (Herzog et al, 2009; 
Mwilu et al, 2013; Ehrenberg et al, 2009; Wang et al, 2013; Misra et al, 2012; 
Aggarwal et al, 2009). It is this ability of biofluids to interact and process foreign bodies 
that make them integral to the defence systems of the body. In this study three 
components of bile were chosen and are referred to as biofluid components throughout 
as they were studied individually.  The biofluid components employed were cholic acid 
(CA), deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA).  
Bile salts are organic solutes synthesized from cholesterol by hepatocytes (Kumar & 
Bohidar, 2010; Perez & Briz, 2009). Cholic acid is one of the major primary bile acids 
in the liver and is synthesized from cholesterol and constitutes about 30-40% of bile 
acids (Debruyne et al, 2001). Formation of these bile acids is important in cholesterol 
homeostasis. Deoxycholic acid is a secondary bile acid and constitutes roughly 10-40% 
of total bile (Marcus & Heaton, 1988). DCA has also been demonstrated to promote 
colonic epithelium proliferation (Deschner et al, 1981; Ochsenkuhn et al, 1999). UDCA 
is a secondary bile acid comprising 3% of total bile acids (Perez & Briz, 2009). Despite 
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its low abundance it has been shown to have direct antioxidant properties and can 
prevent the retention of certain toxic hydrophobic bile acids. UDCA has also a number 
of therapeutic applications including dissolving gall stones and has shown promise as a 
targeted cancer therapy (Arisawa et al, 2009; Lapenna et al, 2002; Debruyne et al, 
2001).  
This study aims to demonstrate if biofluid components can modify nanoparticle toxicity. 
Their incorporation may enhance or reduce cytological effects and has often been 
overlooked in cytotoxicity screening, which will be addressed here. The European 
Union define a nanomaterial as “A natural, incidental or manufactured material 
containing particles in an unbound state or as an aggregate or as an agglomerate, and 
where for 50% or more of the particles in the number size distribution, one or more 
external dimensions is in the range 1-100nm” (European Commission, 2011). In 
keeping with this definition it is important to investigate the interaction of biofluid 
components with nanoparticles to determine if the chemistry is affected resulting in a 
change in size distribution or agglomerative state potentially causing the nanoparticles 
to fall outside the criteria of a nanomaterial as per the EU definition.  This was 
investigated and previously discussed in chapter 4. The cell lines chosen were HepG-2 a 
hepatocellular carcinoma (liver) and Hep2 an epithelial cell line employed as a control.  
A cytotoxic profile of AgNP was carried out using the standard cytotoxic assays 3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and Alamar Blue (AB) 
viability assays. A 2’, 7’-dichlorofluorescin diacetate (DCFH-DA) plate assay was used 
to detect any intracellular ROS generation in response to AgNP exposure.  
 
5.2 Cytotoxicity Testing 
Viability assays were performed to determine the effect of AgNP exposure to HepG-2 
and Hep2 cell lines. The ability of the biofluid components UDCA, CA and DCA to 
modify the toxic response of AgNP was also evaluated. Cytotoxicity data for AgNP 
exposure in the HepG-2 and Hep2 cell lines are presented in table 5.1. The results of the 
MTT assay are presented for each cell line in the presence and absence of the respective 
biofluid component. Both MTT and AB assays were performed for each cell line. 
Results for AB assay are presented in Appendix A5.2.  
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5.2.1 Cytotoxic evaluation HepG-2 cell line to AgNP exposure alone and in the 
presence of UDCA, CA and DCA 
Figure 5.1 represents the cytotoxic response of HepG-2 cells to AgNP exposure 
determined by the MTT assay. In the presence of AgNP cell viability decreases in a 
concentrationand time dependent manner, with a substantial decline in mitochondrial 
integrity detected at concentrations of 15.6µg/ml and above. A significant decrease in 
cell survival occurs at concentrations of 15.6µg/ml after 48 hour exposure while a 
significant reduction in cell viability at all exposure time points occurs at AgNP 
concentrations of 31.25µg/ml and upwards. 
 
 
Figure 5.1 Cytotoxicity of AgNP in HepG-2 cells after 24, 48, 72 and 96hr exposures 
as determined by the MTT assay. Data expressed as percentage of control mean ± SD of 
three individual experiments. * denotes a statistically significant (p<0.01) difference 
from the unexposed control 
 
A DCF-DA plate assay was employed to detect any ROS production in response to 
AgNP exposure over a 24 hour period. Readings were taken every hour for 6 hours. 
Following this, readings were then taken at 12 and 24 hours to detect any delayed 
intracellular ROS production in response to increasing concentrations of AgNP. Figure 
5.2 illustrates ROS generation in response to AgNP exposure. The study showed that 
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the amount of ROS produced increased with increasing length of nanoparticle exposure 
and also with increasing concentration. ROS production was noted at concentrations of 
7.8µg/ml and above after 15 minutes exposure and was shown to increase with 
concentrationand exposure time. The greatest level of ROS production was observed at 
a concentration of 500µg/ml after 12 hours of exposure. A reading at 24 hours showed a 
decline in ROS production compared to the 12 hour time point which can be associated 
with cell death. Confocal microscopy was employed to confirm ROS induction due to 
AgNP exposure at a concentration of 31.25µg/ml in figure 5.3. 
 
 
Figure 5.2 ROS generation in HepG-2 cells after different time points of AgNP 
exposure. Data expressed as percentage of control mean ± SD of six independent 
experiments.  
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Figure 5.3 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in 
cell culture media. Image taken on a Zeiss 510 LSM confocal microscope with an argon 
ion laser, excitation 488nm using a band pass filter 505-530nm to detect DCF. (a) LSM 
image demonstrating intracellular ROS, (b) overlay of LSM and bright field image. 
 
Figures 5.4 and 5.5 show the toxic response of AgNP to HepG-2 cells, but in the 
presence of UDCA. The same concentrationdependent response was noted as with the 
previous assays, following exposure to AgNP alone with this response increasing over 
time. The MTT assay (figure 5.4) showed a significant decline in cell viability after 96 
hours at a concentration of 7.81µg/ml. At a 15.6µg/ml concentration of AgNP a 
significant decrease in viability was observed following 48, 72 and 96 hour exposures. 
It was only at concentrations of 31.25µg/ml and above that a significant reduction in 
cell survival was noted at all exposure time points. Interestingly the presence of UDCA 
appeared to have had no effect on cellular response to AgNP exposure, with almost 
identical patterns of toxicity observed both with and without the addition of UDCA. 
This suggests that the presence of UDCA does not modify AgNP toxicity. 
(a) (b) 
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Figure 5.4 Cytotoxicity of AgNP in HepG-2 cells with added UDCA after 24, 48, 72 
and 96hr exposures as determined by the MTT assay. Data expressed as percentage of 
control mean ± SD of three independent experiments. * denotes a statistically 
significant (p<0.01) difference from the unexposed control 
 
In the presence of UDCA (figure 5.5) a similar pattern of ROS production was observed 
as with the AgNP exposure alone although it appeares more erratic with larger error 
bars. The same concentrationand time dependent response was observed with ROS 
induction detected following 15 minute exposure at concentrations as low as 3.91µg/ml. 
A similar trend was observed with ROS induction in the presence of AgNP alone and a 
maximum ROS production was observed at a concentration of 500µg/ml after 12 hour 
exposure. Following 24 hour exposure ROS production was shown to decline, again this 
can be attributed to cell death. ROS induction by a concentration of 31.25µg/ml AgNP 
was confirmed by confocal microscopy illustrated in figure 5.6. It is apparent from the 
data that UDCA does not alter oxidative stress induced by AgNP exposure and can be 
concluded that UDCA does not modify AgNP ability to induce intracellular ROS 
production. 
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Figure 5.5 ROS generation in HepG-2 cells after different time points of AgNP 
exposure in the presence of UDCA. Data expressed as percentage of control mean ± SD 
of six independent experiments.  
 
 
Figure 5.6 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in 
cell culture media in the presence of UDCA. Image taken on a Zeiss 510 LSM confocal 
microscope with an argon ion laser, excitation 488nm using a band pass filter 505-
530nm to detect DCF. (a) LSM image demonstrating intracellular ROS, (b) overlay of 
LSM and bright field image. 
 
 
(a) (b) 
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Figure 5.7 represents the exposure of HepG-2 cells to AgNP in the presence of CA. 
Again a concentrationand time dependent response to AgNP exposure was observed 
with this assay. A noted decline in cell viability can be seen after 24 hours of exposure 
at an AgNP concentration of 3.91µg/ml and then an apparent increase in viability 
compared to the unexposed control after longer exposure periods at the same 
concentration, indicative of possible cell recovery. At an AgNP concentration of 
3.91µg/ml after a 24 hour exposure a significant decline in cell viability was apparent. 
At exposure times of 48 and 72 hours a significant decline in viability was also 
observed when compared to the unexposed control. At 15.6µg/ml and above, significant 
reduction in cell survival could be seen at all exposure concentrations when compared 
to the unexposed negative control. As observed with UDCA, the addition of CA does 
not appear to modify the toxicity of AgNP and the response in the presence of CA is 
seemingly identical, with no significant difference or change between the two. 
 
 
Figure 5.7 Cytotoxicity of AgNP in HepG-2 cells with added CA after 24, 48, 72 and 
96hr exposures as determined by the MTT assay. Data expressed as percentage of 
control mean ± SD of three independent experiments. * denotes a statistically 
significant (p<0.01) difference from the unexposed control 
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Further studies were performed with the DCF-DA plate assay to determine the ability of 
AgNP with addition of CA to induce oxidative stress. Figure 5.8 demonstrates ROS 
production in a concentrationand time dependent manner. Generation of ROS was noted 
at the higher concentrations of 125, 250 and 500µg/ml. Induction of intracellular ROS 
was noted after 15 minutes of exposure compared to the unexposed control, with the 
highest generation detected after this time and at the highest AgNP concentration, 
500µg/ml. After 15 minutes of exposure ROS production begins to decline in a step-
wise pattern as exposure time progresses with no ROS detected after the 4 hour 
exposure point. In comparison to HepG-2 exposure to AgNP alone, the addition of CA 
alters the pattern of ROS production. In the presence of CA, ROS induction occurs 
almost immediately after exposure to AgNP and then declines rapidly compared to 
earlier time points with no ROS detected after 4 hours. Induction of ROS only occurs at 
the higher exposure concentrations 125, 250 and 500µg/ml. Exposure to AgNP alone 
results in a much lower percentage of ROS induction compared to the unexposed 
control that increases over time and only begins to decline after 12 hours of exposure. In 
the presence of CA induction of ROS occurs much quicker but declines at a similar rate 
whereas in the presence of AgNP only, ROS production is more sustained over time. 
Confirmation of ROS induction by AgNP at a concentration of 3.91µg/ml in the 
presence of 1mM CA was verified by confocal microscopy as illustrated in figure 5.9. 
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Figure 5.8 ROS generation in HepG-2 cells after different time points of AgNP 
exposure in the presence of CA. Data expressed as percentage of control mean ± SD of 
six independent experiments.  
 
 
Figure 5.9 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in 
cell culture media in the presence of CA. Image taken on a Zeiss 510 LSM confocal 
microscope with an argon ion laser, excitation 488nm using a band pass filter 505-
530nm to detect DCF. (a) LSM image demonstrating intracellular ROS, (b) overlay of 
LSM and bright field image. 
 
(a) (b) 
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Figure 5.10 illustrates the toxic response of HepG-2 cells to AgNP exposure in the 
presence of DCA. As can be seen in figure 5.10 a loss in mitochondrial integrity is 
demonstrated at the lowest AgNP concentration of 3.91µg/ml at all exposure time 
points. Significant loss was noted at a concentration 3.91µg/ml after 24 hour exposure. 
There was a significant reduction at this concentration after 72 and 96 hour incubations 
but not after 48 hour incubation again this may be due to cell recovery. As the AgNP 
are in low doses it is possible they have fallen out of solution at this time and any effect 
was induced within the first 6-12 hours following exposure. After this point any 
surviving cells may be starting to recover and replicate. The same pattern is observed at 
a concentration of 7.81µg/ml. A significant reduction was observed at all exposure time 
points from a concentration of 15.6µg/ml and above. 
 
 
Figure 5.10 Cytotoxicity of AgNP in HepG-2 cells with added DCA after 24, 48, 72 
and 96hr exposures as determined by the MTT assay. Data expressed as percentage of 
control mean ± SD of three independent experiments. * denotes a statistically 
significant (p<0.01) difference from the unexposed control 
 
The induction of ROS upon exposure to AgNP with the addition of DCA (figure 5.11) 
follows a similar pattern to that observed with the addition of CA. However it can be 
seen that ROS are induced at much lower concentrations of AgNP when compared to 
the CA and in the presence of AgNP alone. ROS were detected after 15 minutes at a 
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concentration of 31.25µg/ml and higher with maximum ROS production occurring at 
500µg/ml after a 15 minute exposure. After 15 minutes ROS levels began to decline 
with increasing exposure time. When compared to exposure of HepG-2 cell to AgNP 
alone, the observed ROS induction occurs at lower concentrations of AgNP and does 
not increase with time but begins to decline after 15 minutes. Indeed to the case of CA, 
where ROS induction occurs much earlier but is short lived. It appears that AgNP 
exposure in the presence of DCA results in the greatest ROS induction compared to the 
unexposed control and at lower doses when compared to the AgNP exposure with CA 
and AgNP exposure alone. Confirmation of ROS induction by AgNP at a concentration 
of 3.91µg/ml in the presence of 0.125mM DCA is confirmed by confocal microscopy as 
illustrated in figure 5.12. 
 
 
Figure 5.11 ROS generation in HepG-2 cells after different time points of AgNP 
exposure in the presence of DCA. Data expressed as percentage of control mean ± SD 
of six independent experiments.   
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Figure 5.12 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in 
cell culture media in the presence of DCA. Image taken on a Zeiss 510 LSM confocal 
microscope with an argon ion laser, excitation 488nm using a band pass filter 505-
530nm to detect DCF. (a) LSM image demonstrating intracellular ROS, (b) overlay of 
LSM and bright field image. 
 
The AB assay was also performed for the HepG-2 cell line in the presence and absence 
of UDCA, CA and DCA where a concentrationand time dependent response was also 
observed resulting from AgNP exposure. AB gives a more general picture of the loss in 
cell viability by targeting the cytosol of the cell and detecting a change in the cytosolic 
environment. A similar pattern of toxicity was observed with the addition of DCA 
having a substantial effect on cell viability occurring after 24 hours of exposure (see 
Appendix A5.2.1 (a)-(d)). 
Statistical analysis (p<0.05) comparing the differences in toxicity induced by AgNP 
alone and in the presence of the tested biofluid components highlighted statistically 
significant differences between the toxicological data. The presence of CA and DCA 
significantly altered the cytotoxic effect induced by AgNP on HepG-2 cells, at a 
concentration of 15.6µg/ml and above the response curves were found to be statistically 
(p<0.05) different. This change was noted at 48, 72 and 96 hour time points. UDCA was 
noted not to significantly alter the toxicity of AgNP in HepG-2 cells. 
 
(a) (b) 
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5.2.2 Cytotoxic evaluation of Hep2 cell line to AgNP exposure alone and in the 
presence of UDCA  
As a control, another cell line was tested to establish if biofluid components could 
modify the effects of AgNP exposure in areas other than their target organs. To 
investigate this, the Hep2 cell line was selected. The same exposure concentrations were 
employed and the effects of AgNP toxicity in the presence of biofluid components were 
investigated. UDCA was selected as the test bile acid. A concentrationfinding 
experiment was performed to determine the highest concentration of UDCA that the 
Hep2 cell line could withstand without causing toxicity. This concentration was found 
to be 2.2 x 10
-7
 M and this was the working concentration employed for the following 
experiments. 
Figure 5.13 displays the cytotoxic response of Hep2 cells to AgNP exposure determined 
by the MTT assay. This assay demonstrates a typical concentrationand time dependent 
pattern with significant reduction in cell survival noted at all concentrations following 
72 hour exposure. A significant reduction in viability after 72 and 96 hours was 
observed at doses of 7.81µg/ml and above and after 48 hours at a concentration of 
31.25µg/ml and above. Furthermore a significant decrease in cell survival compared to 
the unexposed control was observed for all exposure time points at a concentration of 
62.5µg/ml and upwards. 
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Figure 5.13 Cytotoxicity of AgNP to Hep2 cells after 24, 48, 72 and 96hr exposure as 
determined by the MTT assay. Data expressed as percentage of control mean ± SD of 
three independent experiments. * denotes a statistically significant (p<0.01) difference 
from the unexposed control 
 
Figure 5.14 illustrates the toxic response of AgNP to Hep2 cells in the presence of 
UDCA. The data demonstrate that in the presence of UDCA there is a dramatic 
reduction in cell viability compared to when cells are exposed to AgNP alone. No 
significant change in cell viability occured after 24 hour exposure but a significant 
reduction following 48, 72 and 96 hour exposures was noted at all tested concentrations 
of AgNP. The data presented illustrates that compared to AgNP exposure alone the 
presence of UDCA does modify toxicity.  
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Figure 5.14 Cytotoxicity of AgNP to Hep2 cells with added UDCA after 24, 48, 72 and 
96hr exposures as determined by the MTT assay. Data expressed as percentage of 
control mean ± SD of three independent experiments. * denotes a statistically 
significant (p<0.01) difference from the unexposed control 
 
A DCF-DA plate assay was also employed to investigate intracellular oxidative stress, 
to see if the presence of UDCA could influence the generation of ROS in response to 
AgNP exposure. Exposure to increasing concentrations of AgNP induced ROS 
production in a concentrationand time dependent manner (figure 5.15). ROS production 
was detected at exposure concentrations of 7.81µg/ml and above with maximum 
production noted at 500µg/ml. Induction of ROS was observed after 15 minutes of 
exposure with maximum production observed after 1 hour after which levels of 
detectable ROS began to decline. In the presence of UDCA (figure 5.16) a substantial 
reduction in ROS generation was observed when compared to exposure to AgNP alone 
and ROS were only detected at higher concentrations of AgNP, above 250µg/ml. A 
maximum level ROS production with added UDCA was observed at a concentration of 
500µg/ml after 1 hour and as illustrated by the data the percentage of ROS induction 
when compared to the negative control is substantially reduced compared to the amount 
generated in the absence of UDCA.  
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Figure 5.15 ROS generation in Hep2 cells after different time points of AgNP 
exposure. Data expressed as percentage of control mean ± SD of six independent 
experiments 
 
 
Figure 5.16 ROS generation in Hep2 cells after different time points of AgNP exposure 
in the presence of UDCA. Data expressed as percentage of control mean ± SD of six 
independent experiments 
 
The AB assay was performed for the Hep2 cell line in the presence and absence of 
UDCA where a concentrationand time dependant response was also observed resulting 
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from AgNP exposure. A similar pattern of toxicity was observed with the addition of 
UDCA having a substantial effect on cell viability occurring after 24 hours of exposure 
(see appendix A5.2.2 (a)-(b)). 
Statistical analysis (p<0.05) comparing the differences in toxicity induced by AgNP 
alone and in the presence of UDCA in Hep2 cells highlighted statistically significant 
differences between the toxicological data. A significant effect on toxicity was noted in 
the presence of UDCA from the lowest test concentration up to 250µg/ml after 48 and 
96 hour time points compared with exposure to AgNP alone. 
 
5.3 Discussion 
It is clear from the literature that exposure to nanoparticles is becoming more 
widespread mainly due to their continued incorporation into various consumer products. 
Upon exposure, nanoparticle contact with surfactants and biofluids is inevitable and it is 
important to take these events into account when examining toxicity. This study aimed 
to investigate this interaction to identify a possible modification of toxicity by 
individual components of one of the major biofluids within the body. 
As discussed in chapter 4, the physicochemical characteristics of AgNP play an 
important role in how they will interact with biological systems. The size, associated 
surface area, shape and chemical composition have been shown to be of great 
importance to nanoparticle toxicity (Renwick et al, 2004; Rai et al, 2009; Kam et al, 
2004). Together with the ion release associated with nanoparticle biofluid interaction, as 
previously discussed, a number of contributing factors relating to the physicochemical 
characteristics must be considered when interpreting overall nanoparticle toxicity 
(Warheit, 2007; Beer et al, 2012). 
The cytotoxicity studies undertaken illustrate that mitochondrial integrity (MTT) and 
the general health of the cell (AB) is affected by exposure to AgNP and that the chosen 
biofluid components have different modifying effects. Table 5.1 concisely illustrates 
IC50 values for both assays providing an overall synopsis of toxicity. From the data 
presented it can be suggested CA and DCA do have some modifying effects. While not 
altering the pattern of toxicity in the viability assays, the pattern of ROS induction is 
altered upon their addition. The addition of CA and DCA induces greater levels of ROS 
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induction with DCA producing the greatest response following a 15 minute exposure at 
the highest concentration of AgNP compared to the unexposed control. AgNP exposure 
alone produces much lower levels of ROS with maximum values only slight higher 
compared to the unexposed control. This increase in ROS production and at earlier 
points of exposure may suggest a more rapid or alternative pathway of cell death in the 
presence of CA and DCA. Previous studies have shown that lipid peroxidation by 
nanomaterials is a contributing factor to the generation of ROS and the overwhelming 
of natural antioxidant systems. ZnO is noted as enhancing lipid peroxidation 
contributing to increased ROS generation while AgNP exposure in rats can cause 
increased lipid peroxidation and quench naturally occurring antioxidants. It is postulated 
that the increased levels of ROS following AgNP-CA and AgNP-DCA exposure 
enhances lipid peroxidation within cells resulting in the greater levels of ROS noted 
compared to AgNP exposure alone (Premanathan et al, 2011; Adeyemi & Faniyan, 
2014). This upsurge in generation may be the result of a reactive product formed by the 
interaction of AgNP and biofluid components. Further investigation into the mechanism 
of cell death and the potential role of lipid peroxidation within cells must be 
investigated.  
 
Table 5.1 Calculated IC50 values (µg/ml) resulting from exposure to AgNP for the AB 
and MTT assays in the HepG-2 and Hep2 cell lines. * Denotes lethal concentrationless 
than the lowest exposure concentration. IC50 values were calculated from the average 
response of three independent experiments fitted to a sigmoidal curve and a four 
parameter logistic model used to calculate Inhibitory Concentration (IC50) with a 
(p<0.05) 
Cell Line AB assay IC50 (µg/ml) MTT assay IC50 (µg/ml) 
 24hr 48hr 72hr 96hr 24hr 48hr 72hr 96hr 
HepG-2 5.50 7.80 5.50 4.20 119.51 45.34 44.59 49.20 
HepG-2 + UDCA 6.30 9.10 5.30 5.70 135.06 66.52 31.81 10.97 
HepG-2 + CA 4.03 6.24 4.78 7.94 0.0004 0.0003 0.001 215.48 
HepG-2 + DCA 4.28 6.49 2.99 6.24 1389.30 746.29 0.002 0.003 
Hep2 45.06 31.58 8.80 91.90 388.39 157 2.19 43.41 
Hep2 + UDCA 439.16 4.25 0.27 0.94 0.0007 <3.91* <3.91* <3.91* 
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While no modification in toxicity by UDCA was noted in the HepG-2 cell line, 
modification was noted in Hep2 cells. A delay in toxicity in the first 24 hours after 
exposure together with a reduction in ROS production strongly suggests that UDCA can 
modify Hep2 toxic response to AgNP exposure. While it appears to increase AgNP 
toxicity, ROS induction is significantly reduced suggestive of an antioxidant effect. This 
may indicate an alternative mechanism of cell death. These data indicate that UDCA 
can modify AgNP toxicity in a cell type different from that of its normal target. 
While it is clear AgNP cause toxicity, it must be considered how much of this toxicity is 
attributed to the release of silver ions. A study by Beer et al (2012) addressed this 
phenomenon, identifying to what level the fraction of silver ions in various AgNP 
suspensions (commercially available and laboratory synthesized) influence toxicity 
(Beer et al, 2012). The study concluded that free silver ions in AgNP preparations do 
indeed play a considerable role in the overall toxicity of AgNP suspensions. However 
other studies are in agreement that at lower concentrations of metal ions, the uptake of 
nanoparticles leads to additional toxicity compared to higher concentrations where it 
appears the particles do not contribute to further toxicity (Navarro et al, 2008; Kim et 
al, 2009). Beer et al (2012) postulate that the mechanism of toxicity for AgNP is 
dissolution of particles in lysosomes, previously observed for copper oxide (CuONP) 
nanoparticles, possibly due to a protective barrier effect of the plasma membrane but 
this barrier can be evaded by a Trojan horse mechanism when nanoparticles are taken 
up by cells (Studer et al, 2010; Limbach et al, 2007). It must also be considered that 
sonication of AgNP suspensions and other preparation methods may have contributed to 
silver ion release and therefore toxicity. For example during sonication the energy 
released in order to break up large AgNP aggregates is converted to thermal energy 
which may promote dissolution of silver ions from particles (Liu & Hurt, 2010).  From 
this information it is clear that when investigating AgNP toxicity, the role of both silver 
ions and the particles themselves must be considered. 
In order to monitor the potential modification of the chosen biofluid components on 
AgNP toxicity in cells found outside of their normal target area, an epithelial laryngeal 
cell line was chosen. The biofluid components under study have been employed as 
pharmaceutical agents and medications. UDCA is widely used as a method of gallstone 
dissolution (Arisawa et al, 2009; Lapenna et al, 2002). This treatment has numerous 
trade names, including Actigall™ and BILIVER™, and is an oral treatment presented 
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as an alternative to surgery. CA and DCA also have medical applications. CA is used as 
treatment for children and adults with inborn errors in bile acid synthesis. Orphacol™ as 
it is known is taken orally and is vital in preventing the development of cholestatic liver 
disease (European Medicines Agency, 2013). DCA also has uses as a therapeutic drug 
used to treat localized fat deposits via subcutaneous injection. Studies have also 
reported the conjugation of heparin to deoxycholic acid in order to develop an oral 
delivery system for anticoagulant treatment preferable to the standard intravenous and 
subcutaneous injection (Lee et al, 2001; Kim & Vaishali, 2006). The fact that these bile 
acids are or may be utilized in a medicinal capacity highlights that they will be present 
in areas of the body other than the liver. As such the data presented here on a laryngeal 
cell line is a relevant line of investigation given that in most cases these bile acid 
derived treatments are given orally. As the data demonstrate, the effect on toxicity in 
cell lines of different origins must be seriously considered and a more complete 
cytotoxic profile of AgNP to include exposure site contributions be established. 
 
5.4 Chapter Summary 
This chapter has demonstrated the modifying effect of some of the common biofluid 
components on AgNP toxicity. The data presented demonstrate that biofluid 
components can significantly influence the toxic profile of AgNP. As such future 
studies must consider the effects various biofluids and their components have on the 
processing of nanoparticles upon entry to the body, their presentation to cells, 
distribution and the biological processes they induce. Finally researchers must not just 
consider the toxicity of the isolated nanoparticles but that of a combined effect 
including, the local environment and the ions they release which have been shown to 
contribute considerably to toxicity. 
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Chapter 6 
Adapted from “The surfactant dipalmitoylphophatidylcholine modifies acute 
responses in alveolar carcinoma cells in response to low concentrationsilver 
nanoparticle exposure” 
 
6.1 Introduction 
Nanoparticle exposure via inhalation is probably the most common entry point for 
nanoparticles and during recent decades the generation of engineered nanoparticles for 
applications in medicine, food, cosmetics and electronics to name a few has increased 
the likelihood of exposure exponentially (Sozar & Kokini, 2009; Bouwmeester et al, 
2009).  
Inhalation provides an easy entry route for engineered nanoparticles in nano-carrier 
systems for drug delivery allowing an easy route for targeted, controlled and non-
invasive delivery. Liposomes in particular have been the nano-carrier of choice in the 
development of improved and intelligent drug delivery systems (Varez-Lorenzo et al, 
2009; Shum et al, 2001). While inhalation provides an alternative method of 
pharmaceutical delivery, improving both the treatment and comfort of patients, it also 
provides easy entry for undesirable nanoparticles. A number of studies have been 
undertaken to explore lung entry of various nanoparticles and their subsequent 
distribution around the body. Cerium oxide (CeO2) nanoparticles have been shown to 
cause acute toxicity in the lungs following exposure. It was postulated that this could 
lead to chronic inflammation days after the exposure period with particles deposited in 
the lungs as they penetrate through the alveolar wall into the systemic circulation 
(Srinivas et al, 2010). Silver nanoparticle (AgNP) exposure in the lung has also been 
shown to induce cytotoxicity along with zinc oxide (ZnO) and titanium dioxide (TiO2). 
Although all nanometals induced toxicity they did so at differing levels with ZnO 
inducing greater levels of toxicity in alveolar macrophages compared with the other two 
nanometals. The induced toxicity may also lead to excessive secretion of certain 
biological agents causing dysfunction in the cytokine network, reducing the efficiency 
of the respiratory immune system (Liu et al, 2013). 
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Due mainly to their antibacterial qualities AgNP are currently one of the most utilized 
nanomaterials on the market providing a diverse range of applications including medical 
devices, antibacterial textiles and toys and food packaging (Sozar & Kokini, 2009; 
Bouwmeester et al, 2009). While AgNP have been highly regarded for their benefits, 
their increased incorporation into everyday consumer products has generated 
considerable interest in establishing the risk exposure has on human health and the 
environment. A more in depth toxicological assessment of nanoparticle-biological 
interaction is required and a focus must now be shifted onto the influence of biofluids 
and surfactants on toxicological outcome (Mwilu et al, 2013; Ehrenberg et al, 2009; 
Wang et al, 2013; Misra et al, 2012; Aggarwal et al, 2009). In light of this and the easy 
entry of nanoparticles both beneficial and otherwise, this study investigates the 
interaction and toxicological influence of a component of lung surfactant on AgNP 
toxicity on the lung. 
Pulmonary surfactant is composed of a variety of complex phospholipids, lipids and 
surfactant specific proteins. Dipalmitoylphosphatidylcholine (DPPC) is the most 
abundant phospholipid, comprising 70-80% of total surfactant. The overall function is 
to reduce surface tension at the liquid-air interface at the bronchoalveolar surface with a 
dysfunction in surfactant associated with certain respiratory disorders (Kumar & 
Bohidar, 2010; Serrano & Perez-Gil, 2006; Bakshi et al, 2008). In recent studies DPPC 
has been used to improve the properties of liposomes to produce more successful in vivo 
methods of delivery. For example its inclusion in liposome encapsulation of cancer 
drugs can improve delivery of the complete drug concentration to tumour cells 
improving killing of cancer cells (Yavlovich et al, 2011). 
The aim of this investigation is to assess the toxic response of a carcinogenic lung cell 
line, A549, to in vitro exposure to AgNP.  The ability of DPPC to affect or modify any 
observed toxicity was also established. The physicochemical characteristics of 
nanoparticles play a vital role in toxicological investigation and were previously 
discussed in chapter 4 together with the effect of DPPC on their characteristics.  A 
cytotoxic profile was carried out using a number of viability assays including 3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), alamar blue and a 2’, 
7’-dichlorofluorescin diacetate (DCFH-DA) plate assay to detect intracellular oxidative 
stress induced by exposure. The influence of DPPC on the outcome of toxicity was also 
assessed using the same assays. A subsequent study was performed to monitor the effect 
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on the release of inflammatory markers interleukin-8 (IL-8) and tumour necrosis factor 
alpha (TNF-α) upon exposure to AgNP in the presence of DPPC. 
 
6.2 Cytotoxicity Testing 
The cytotoxicity of AgNP on A549 cells was assessed using the viability assays MTT, 
Alamar blue (AB) and a DCF-DA plate assay to detect intracellular oxidative stress. 
The influence of DPPC on the observed toxicity was investigated using the same array 
of toxicological assays. A positive control of 10% DMSO was employed for all viability 
assays and 5µM H2O2 was employed for ROS studies. The ability of AgNP to induce an 
inflammatory response and the impact of DPPC on this response was also investigated 
using ELISA based assays for the detection of IL-8 and TNF-α release. Cytotoxicity 
data for AgNP exposure is presented in table 6.1. The results of the MTT assay are 
presented for toxicity testing in the presence and absence of DPPC. Both MTT and AB 
assays were performed. Results for AB assay are presented in Appendix A6.2. 
 
6.2.1 Cytotoxic evaluation A549 cell line to AgNP exposure alone and in the 
presence of DPPC 
Figure 6.1 represents the cytotoxic response of A549 cells to AgNP exposure as 
determined by the MTT assay. Reduction in cell viability due to exposure occurred in a 
concentrationand time dependent manner. A significant reduction in mitochondrial 
integrity was observed after 48 hours at all AgNP concentrations. Significant reduction 
after 72 and 96 hour exposures was noted at concentrations of 15.6μg/ml and above 
compared to the unexposed control, while a significant reduction in cell survival at all 
exposure times occurred at 31.25μg/ml and above.  
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Figure 6.1 Cytotoxicity of AgNP in A549 cells after 24, 48, 72 and 96hr exposure as 
determined by the MTT assay. Data expressed as percentage of control mean ± SD of 
three individual experiments. * denotes a statistically significant (p< 0.05) difference 
from the unexposed control 
 
A DCF-DA plate assay was employed to detect any ROS production in response to 
AgNP exposure over a 6 hour period with readings taken every hour. This study 
indicated no intracellular ROS production in response to AgNP exposure. The 
generation of intracellular hydro peroxides was noted at the highest concentration, 
500μg/ml, with production increasing in a time dependant manner. Induction of ROS 
was first detected at this concentration after 15 minutes, with the highest induction 
observed after 1 hour. Results are presented in Appendix A 6.2. 
The ability of DPPC to influence toxicity was investigated using the same array of cyto-
toxicological tests. 
Figure 6.2 displays the toxic response of A549 cells to AgNP in the presence of 
0.25μg/ml DPPC. A concentrationdependant response to AgNP exposure was observed. 
A change in toxicity was not noted, however the pattern appeared altered in the 
presence of DPPC. A short delay in toxicity between 48 and 72 hours was observed 
after which a significant reduction in cell viability occurred. Significant reduction in cell 
survival to all exposure concentrations was noted after 72 hours. After 24 hours, 
significant loss in cell viability was observed at a concentration of 15.6μg/ml with a 
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significant decline at 7.8μg/ml and above following 96 hour exposure. Significant cell 
death compared to the unexposed control at all exposure intervals was observed at 
62.5μg/ml and above. The addition of DPPC may alter the pattern of toxicity by causing 
a delay in the first 48 hours, after which a significant reduction in viability is observed 
at 72 hours.  
 
 
Figure 6.2 Cytotoxicity of AgNP in A549 cells with added DPPC after 24, 48, 72 and 
96 hour exposures as determined by the MTT assay. Data expressed as percentage of 
control mean ± SD of three independent experiments. * denotes a statistically 
significant (p < 0.05) difference from the unexposed control 
 
The delay and increase in viability at lower nanoparticle concentrations at 48 hours may 
result from surviving cells beginning to replicate. DPPC is a surfactant and as such will 
associate with the nanoparticles surface. This association may result in a “Trojan horse” 
effect or delayed toxicity as observed at lower concentrations in the first 48 hours. After 
this time it is possible the DPPC coating has been removed following nanoparticle entry 
to the cell and trafficking to various cellular compartments allowing the naked 
nanoparticle to exert its toxic effects (Wang et al, 2013). 
In addition to cytotoxic evaluation, the clonogenic assay was performed to analyse the 
effect of longer exposures to AgNP. This assay was performed over a 10 day exposure 
period and monitored the ability of cells to form colonies in the presence of AgNP. The 
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ability of cells to proliferate following AgNP exposure with the addition of DPPC was 
significantly reduced compared to the unexposed control. This was observed at all 
exposure concentrations. It was found that the ability of A549 cells to proliferate was 
inhibited at the lowest concentration of 3.91μg/ml and above with no colony formation 
and therefore no cell survival at concentrations of 62.5μg/ml and above, as shown in 
figure 6.3. Interestingly, it appeared that the addition of DPPC increased the toxicity of 
AgNP towards cells with significant reductions in colony formation compared with 
exposure to AgNP alone. 
 
 
Figure 6.3 Cytotoxicity of AgNP alone and with added DPPC after 10 day exposure as 
determined by the clonogenic assay. Data are expressed as percentage of control mean ± 
SD of four independent experiments. * denotes a statistically significant (p<0.05) 
difference from the unexposed control 
 
A DCF-DA plate assay was employed to investigate the effect of DPPC on ROS 
generation in A549 cells following AgNP exposure. From the data it appeared that in 
the presence of DPPC there was increased generation of intracellular ROS from a 
concentrationof 31.25µg/ml and above. Figure 6.4 illustrates ROS production in a 
concentrationand time dependant manner. Induction was detected at concentrations as 
low as 31.25μg/ml after 15 minutes exposure, with maximum production noted at 
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500μg/ml after 30 minutes. ROS production was detected up to 6 hours after initial 
exposure at a concentration of 500μg/ml and up to 4 hours after initial exposure at 
250μg/ml.  Significant increases were noted at doses of 62.5µg/ml after 30 minutes, 
125µg/ml after 15 and 30 minute exposures and at higher doses significant generation 
was observed from 15 to 30 minutes and 2 to 3 hours at 250µg/ml and at 15 minutes to 
5 hours at 500µg/ml.  From the data it is clear that the presence of DPPC modifies 
oxidative stress in A549 cells by increasing intracellular ROS formation following 
AgNP exposure. 
 
 
Figure 6.4 ROS generation in A549 cells after different time points of AgNP exposure 
in the presence of DPPC. Data expressed as percentage of control mean ± SD of six 
independent experiments. * denotes a statistically significant (p<0.05) difference from 
the unexposed control 
 
6.3 Inflammatory Studies 
The ability of AgNP to induce IL-8 and TNF-α production and the effect of the addition 
of DPPC was investigated using ELISA based assays. 
Figure 6.5 demonstrates IL-8 release following exposure to AgNP. At the highest 
concentration, 50µg/ml, production of IL-8 was observed after 2 hours. Levels were 
shown to decline after 3 hours with a second peak in levels demonstrated after 4 hours. 
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The lower concentrationof AgNP caused IL-8 release initially after exposure with 
increasing generation up to 2 hours after exposure. A similar reduction in levels was 
detected at 3 hours after which an increase in IL-8 was detected at 4 and 6 hours. A 
significant increase in IL-8 compared to the unexposed control was noted at 2, 3, 4 and 
6 hours at a concentration of 50µ/ml and at all intervals at 25µg/ml.  The data suggest 
that at sub-lethal levels of AgNP, 25µg/ml, a more immediate and long lived 
inflammatory response is initiated compared to higher toxic doses. 
 
 
 
Figure 6.5 Induction of IL-8 in A549 cells at 1-4 and 6 hours following exposure to 
AgNP. Data expressed as percentage of control mean ±SD of three individual 
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed 
control 
Figure 6.6 represents IL-8 release in A549 cells following AgNP exposure with the 
addition of DPPC. The data show that the presence of DPPC alters the pattern of IL-8 
release in cells. The levels of IL-8 detected were substantially higher than exposure to 
AgNP alone and production occurs at a faster rate with greater levels detected after 1 
hour exposure. Similar to figure 6.5 a second spike in release was detected at 6 hours. 
The presence of DPPC generated an immediate and prolonged inflammatory response 
compared to exposure to AgNP alone as illustrated by IL-8 levels detected at 1 and 6 
hours. Significant release was noted at 1, 2, 3 and 6 hours for all doses compared to the 
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unexposed control. While DPPC leads to an enhanced production of IL-8, the pattern 
appears not to be dependent on concentration suggesting that regardless of AgNP 
concentrationthe same biological response is initiated.  
 
 
Figure 6.6 Induction of IL-8 in A549 cells at 1-4 and 6 hours following exposure to 
AgNP in the presence of DPPC. Data expressed as percentage of control mean ±SD of 
three individual experiments. * denotes a statistically significant (p<0.05) difference 
from the unexposed control 
Figure 6.7 illustrates TNF-α release following AgNP exposure. Generation of TNF-α at 
a concentrationof 25µg/ml was immediate and short lived with peak levels detected 
after 1 hour and a rapid reduction observed at 2 hours and above. A similar pattern was 
detected at the highest concentrationwith high levels released after 1 hour followed by a 
swift decline. However as demonstrated with IL-8, a second spike in TNF-α levels 
occurs at 6 hours. Significant TNF-α release was detected after 1 hour following 
25µg/ml exposure and after 1, 2, 3 and 6 hours after 50µg/ml exposure. 
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Figure 6.7 Induction of TNF-α in A549 cells at 1-4 and 6 hours following exposure to 
AgNP. Data expressed as percentage of control mean ±SD of three individual 
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed 
control 
In the presence of DPPC (figure 6.8) substantially lower levels of TNF-α were released 
compared to AgNP alone. TNF-α was generated after 1 hour exposure with a decline in 
levels detected after at 2 hours. Unlike exposure to AgNP alone, the second increase in 
levels was detected at 3 hours and gradually increased with time. Significant increases 
in TNF-α release were noted at 1, 3, 4 and 6 hours at a concentrationof 50µg/ml and at 
1, 4 and 6 hours at 25µg/ml. It appears the presence of DPPC produces a prolonged 
inflammatory response similar to that observed with IL-8 release. The addition of DPPC 
also modifies the pattern of TNF-α release, which similar to IL-8, is not dependent on 
AgNP concentration. 
123 
 
 
Figure 6.8 Induction of TNF-α in A549 cells at 1-4 and 6 hours following exposure to 
AgNP in the presence of DPPC. Data expressed as percentage of control mean ±SD of 
three individual experiments. * denotes a statistically significant (p<0.05) difference 
from the unexposed control 
 
6.4 Discussion 
It is apparent from the literature that exposure to nanoparticles is becoming more 
widespread mainly through their continued incorporation into consumer products. As a 
result there is an increasing incidence of direct contact between nanoparticles and 
biological systems. This growing concern of nanoparticle exposure highlights the need 
for a complete and thorough toxicological investigation to determine what effects are 
induced and what factors within biological systems play a role in the resulting effects. 
The physicochemical characteristics of AgNP play an important role in how they will 
interact with biological systems. In this instance a thorough characterisation of 
nanoparticles was undertaken and previously discussed in chapter 4, with no interaction 
between components evident. Despite the lack of interaction, the effect individual 
components play on resulting toxicity must always be considered as physicochemical 
characterisation can never truly represent interactions occurring in vitro or in vivo. 
Table 6.1 displays cytotoxic data for both viability assays. The AB assay demonstrates 
an increase in IC50 values at 72 and 96 hours. This assay has multiple sites of conversion 
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within the cell and thus gives an indication into both viability and general cell function. 
As such the increase in cell viability observed may be attributed to cell recovery. The 
A549 cell line has a doubling time of 22 hours and it is possible that after the first 48 
hours of exposure where toxicity is observed any surviving cells begin to replicate again 
slowly resulting in an increase in IC50 values. This was also observed at 96 hours with 
the addition of DPPC. In the MTT assay which is indicative of mitochondrial integrity 
only, a time dependant reduction in values was observed. Exposure to AgNP was also 
noted to induce an inflammatory response with release of IL-8 and TNF-α. The 
presence of DPPC significantly altered the levels of release induced by exposure on 
A549 cells. The difference in levels released when DPPC was present compared to 
AgNP exposure alone was found to be statistically (p<0.05) significant at all exposure 
concentrations and time points.  
 
Table 6.1 Calculated IC50 values (µg/ml) resulting from exposure to AgNP for the AB 
and MTT assays in the A549 cell line. ** Denotes where a 50% effect was not 
observed. IC50 values were calculated from the average response of three independent 
experiments fitted to a sigmoidal curve and a four parameter logistic model used to 
calculate Inhibitory Concentration (IC50) with a (p<0.05) 
Cell Line AB Assay IC50 (µg/ml) MTT Assay IC50 (µg/ml) 
 24hr 48hr 72hr 96hr 24hr 48hr 72hr 96hr 
A549 116.23 11.68 39.86 118.40 340 115 116 91 
A549 + DPPC 46.06 45.30 41.78 96.84 ** ** 49 80 
 
 
The mechanism of cell death caused by AgNP can be related to oxidative stress. 
Mitochondrial cell death by ROS generation has been described in a number of studies 
as the primary mechanism of nanoparticle related cell death with its generation forming 
a critical step in initiation of apoptotic pathways (Martindale & Holbrook, 2002; Sastre 
et al, 2000; Piao et al, 2011). ROS are generated under normal physiological conditions 
and are continually eliminated by naturally occurring antioxidants. Under certain 
“stressful” conditions cells are unable to maintain homeostasis as increased quantities of 
(b) 
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ROS are produced which overwhelm the antioxidant systems (Arora et al, 2008; Piao et 
al, 2011). Previous studies have shown that AgNP not only induce ROS but can also 
inhibit antioxidants such as glutathione (Arora et al, 2008; Hussain et al, 2005; 
Chairuangkitti et al, 2013; Piao et al, 2011). This process may be in part due to lipid 
peroxidation caused by nanoparticle exposure. AgNP and ZnO have been identified as a 
cause of lipid peroxidation enhancing ROS production while also quenching naturally 
occurring antioxidants (Premanathan et al, 2011; Adeyemi & Faniyan, 2014). This 
response induces downstream dysfunction such as inflammation and DNA damage 
within the cell, culminating in cell death (Nel et al, 2006). While mitochondrial 
involvement appears to be the mechanism of cell death, other pathways have been 
hypothesised. Death via a ROS-independent pathway has also been observed in A549 
cells following exposure to AgNP. This results in cell cycle arrest rather than cell death 
by interfering with a regulatory protein critical in progression of the cell cycle 
(Chairuangkitti et al, 2013). This may partially explain the lack of ROS induction 
observed following AgNP exposure but with a reduction in viability still evident. Cells 
may be arrested at various stages of the cell cycle without the involvement of ROS 
following AgNP exposure as demonstrated in the data.  
The induction of oxidative stress is a critical step in the biological response to 
nanoparticle exposure and causes a number of cellular implications including an 
enhanced inflammatory response. Excessive ROS production leads to activation of a 
number of pro-inflammatory cytokines including IL-8 and TNF-α within the lung, 
which have been implicated in certain respiratory disorders (Henricks & Nijkamp, 
2001; Zuo et al, 2013). IL-8 is involved in the activation and migration of cells such as 
neutrophils, during acute inflammation. It can also up-regulate adhesion molecules 
involved in adherence and migration of cells through the endothelium (Feghali & 
Wright, 1997; Lim et al, 2012). The lung epithelium in particular is an important source 
of IL-8 and as such is a key player in the mediation of lung inflammation (Donaldson et 
al, 1998). IL-8 has been the focus of a number of studies related to nanoparticle 
toxicity, with its release implicated in the recruitment of inflammatory cells to the lung 
(Singh et al, 2007). Specifically, following AgNP exposure, significant release of IL-8 
from macrophages has been demonstrated, with both particle size and the generation of 
ROS playing a crucial role in its release (Lim et al, 2012; Park et al, 2011). 
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TNF-α is a potent cytokine involved in the initiation and maintenance of inflammation 
(Nathan, 2002). TNF-α can mediate a number of responses directly such as fever and, 
tissue damage, as well as causing indirect effects by downstream signalling leading to 
the activation of other inflammatory factors including IL-6 (Feghali & Wright, 1997; 
Warren, 1990).  This cytokine has been implicated in the development of pulmonary 
fibrosis following silica micro-particle exposure causing increased endothelial 
permeability to macromolecules as well as its up-regulation following exposure to 
various nanoparticles (Napierska et al, 2012; Henning et al, 1987; Pryhuber et al, 2003; 
Piguet et al, 1990). The detection of increased levels of both IL-8 and TNF-α following 
exposure implicates AgNP in the inflammatory process with an augmented response 
observed following the addition of DPPC. The increased levels of IL-8 in particular 
correlates to the ROS generation observed following its addition. In the case of IL-8, an 
immediate release is observed in the presence of DPPC and its early release has been 
proposed as a potential bio-marker for acute inflammation in relation to AgNP exposure 
which the data presented here supports (Lim et al, 2012; Park et al, 2011).  
The ability of the DPPC to increase and prolong the activation of both cytokines 
compared to AgNP alone suggests progression from acute to chronic inflammation. It 
has been proposed that high levels coupled with sustained release of these cytokines 
may prevent resolution resulting in the development of chronic inflammation. It was 
observed that in certain cases it was not the highest AgNP concentration that generated 
the greatest cytokine release. This is not surprising as high concentrations can cause 
cells to enter a death process whereas lower concentrations can induce an inflammatory 
reaction. Lim et al demonstrated cytokine gene expression at sub lethal concentrations 
of AgNP, in particular IL-8 release at 2.5µg/ml (Lim et al, 2012). 
DPPC is a major component of lung surfactant produced by type II alveolar cells, 
similar to A549 cells, and as such has been used as a surfactant model in numerous 
toxicity studies (Kumar & Bohidar, 2010; Dobbs et al, 1987; Foucaud et al, 2007; 
Porter et al, 2008; Sager et al, 2007). Employed as a particle coating, DPPC has been 
shown to exert a protective effect preventing degradation and allowing controlled 
release of encapsulated drug compounds; however there is increasing evidence of its 
contribution to toxicity and induction of oxidative stress (Kaviratna & Banerjee, 2009; 
Herzog et al, 2009; Foucaud et al, 2007; Hamilton Jr et al, 2008). The data highlight the 
importance of ROS in cell toxicity particularly in the presence of DPPC. DPPC appears 
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to increase oxidative stress within the cell in agreement with other studies where it was 
also found that its addition significantly increased ROS production in A549 cells 
(Herzog et al, 2009; Foucaud et al, 2007). An investigation into different variations of 
silica nanoparticles including iron- and titania- containing particles, noted increased 
levels of intracellular ROS generation. This was believed to occur through nanoparticle 
entry by a Trojan-horse type mechanism dependant on surface chemistry of particles 
(Limbach et al, 2007). A similar theory can be applied to this study and the increased 
oxidative stress observed following the addition of DPPC. It is possible that interaction 
with DPPC causes particles to have a higher level of dispersion, increasing the surface 
area available for interaction and therefore increasing the likelihood of cellular uptake - 
resulting in generation of ROS.  It must also be considered that the surface chemistry 
and activity of particles is altered by DPPC, changing its toxicity, making the particles 
more reactive and thus more toxic (Herzog et al, 2009; Hamilton Jr et al, 2008; Buford 
et al, 2007). 
The observation that cell death can occur via a number of pathways in A549 cells 
indicates a two tiered mechanism of cell death, cell cycle arrest and ROS mediated 
mitochondrial dependant cell death (Piao et al, 2011). The data in this study suggest that 
while not changing nanoparticle toxicity DPPC may influence death pathways as 
demonstrated by the induction of oxidative stress. The observation that DPPC leads to 
ROS generation in A549 cells suggests a possible switching from a ROS independent 
pathway as described by Chairuangkitti et al, 2013 causing cell cycle arrest to a ROS 
dependent pathway culminating in apoptotic cell death (Chairuangkitti et al, 2013). 
Further mechanistic studies are required to conclusively determine if pathway switching 
due to DPPC interaction is occurring.  
 
6.5 Chapter Summary 
This chapter has demonstrated the role of DPPC in modifying toxicity, namely inducing 
intracellular ROS production. Its interaction with AgNP highlights the importance of 
particle-surfactant interactions and the altered effects produced when in contact with 
mammalian cells. The data presented are in agreement with previous studies illustrating 
the impact on toxicity caused by nanoparticle contact with DPPC and the resulting 
alteration in ROS generation and inflammatory response. These findings may contribute 
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to developing a realistic risk assessment of nanoparticle exposure and the potential 
biological outcomes following entry and interaction with various fluids and surfactants 
present in the body. 
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Chapter 7 
Silver nanoparticle induce pro-inflammatory gene expression and inflammasome 
activation in human monocytes 
 
7.1 Introduction 
Silver nanoparticles (AgNP) are one of the most commonly utilized nanoparticles due to 
their antimicrobial properties (Duncan, 2011). As a result, the likelihood of exposure is 
becoming more frequent thus posing potential health risks that must be addressed. 
Cytotoxicity induced by AgNP exposure has been demonstrated in a number of studies 
with a variety of factors influencing observed cyto- and geno-toxic effects (Choi et al, 
2010; Kim et al, 2009; Lankoff et al, 2012). Upon exposure AgNP have been shown to 
induce immune reactions at sub-lethal concentrations, including IL-8 induction and are 
involved in the generation of reactive oxygen species (ROS) (Lim et al, 2012). 
Following inhalation, nanoparticles have been shown to infiltrate the alveolar cell wall 
causing toxicity in alveolar macrophages which leads to dysfunction in the cytokine 
network by potentially penetrating the alveolar wall and infiltrating the bloodstream. 
This results in the translocation and distribution of nanoparticles to various organs and 
potential detection by circulating blood monocytes (Liu et al, 2013; Johnson et al, 2010; 
Kim & Choi, 2012).  
An intact and functioning immune system is vital in the protection against harmful 
external stimuli. The controlled and rapid initiation and effective resolution of 
inflammation is vital to maintain normal homeostasis. Dysregulation of the immune 
response has been implicated in many human disease processes including 
autoimmunity, allergy and cancer (Lin & Karin, 2007; Scheller et al, 2011). The innate 
immune response is the first line of active defence and comprises a number of 
phagocytic cells with monocytes particularly, the primary cell type which are involved 
in the initial immune response by recognising distinct pathogen associated molecular 
patterns (PAMPs) such as lipopolysaccharide (LPS) via toll-like receptors (TLRs) on 
the cell surface (Matzinger, 1994; Beutler, 2009; Oberbarnscheidt et al, 2011). The 
subsequent release of cytokines from immune cells co-ordinate the immune response 
and are vital in determining the type of response required and can synchronize the 
various immunological elements required.   
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The production of cytokines must be tightly regulated in order to prevent an 
overstimulation of the immune response which may lead to the initiation of a 
pathological process. IL-1β is one cytokine that is tightly regulated at the transcriptional 
and post-translational level by inflammasomes. Due to its vast influence both on innate 
immunity and the systemic response its production requires a two-step signalling 
process; an initial priming step resulting in gene expression followed by inflammasome 
activation which results in the cleavage of the inactive form essential for IL-1β 
maturation and subsequent secretion (Dinarello, 2009; Schroder & Tschopp, 2010; 
Gross et al, 2011; Latz et al, 2013). Nanoparticles including titanium dioxide (TiO2), 
silica and also AgNP have been shown to cause inflammasome activation resulting in 
IL-1β release (Winter et al, 2011; Yang et al, 2012). 
As the initial release of cytokines following exposure to an external threat is pivotal in 
mounting an effective immune response, the aims of this study were to investigate the 
ability of AgNP to induce such a response in a monocyte cell line and to compare the 
response to that which occurs from LPS stimulation alone. Following this investigation 
the immunological response of AgNP on primary human monocytes was investigated to 
determine if a similar response was induced following exposure. The AgNP induced 
transcription of pro-inflammatory cytokines- IL-1, IL-6 and TNF-α as well as well as 
release of IL-1β as an indirect marker of inflammasome activation was investigated. 
This study aims to provide an insight into the activation of innate immune responses 
following AgNP exposure in human whole blood monocytes and provide an indication 
of the role of the inflammasome in this response by secretion of mature IL-1β, which 
drives inflammation. 
 
7.2 Results 
7.2.1 Cytotoxicity Testing 
The AB assay was performed to determine the active and cytotoxic concentrations of 
THP-1 cells to AgNP exposure so that IC50 concentration values could be used to elicit 
a gene response for the follow up studies.  A concentrationdependent reduction in cell 
viability was observed (figure 7.1) following AgNP exposure for 24 hours. IC50 
concentration was calculated as described previously. From this data it was determined 
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that the most active and cytotoxic concentrations of AgNP for the remaining gene THP-
1 monocyte studies were 50 and 100µg/ml (IC50). 
 
 
Figure 7.1 Cytotoxicity of AgNP in THP-1 cells after 24hr exposure as determined by 
the AB assay. Data expressed as percentage of control mean ± SD of three independent 
experiments. * denotes a statistically significant (p<0.01) difference from the unexposed 
control 
 
7.2.2 THP-1 pro-inflammatory cytokine gene expression in response to AgNP 
exposure 
The induction of pro-inflammatory gene expression by THP-1 monocyte cell line as a 
result of AgNP exposure was investigated. The response to AgNP at concentrations of 
100 and 50µg/ml, based on IC50 values, were tested. To determine immune response 
following exposure, transcript levels of pro-inflammatory cytokines IL-1, IL-6 and 
TNF-α in THP-1 monocytes were quantified by RT-PCR. Actin was used as the internal 
control. Results revealed a significant increase in transcript levels of all cytokines. In an 
experiment to establish possible endotoxin contamination of AgNP, THP-1 cells were 
incubated with polymyxin B (20µg/ml) for 1 hour prior to AgNP exposure. Endotoxin 
was not detected in AgNP used in this study (Appendix A7.2). 
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Induction of IL-1 transcript levels demonstrate a significant increase at both 
concentrations after 1, 6 and 8 hour exposures at 50µg/ml and after 6 and 8 hour 
exposures at 100µg/ml (figure 7.2) compared to the unexposed control. At all exposure 
concentrations a time dependent increase was noted peaking at 8 hours. At both 
concentrations, levels of IL-1 begin to decrease after 24 hour exposure. Levels of IL-1 
at this time point were not significant compared to the unexposed control. 
A statistically significant up-regulation in IL-6 induction (figure 7.3) was noted 
following all exposure time points at all exposure doses compared to the unexposed 
control. The increase in transcript levels occurs in a time dependent manner at AgNP 
concentration of 100µg/ml. IL-6 induction peaks 1 hour after exposure at a 50µg/ml 
concentrationwith a step-wise reduction observed with time. At 24 hours a significant 
increase in transcript levels compared to the unexposed control was noted at this 
concentration.  
Induction of TNF-α (figure 7.4) was detected after 1, 8 and 24 hours at 50µg/ml with a 
significant increase in induction compared to the unexposed control. At the highest 
exposure concentration, 100µg/ml, up-regulation of TNF-α was detected after 1 and 6 
hour exposures with a significant increase in transcript levels observed after 24 hours 
compared to the unexposed control.  
The increase in transcript levels for TNF-α and IL-6 after 24 hours suggests prolonged 
induction and longer time points need to be investigated to determine if levels continue 
to rise. 
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Figure 7.2 Fold increase in IL-1 induction in THP-1 cells exposed to 50µg/ml and 
100µg/ml AgNP and compared to the unexposed control ± SD of three independent 
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed 
control. Actin was used as the internal control 
 
 
Figure 7.3 Fold increase in IL-6 induction in THP-1 cells exposed to 50µg/ml and 
100µg/ml AgNP and compared to the unexposed control ± SD of three independent 
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed 
control. Actin was used as the internal control 
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Figure 7.4 Fold increase in TNF-α induction in THP-1 cells exposed to 50µg/ml and 
100µg/ml AgNP and compared to the unexposed control ± SD of three independent 
experiments. * denotes a statistically significant (p<0.05) difference from the unexposed 
control. Actin was used as the internal control 
 
7.2.3 Synergistic effect of LPS and AgNP on pro-inflammatory gene expression 
AgNP were investigated for any potential synergism with LPS with respect to pro-
inflammatory gene expression. Following exposure to a combination of LPS and AgNP, 
THP-1 cells demonstrated enhanced levels of gene expression compared to both the 
unexposed control and exposure to LPS or AgNP alone. Significant increases in IL-1 
gene expression were observed at 6, 8 and 24 hours following LPS and combined 
50µg/ml AgNP and LPS exposures (Figure 7.5). For exposure to combined 100µg/ml 
AgNP and LPS, significant increases compared to the unexposed control were noted at 
6 and 8 hours. IL-6 induction (Figure 7.6) demonstrated significant increases in all 
exposure scenarios at 6, 8 and 24 hours compared to the unexposed control with 
significant increases in expression of TNF-α (Figure 7.7) observed at all time points and 
in all exposures compared to the unexposed control. For all of the cytokines, greater 
levels of induction were noted in the combined AgNP-LPS exposures compared to LPS 
exposure alone. 
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In addition to significant differences compared to the unexposed control student-
newman-keuls multiple comparison tests were performed to determine if the difference 
in levels of expression between LPS exposed, AgNP exposed and AgNP-LPS exposed 
samples was significant. For IL-1 expression significant differences were noted for 6 
(p<0.001), 8 (p<0.05) and 24 hours (p<0.01) between all exposure scenarios with the 
exception of 100µg/ml AgNP compared to 100µg/ml AgNP-LPS and compared to 
50µg/ml AgNP-LPS which showed no significant difference in IL-1 induction after 24 
hour exposure. Following 1 hour exposure no significant differences in IL-1 gene 
expression were observed. IL-6 expression demonstrated statistically significant 
differences between all exposure scenarios with p values of p<0.001 at all exposure 
time points. Levels of TNF-α up-regulation demonstrated a significant difference 
between all exposure scenarios at all time points, with p values of p<0.01 after 1 hour 
and p<0.001after 6, 8 and 24 hours.  
 
 
Figure 7.5 Fold increase in IL-1 induction in THP-1 cells following exposure to 1µg/ml 
LPS and a combination of AgNP and LPS compared to the unexposed control ± SD of 
three independent experiments. * denotes a statistically significant (p<0.05) difference 
from the unexposed control. Actin was used as the internal control 
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Figure 7.6 Fold increase in IL-6 induction in THP-1 cells following exposure to 1µg/ml 
LPS and a combination of AgNP and LPS compared to the unexposed control ± SD of 
three independent experiments. * denotes a statistically significant (p<0.05) difference 
from the unexposed control. Actin was used as the internal control 
 
 
Figure 7.7 Fold increase in TNF-α induction in THP-1 cells following exposure to 
1µg/ml LPS and a combination of AgNP and LPS compared to the unexposed control ± 
SD of three independent experiments. * denotes a statistically significant (p<0.05) 
difference from the unexposed control. Actin was used as the internal control 
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7.2.4 Primary monocyte cytokine gene expression in response to AgNP exposure 
Human blood monocytes were extracted from a cohort of 20 healthy donors and 
examined to determine whether a similar innate immune response was induced to the 
THP-1 monocytes. These monocytes were exposed only to a concentration of 50µg/ml 
AgNP for 8 hours due to the limited supply of monocytes extracted per donor sample. 
This exposure concentration and time point was chosen from the previous THP-1 
studies as they appeared to be the most active test points.   
The following results are presented for the average response to AgNP exposure in 20 
healthy donors. As expected all donors displayed individual variation in response to 
AgNP for each cytokine. Therefore, the coefficient of variation (CV) was calculated for 
each cytokine between donors to determine the levels of variation between all blood 
donor samples. IL-1 demonstrated a CV of 63.7%, IL-6 54.5% and TNF-α 51.2%. 
The results (figure 7.8) demonstrate general up-regulation of all cytokines in all donors 
responding to AgNP exposure compared to an unexposed control. Non-parametric 
statistical analysis was performed due to the donor samples being one-off samples. 
Combined levels (n=20) of IL-1 and TNF-α showed statistically significant up-
regulation compared to the unexposed control as determined by the Mann-Whitney test. 
Figure 7.9 demonstrate the individual responses of 10 donors to AgNP exposure. As the 
data illustrate variation in individual gene expression was observed between donors as 
well as variation in the expression of each cytokine per donor. Kruskal-Wallis non-
parametric analysis comparing the difference in expression levels of each individual 
cytokine between each of the 10 donors was found to be non-significant for all three 
cytokines. Spearman non-parametric assessment of differences between the levels of 
expression of the three cytokines per donor sample was shown to be non-significant. 
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Figure 7.8 Fold increase in IL-1, IL-6 and TNF-α gene expression in primary 
monocytes following 8 hour AgNP exposure compared to an unexposed control ± SD of 
twenty independent experiments. * denotes a statistically significant (p<0.05) difference 
from the unexposed control. Actin was used as the internal control 
 
 
Figure 7.9 Fold increase in pro-inflammatory cytokine gene expression, IL-1, IL-6 and 
TNF-α in primary monocytes of 10 donors following 8 hour AgNP exposure compared 
to an unexposed control ± SD of three independent experiments. Actin was used as the 
internal control 
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7.2.5 AgNP-induced inflammasome activation and cytokine secretion 
Following the investigation into pro-inflammatory cytokine up-regulation by AgNP 
exposure, it was hypothesized that the induction of cytokine secretion could be due to 
inflammasome activation. The ability of AgNP to induce cytokine release following 
pre-treatment of cells with LPS was investigated to determine the potential 
inflammasome activation by AgNP themselves. An ELISA assay for IL-1β secretion 
(Figure 7.10) was performed on the supernatant of THP-1 cells following 6 hour 
exposure to AgNP to detect inflammasome induced cleavage of pro-IL-1β. The assay 
was also employed to confirm pro-inflammatory gene expression through detection of 
protein product, IL-1β, in cell supernatant. Production of the protein confirmed 
inflammasome activation driven by AgNP exposure. 
 
 
Figure 7.10 Release of IL-1β (pg/ml) from THP-1 cells following 6 hour exposure to 
AgNP. LPS (10ng/ml) was pre-treated 4 hours before exposure and Ac-YVAD-CMK 
(20µM) inhibitor was treated 1 hour before exposure. ATP (5mM) was employed as a 
positive control. Data expressed as percentage of control mean ± SD of five independent 
experiments. *denotes a statistically significant difference (p<0.05) from the unexposed 
control. 
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An increase in IL-1β levels compared to the unexposed control was noted for both 
exposure concentrations. While IL-1β release was significantly increased compared to 
the unexposed control, levels were still low coming in under 20pg/ml. Following pre-
treatment with LPS for 4 hours levels of IL-1β release significantly increased to levels 
of 20pg/ml and above. The highest increase was noted at the 50µg/ml dose. Pre-
treatment of cells with LPS only, resulted in a significant increase in IL-1β release 
compared to the unexposed control similar to the levels observed for treatment of cells 
with AgNP only. The combined pre-treatment with LPS and exposure to AgNP caused 
significant IL-β release compared to the unexposed control and significantly higher 
levels when compared to AgNP and LPS exposure alone. This suggests a synergistic 
effect between AgNP and LPS in inflammasome activation.   
Inclusion of the inhibitor prevented IL-1β release in all exposure scenarios. The 
inhibitor is specific to caspase-1which prevents the proteolytic cleavage of pro-IL-1β 
into the mature active form. These results indicate a possible role of caspase-1 in AgNP 
mediated inflammasome activation.  
 
7.3 Discussion 
The prevalence of AgNP in consumer products as well as their use for the improvement 
of medical devices and in biomedical applications increases in the incidence of human 
exposure
 
(Sotiriou & Pratsinis, 2011; Chen & Schluesner, 2008). Translocation and 
systemic distribution of nanoparticles has been documented and as such the influence of 
exposure in the circulatory system and the associated risk must be assessed (Johnson et 
al, 2010; Van der Zande et al, 2012; Loeschner et al, 2011).
 
 
In this study it was established that exposure to AgNP resulted in significant 
transcription of inflammatory cytokines IL-1, IL-6 and TNF-α. AgNP exposure can 
generate intracellular reactive oxygen species (ROS) in mammalian cells, with 
excessive production linked to cell damage and initiation of an inflammatory response 
(Lim et al, 2012; Asharani et al, 2009). Oxidative stress in monocytes coupled with the 
release of inflammatory cytokines is a natural protective response; however, this process 
can become pathogenic when normal cell control systems are overwhelmed. Evidence 
has indicated a correlation between ROS production and inflammation resulting in an 
amplified response. Oxidative stress causes expression of cytokines including IL-1, IL-6 
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and TNF-α which in turn contribute to ROS generation. This produces an amplification 
loop between oxidative stress and inflammation initiated by AgNP exposure (Kim & 
Ryu, 2013). This loop while potentially contributing to resolution may also cause 
continued pro-inflammatory cytokine induction past the threshold of resolution thus 
inducing a continued inflammatory response and toxicity (Lander, 1997; Acker, 2005; 
Franco et al, 2012). The pro-inflammatory cytokine expression detected following 
AgNP exposure and the amplified expression noted following exposure to AgNP and 
LPS combined may result from ROS production. These AgNP have previously been 
shown to be potent inducers of ROS (Murphy et al, 2015; Gupta Mukherjee et al, 
2012). Further investigation is required to determine if a similar ROS driven mechanism 
occurs following exposure to these specific AgNP.  
The increased gene expression observed by the combination of AgNP and LPS 
exposures indicated a synergystic effect and may further indicate a potential interaction 
which exacerbates the inflammatory response, potentially contributing to a greater 
immune reaction. As previously discussed, significant increases in levels of all 
cytokines compared to the unexposed control were noted. Significant differences in the 
expression of all cytokines after 6, 8 and 24 hours, were determined when comparing 
the differences in cytokine levels of cells exposed to either a combination of AgNP and 
LPS compared to AgNP, or LPS alone. An interaction between AgNP with LPS would 
explain the increased gene expression compared with exposure to AgNP or LPS alone. 
An important part of AgNP toxicity is attributed to nanoparticle-biomolecule 
interactions. Upon entry, nanoparticles associate with various biomolecules producing a 
surface coating. The variety of biomolecules within the body leads to any number of 
combinations coating the particle surface, making it an important contributory factor of 
cellular response to nanoparticles and the extent of toxicity (Murphy et al, 2015; Lynch 
et al, 2006; Monopoli et al, 2012; Dubey et al, 2015). A nanoparticles biomolecule 
surface coating can induce a Trojan horse effect whereby toxicity appears delayed only 
to occur days later, resulting from dissolution of the biomolecule coating within the 
lysosome following cellular internalisation (Wang et al, 2013). An interaction between 
AgNP and LPS must be considered, and it is clear that numerous factors contribute to 
the responses induced. Further investigation is required to determine this interaction 
with particular attention paid to the biomolecule surface coating in order to understand 
the complete effect of AgNP exposure. 
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Following investigation into gene expression by AgNP exposure in THP-1 cells, human 
blood monocytes extracted from a cohort of 20 healthy donors were exposed to AgNP 
to determine if a similar innate immune response was induced. While significant up-
regulation in IL-1 and TNF-α compared to the unexposed control was observed when 
comparing the donors as a whole, variation between individual donors in their 
expression of a particular cytokine and variation between the levels of the three 
cytokines expressed by each donor was also noted. Even under the same experimental 
conditions variation in gene expression was expected. There is evidence of donor-
specific gene expression patterns which can be attributed to the data shown here and 
also the large error observed when the expression patterns for a particular cytokine were 
grouped and averaged. Statistical analysis of the variation, which ranged from 51.2-
63.7%, were performed but indicated the variations between donors were non-
significant. Several studies involving donor blood samples have demonstrated variation 
in gene expression patterns with each donor producing differing levels following 
exposure to a particular stimulus. Many factors can contribute to the variation in 
expression, from environmental and physiological factors to the time of day of sample 
taking (Howe et al, 2005, 2009; Whitney et al, 2003). The inflammatory response in 
human circulating blood is a complex systemic process involving numerous factors 
which contribute to the large CVs and varied results. A larger cohort of samples to 
include other cells per donor such as lymphocytes would be an interesting investigation 
to elucidate this response on a more clinical level. 
The effect of AgNP on the release of IL-1β and its potential to cause inflammasome 
activation yielded some interesting results. Exposure to AgNP alone resulted in a low 
but significant level of IL-1β release compared to the unexposed control. Pre-treatment 
of cells with LPS followed by AgNP resulted in significantly higher IL-1β release 
indicative of a synergistic relationship between the two. This result corresponds to the 
increase in gene expression observed following combined AgNP-LPS exposure. This 
effect on IL-1β release may potentially have pathological consequences and result in a 
greater immune response produced by minimally activated cells when AgNP are 
present. Given their commonality in consumer products and the incidence of exposure, 
their presence may trigger an exacerbated immune reaction in what would have been a 
minimal immune response. Another interesting observation was that the lower 
concentrationexposure produced the greatest release indicating that at sub-lethal 
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concentrations of AgNP a greater response is induced, and this is an important 
dosemetric consideration. This type of reaction has been observed in other studies 
examining AgNP exposure which the findings here support (Lim et al, 2012; Yang et 
al, 2012). The inclusion of an inhibitor highlights the involvement of caspase-1 in 
inflammasome activation and potentially the specific involvement of the NLRP3 
inflammasome which has been shown to become activated upon AgNP exposure (Yang 
et al, 2012; Simard et al, 2015). The involvement of caspase-1 would explain the low 
levels of IL-1β release following cell exposure to AgNP or LPS alone as it has been 
shown that monocytes constitutively express activated caspase-1 and as a result only 
require one stimulating event in order to cleave pro-IL-1β, which may explain the low 
levels detected following exposure to AgNP or LPS alone (Netea et al, 2009). 
The first signal in inflammasome activation leading to production of pro-IL-1β is often 
NF-κB. AgNP have been shown to stimulate this pathway resulting in downstream 
effects ranging from cell cycle arrest to apoptosis (Eom & Choi, 2010). A causative 
mechanism of NF-κB expression is ROS, which can lead to several inflammatory 
responses including mitochondrial DNA release, causing NLRP3 inflammasome 
activation (Gloire et al, 2006; Shimada et al, 2012; Hehner et al, 2000). AgNP entry 
into cells is believed to occur via receptor-mediated endocytosis, and evidence suggests 
that AgNP can activate toll like receptor pathways, another mechanism of NF-κB 
activation (Kim et al, 2007; Kim et al, 2012). It is possible that TLR-2 is involved as it 
has been shown that AgNP induced apoptosis can be partially mediated by the TLR-2 
signaling pathway (Kim et al, 2012; Dubey et al, 2015). Interaction of AgNP with a 
TLR coupled with AgNP induction of NF-κB highlights a possible mechanism for 
inflammasome activation. Further investigation into specific TLR-AgNP interactions is 
required to determine any involvement. The heightened gene expression to combined 
AgNP-LPS exposure may suggest involvement of the TLR-4 signaling pathway, a 
receptor that specifically recognizes LPS, as another potential initiation event in 
inflammasome activation.  
ROS, specifically mitochondrial superoxide, have been implicated in the formation of 
the inflammasome complex. Two additional mechanisms have also been identified, one 
involves interaction of AgNP with cell membrane affecting integrity and resulting in 
alteration to K
+
 efflux channels, the other involves cathepsin release following particle 
entry into the lysosome which in turn affects mitochondrial function resulting in ROS 
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release and thus inflammasome formation (Yang et al, 2012). Another contributor to 
inflammasome activation by AgNP was recently identified as degradation of a stress 
sensor associated with the endoplasmic reticulum brought on by exposure (Simard et al, 
2015). Further investigation is required to determine if one or all of these mechanisms 
are responsible for inflammasome activation by the specific AgNP utilized in this study. 
In addition, AgNP have been investigated for their potential adjuvant properties with 
studies indicating a significant adjuvant effect in mice (Xu et al, 2013). This evidence 
of the immunostimulatory effect of AgNP highlights the immunological significance of 
AgNP and is in agreement with the data presented in this study regarding gene 
expression and IL-1β release induced by AgNP exposure alone and the increased levels 
released following the combined exposure to AgNP and LPS. 
 
7.4 Chapter Summary 
This chapter has highlighted the immunological significance of AgNP exposure and 
consideration must be given when assessing the influence of AgNP on the cells of the 
immune system. These results indicate that AgNP could potentially have pathological 
implications or indeed exacerbate already existing pathological conditions.  
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Chapter 8 
General Discussion and Future Work 
 
8.1 Discussion  
This thesis has clearly demonstrated that AgNP exposure can induce an innate immune 
response in monocytes through pro-inflammatory cytokine up-regulation with 
inflammasome involvement. In addition this study has illustrated the importance of 
components of biological fluids in the modification of AgNP toxicity. In chapter 1 a 
number of questions were asked regarding AgNP toxicity and their influence on 
biological systems following oral exposure, below the main findings of this thesis are 
identified and discussed.  
To date the work performed for this project has included: 
1. Characterisation of pristine AgNP and AgNP in the presence of biofluid 
components UDCA, CA, DCA and DPPC, identifying any modifying effects 
2. Cytotoxic evaluation of AgNP on multiple cell lines associated with oral 
exposure, liver, larynx and lung (HepG-2, Hep2 and A549 respectively) 
3. Investigation into the modifying effects of the aforementioned biofluid 
components on the observed toxicity  
4. Investigation into the innate immune response induced by AgNP exposure on a 
monocyte cell line (THP-1) 
5. Investigation into the innate immune response induced by AgNP exposure on 
primary human monocytes and how this compares to the response induced in 
THP-1 cells 
6. Identifying the involvement of the inflammasome complex in AgNP induced 
innate immune response 
The aim of this work was to fully characterise AgNP and to explore their toxic potential 
on a variety of cell lines associated with oral exposure. Following this, the ability of 
certain biofluid components associated with oral exposure to modify the cytotoxicity of 
AgNP was established. Prior to cytotoxic evaluation, it was determined if the presence 
of biofluid components could alter the physicochemical characteristics of AgNP. Most 
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cyto-toxicological studies are aimed at the risk associated with dermal exposure and 
inhalation, this study aimed to assess the risk of oral exposure to AgNP to include 
ingestion but also inhalation, as the two systems operate millimetres apart and the 
likelihood of cross exposure between the two is unavoidable. Following initial 
investigation, this study went on to focus on the potential innate immune response 
induced by AgNP in circulating white blood cells following absorption into the blood 
stream. The focus of this work was to mimic more realistic exposure scenarios and 
concentrationmetrics associated with real world nanoparticle exposure. The interaction 
between humans, the environment and nanoparticles is becoming more widespread and 
frequent, highlighting the importance of establishing the real risks associated with 
exposure. 
The first step in any cyto-toxicological investigation is to establish the physicochemical 
characteristics of the nanoparticle of interest. A number of methods including scanning 
electron microscopy, dynamic light scattering analysis and UV/VIS absorption 
spectroscopy were performed independently to provide a complete picture of the 
characteristics of AgNP. BET was also employed to determine the surface area of 
particles. All techniques were performed on the particle powder as purchased. Analysis 
revealed a particle size between 50-70nm by SEM. DLS analysis which determines the 
hydrodynamic radius of particles, revealed an average size of 34nm ± SD 3.5. BET 
analysis on the nanoparticle powder revealed a surface area of 2.3 ± 0.1 m2/g. The same 
techniques were also performed on the AgNP in the presence of the biofluid 
components under investigation, UDCA, CA, DCA and DPPC to determine any 
alteration to the size or agglomerative state of the particles. On the addition of biofluid 
components to nanoparticle suspensions dispersed in the appropriate cell culture media 
(RPMI or DMEM); DLS revealed a shift in particle size in the presence of DPPC and 
UDCA but remained within the size range observed for AgNP dispersed in media alone. 
Following addition of UDCA, CA and DCA (dispersed in DMEM); particle size was 
revealed to fall within the size range for the cell culture media. It has been observed that 
upon entry into the body a material becomes almost immediately coated in protein and 
this may be the case upon addition of the various biofluid components. These 
components may associate with and coat the particle upon contact causing alterations to 
particle size. However it has also been demonstrated that proteins contained in cell 
culture media can also associate with particles and it can be assumed that this is also 
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occurring. With this in mind it would be expected that the association or coating with 
various proteins would cause particles to agglomerate and an increase in particle size 
observed but, neither scenario occurs. The lack of an increase in particle size in the case 
of UDCA and DPPC (dispersed in RPMI) may be attributed to a shift in the plane of 
shear. This shift was also noted when particles were dispersed in cell culture media 
only. Addition of UDCA, CA or DCA resulted in a large shift in hydrodynamic radius 
demonstrating one peak falling within the size range of DMEM. These biofluid 
components have a large size distribution (greater than 200nm) and may cause the 
formation of large agglomerates with AgNP, resulting in precipitation of particles out of 
solution at an elevated rate preventing their detection by DLS analysis. This may 
explain why only one peak is observed following analysis of these dispersions which is 
attributed to DMEM. Further investigation is required to determine why these particular 
AgNP-biofluid dispersions cannot be detected by DLS analysis. Whatever the process 
may be interaction between AgNP and biofluid components may potentially influence 
their interaction with living systems, their distribution and the biological responses they 
induce. 
In terms of producing a toxic response in cells, it was important to establish whether 
AgNP could interact with the components and various growth factors of cell culture 
media thus influencing toxicity. Any interaction with media components could lead to a 
secondary toxicity due to depletion of vital growth factors essential for cell survival. 
UV/VIS absorption was employed to study this effect. The spectra revealed all of the 
features for cell culture media at 360, 410 and 560nm with AgNP and DPPC, UDCA, 
CA and DCA revealing no features. The results indicated no interaction of particles 
with cell culture media or biofluid components. It was concluded that no secondary 
toxicity occurs due to depletion of media components.  
 
Zeta potential analysis was also carried out to assess the overall stability of AgNP in the 
various dispersions. Values varied among the suspensions. The overall system is stable 
at values above +30mV and below -30mV. Analysis of AgNP dispersed in dH2O was 
unstable at all test concentrations. Dispersion in RPMI was shown to stabilize the 
system and with the addition of DPPC showed no change. Similar stability data was 
obtained for AgNP dispersed in DMEM and addition of UDCA, CA or DCA had no 
effect. The lack of change in zeta potential values corresponds to the DLS data where no 
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significant change in hydrodynamic radius was observed. A change in hydrodynamic 
radius, indicating interaction between particles and biofluid components, would 
correspond to a change in zeta potential values suggesting indirect toxicity resulting 
from an interaction (Casey et al, 2007; Casey et al, 2008). The large values noted for 
AgNP in RPMI with DPPC and UDCA correspond to the DLS data, suggesting that 
particle have a tendency to repel each other preventing the likelihood of agglomeration 
and a change in size. The low unstable values noted for AgNP dispersion in DMEM 
with UDCA, CA and DCA while indicting no change in the overall system may explain 
the lack of particle size data. The lower values suggest a reduced repulsion force 
increasing the tendency to agglomerate (Xia et al, 2006). The addition of these biofluid 
components together with DMEM may result in agglomeration and thus precipitation of 
particle out of solution preventing detection by DLS analysis. However no significant 
changes were noted indicating biofluid components do not affect the overall stability of 
cell media-nanoparticle system.  
 
Following physicochemical characterisation of AgNP and establishing their interactions 
with the selected biofluid components, the ability of these components to modify 
toxicity was assessed. A number of toxicological tests were performed to determine the 
toxic effect induced by AgNP on two cell lines associated with the GI tract, liver 
(HepG-2) and laryngeal (Hep2) and if biofluid components associated with these tissues 
had modifying effects. In terms of the effect of UDCA on the HepG-2 cell line, no 
change in toxicity was noted however, CA and DCA did have modifying effects. The 
pattern of toxicity as demonstrated in the AB and MTT viability assays remained 
unchanged following addition of CA and DCA to the system but significant changes 
were observed in the levels of ROS generated. The levels of ROS were significantly 
greater in AgNP-CA and AgNP-DCA dispersions compared to AgNP exposure alone. 
The increased production of ROS is potentially due to increased levels of lipid 
peroxidation caused by the combination of AgNP and biofluid components. Lipid 
peroxidation is a naturally occurring process driven by ROS but in an uncontrolled state 
may lead to altered cell structure and function (Mylonas & Kouretas, 1999). It has been 
demonstrated that certain nanomaterials such as ZnO nanoparticles can enhance this 
process causing increased ROS production with AgNP also implicated in this process 
due to the quenching of natural antioxidant systems and increased ROS generation 
(Premanathan et al, 2011; Adeyemi & Faniyan, 2014). From the data it is postulated 
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that it is this mechanism of cell destruction occurring as the levels of ROS are 
substantially increased in the presence of both AgNP-CA and AgNP-DCA compared to 
AgNP alone. While exposure to AgNP alone can result in an increase in lipid 
peroxidation it is possible that the addition of CA and DCA can result in an escalation 
of this process which then has a knock on effect on cell viability. This may be the result 
of a reactive product produced from the interaction of AgNP with CA and DCA. Further 
investigation is required to determine the mechanism of cell death and the role of lipid 
peroxidation in the pathway. 
 
As a continuation of this investigation into biofluid modification of toxicity, a laryngeal 
(Hep2) cell line was investigated to establish if the biofluid components could have 
modifying effects on areas of the body outside their normal target organs. For this 
UDCA was chosen as the biofluid component to be investigated. A significant 
modification in AgNP toxicity was observed in this study. A delay in cytotoxicity was 
noted at 24 hour exposure with a significant reduction in viability following prolonged 
exposure (48, 72 and 96 hours). This delay was coupled to a significant reduction in 
ROS generation following UDCA addition suggesting a possible antioxidant effect of 
UDCA within the first 24 hours after exposure. It is possible that UDCA causes a 
delayed toxicity following association with AgNP in the first 24 hours due to a Trojan 
horse type mechanism after which particle trafficking and dissolution within the cell 
results in degradation of UDCA leaving the “naked” AgNP free to cause toxicity (Wang 
et al, 2013; Mwilu et al, 2013).  
 
The biofluid components investigated in this thesis are employed as pharmaceutical 
agents and medications and as such highlights their potential to be present systemically 
and not just confined to the liver. As a result the observations in this thesis are a 
relevant line of investigation particularly as these bile acid derived treatments are given 
orally. The data highlight the need for a complete and detailed cytotoxic profile of 
AgNP and not just of the isolated effects but of the combined effect encompassing the 
local environment, cellular components and other contributors at the exposure site.  
 
As exposure through inhalation is the most common route of nanoparticle entry a follow 
up study was undertaken to investigate the interaction of a component of lung 
surfactant, DPPC, with AgNP and its potential to influence toxicity and induce an 
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inflammatory response. Toxicity data demonstrated the effect of AgNP on the viability 
of a lung cell line, A549. Due to the rapid doubling time of this cell line, 22 hours, the 
greatest level of toxicity was at higher doses and shorter exposure times (24-48 hours). 
The apparent cell recovery at lower AgNP concentrations at 72 and 96 hours was 
attributed to replication of the surviving cells. Long term viability studies demonstrated 
a reduced capacity for cell proliferation and colony formation in the presence of DPPC. 
The greatest modification in toxicity was noted in the generation of ROS in the presence 
of DPPC compared to substantially lower levels generated following exposure to AgNP 
alone. The induction of oxidative stress plays a central role in cell death caused by 
AgNP exposure. AgNP are potent inducers of oxidative stress and coupled with their 
ability to diminish natural antioxidant stocks are critical in initiating apoptosis 
(Martindale & Holbrook, 2002; Sastre et al, 2000; Piao et al, 2011; Arora et al, 2008; 
Hussain et al, 2005; Chairuangkitti et al, 2013). Lipid peroxidation may also play a role 
in this process enhancing ROS generation (Premanathan et al, 2011; Adeyemi & 
Faniyan, 2014). This cell death process requires involvement of the mitochondria 
however another death pathway has been identified in this particular cell line which 
does not require the induction of ROS. This ROS-independent pathway results in cell 
cycle arrest halting proliferation rather than inducing apoptosis (Chairuangkitti et al, 
2013). It is possible that the results observed in this thesis indicate death pathway 
switching following addition of DPPC. Exposure to AgNP alone produced low levels of 
ROS at high concentrations only but addition of DPPC resulted in significant ROS 
induction at a number of different concentrations suggesting a switch from a ROS-
independent mechanism causing cell cycle arrest to a ROS-dependent mechanism 
culminating in apoptotic cell death. 
 
The induction of oxidative stress resulting from AgNP exposure has a number of 
important knock on effects including cellular and DNA damage and the induction of 
inflammatory cytokine release (Nel et al, 2006). In this study the release of IL-8 and 
TNF-α were investigated and these particular cytokines have been associated with 
AgNP exposure and implicated in certain lung disorders (Singh et al, 2007; Lim et al, 
2012; Park et al, 2011; Napierska et al, 2012). While AgNP exposure resulted in their 
release from A549 cells, the addition of DPPC caused a significant increase in release. 
This implicates AgNP as an initiator of inflammation with its interaction with DPPC 
serving to increase its potency. The increased levels and immediate release of IL-8 in 
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particular support reports of its potential use as a bio-marker of acute inflammation in 
response to AgNP exposure (Lim et al, 2012; Park et al, 2011). The alteration in both 
IL-8 and TNF-α release caused by DPPC suggest the potential to induce a chronic 
inflammatory state due to high levels released at prolonged exposure times. The data 
also suggest that it is at sub-toxic doses of AgNP that produce the greatest inflammatory 
response which has previously been reported (Lim et al, 2012). The alterations in ROS 
generation and inflammatory cytokine release by DPPC can possibly be explained by 
interactions between this surfactant and AgNP. Any potential interaction may increase 
particle dispersion or alter the surface chemistry resulting in greater surface area 
available for interaction increasing the likelihood of cellular uptake and cellular 
trafficking. A similar Trojan horse mechanism has been suggested for other 
nanoparticles which result in increased levels of ROS generation (Limbach et al, 2007). 
It is possible that DPPC-AgNP interaction results in alteration to particle characteristics 
producing a more reactive and thus more toxic particle. The results indicate that not 
only are sub-lethal concentrations of AgNP potent inducers of an inflammatory 
response but that the favoured protective surface coating DPPC is a major contributor to 
oxidative stress induction. 
 
The final part of this thesis involved identifying the ability of AgNP to induce an innate 
immune response in circulating blood cells. Due to the possibility of AgNP 
translocation into the blood stream it is an important part of any risk assessment to 
investigate any potential effects on the circulatory system (Loeschner et al, 2011; 
Gaillet & Rouanet, 2015). AgNP exposure to THP-1 cells showed a significant up-
regulation in gene expression of IL-1, IL-6 and TNF-α. Oxidative stress has been 
implicated in the up-regulation of inflammatory cytokines. The induction of pro-
inflammatory cytokines by ROS generation can result in a positive feedback loop 
whereby the subsequent cytokine expression further drives the production of ROS (Kim 
& Ryu, 2013; Lander, 1997; Acker, 2005; Franco et al, 2012). While this mechanism 
may result in resolution, uncontrolled amplification may cause this process to turn 
pathogenic, eventually resulting in toxicity. The cytokine up-regulation following AgNP 
and combined AgNP-LPS exposure may result from ROS production. As these AgNP 
have previously been shown to be potent inducers of ROS in certain mammalian cell 
lines, further investigation is required to determine if this mechanism is what drives the 
innate immune response caused by exposure (Gupta Mukherjee et al, 2012; Lim et al, 
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2012; Asharani et al, 2009). The increased gene expression following combined 
exposure to AgNP and LPS indicated a synergistic relashionship between the two. This 
combined effect produced pro-inflammatory cytokine gene expression at significantly 
higher levels compared with exposure to AgNP or LPS alone. An interaction between 
AgNP and LPS would explain the significantly increased levels generated. An 
important consideration in nanoparticle toxicity is the interaction with various 
biomolecules following exposure. Nanoparticle interaction with biomolecules can result 
in particle coating and this coating has the potential to determine the biological 
responses induced and also determine particle trafficking through the body (Lynch et al, 
2006; Laurent et al, 2012; Monopoli et al, 2012; Dubey et al, 2015). It must be 
considered therefore the potential interaction between AgNP and LPS, in particular the 
biomolecule surface coating, and how this contributes to the augmented response.  
As a continuation of the initial investigation into AgNP induced immune response, an 
identical set of experiments was performed on primary human monocytes extracted 
from a cohort of twenty healthy donors to determine if a similar response was generated 
in primary cells. The results demonstrated significant up-regulation of IL-1 and TNF-α 
compared to the unexposed control. The main finding from this study was the large 
variation between donors in the levels of expression and also the variation in the 
expression of each cytokine by each donor. These results while demonstrating large 
errors only highlight the importance of donor variation and agree with existing evidence 
of donor specific responses and individual variation. Studies involving blood samples 
have noted donor-specific gene expression patterns with different levels of a particular 
target generated in response to the same stimulus and under identical conditions. The 
reasons for this varied response can range from environmental factors to the time of day 
of sample taking (Howe et al, 2005, 2009; Whitney et al, 2003). Although AgNP were 
shown to induce pro-inflammatory cytokine gene expression in primary monocytes, the 
variation between donors must be considered and further investigations into AgNP 
immune responses should be performed using a larger cohort of samples and perhaps 
also the inclusion of other donor cells to form a complete account of the response. 
Following the determination of pro-inflammatory cytokine up-regulation, an 
investigation into the release of IL-1β protein was performed to determine if 
inflammasome activation plays a role in AgNP mediated immune response. Low levels 
of IL-1β were released following AgNP exposure but pre-treatment with LPS followed 
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by AgNP exposure produced the greatest levels of release. As with the gene expression 
data this may suggest an interaction between the two. This result may have pathological 
consequences potentially producing a greater immune response in minimally active cells 
due to the presence of AgNP. The results also demonstrated that at sub-lethal 
concentrations of AgNP the greatest IL-1β release was observed which has been 
detailed in other investigations into the inflammatory activity of AgNP (Lim et al, 2012; 
Yang et al, 2012). The reduction in IL-1β release following the inclusion of an inhibitor 
suggests the involvement of caspase-1 and specifically the activation of the NLRP3 
inflammasome upon exposure. Its involvment may also explain the low levels of IL-1β 
release following exposure to AgNP or LPS alone as monocytes have been shown to 
constitutively express caspase-1 allowing cleavage of pro-IL-1β into the bioactive form 
and its subsequent release from the cell requiring (Yang et al, 2012; Simard et al, 2015; 
Netea et al, 2009).  
Inflammasome activation involves a two signal sequence. The first stimulates gene 
expression; the second involves cleavage of the inactive cytokine to the mature active 
form. The first signal is often NF-κB and AgNP have been shown to stimulate this 
pathway resulting in downstream effects ranging from cell cycle arrest to apoptosis. 
ROS have been shown to cause NF-κB induction with AgNP contributing to ROS 
generation. AgNP have also been shown to interact with TLRs which can then lead to 
activation of the NF-κB signalling pathways. TLR-2 in particular has been involved in 
AgNP mediated apoptosis and due to the interaction of AgNP with LPS it is also a 
possibility that TLR-4 may be involved as it specifically recognises LPS (Kim et al, 
2007; Kim et al, 2012; Dubey et al, 2015). The interaction of TLRs with AgNP 
highlights a possible initation event in inflammasome activation involving NF-κB. 
Additional mechanisms have also been identified in AgNP mediated inflammasome 
activation. ROS, specifically mitochondrial superoxide, have been implicated together 
with alteration in K
+
 efflux channels and cathepsin release causing mitochondrial 
dysfunction and ROS generation, all resulting from AgNP exposure (Yang et al, 2012). 
Another contributor to inflammasome activation by AgNP was recently identified as 
degradation of an endoplasmic reticulum stress sensor (Simard et al, 2015). Further 
investigation is required to determine if one or all of these machanisms is responsible 
for inflammasome activation and subsequent IL-1β release brought on by exposure to 
the specific AgNP investigated in this study.  
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The antimicrobial potential of AgNP has led to their application in a variety of areas 
ranging from medical devices and drug therapies to cosmetics. The continuing growth 
of this industry means that exposure is becoming more common, which has highlighted 
a lack of information regarding the toxic potential of AgNP and other nanomaterials. 
The results of this study could provide preliminary information relating to the toxic 
potential of AgNP and more importantly provide a more realistic picture of their 
interaction with biological systems, and how this can influence nanoparticle interaction 
with living systems upon exposure. The results presented here also lend themselves to 
providing a preliminary insight into the toxic effect of AgNP upon oral exposure, the 
modifying effects on toxicity upon interaction with biofluids and the immune response 
provoked following absorption into the bloodstream, and finally, highlighting that the 
application of nanomaterials into consumer products should be approached with 
caution. 
This report has highlighted that a certain level of caution should be undertaken when 
considering incorporating nanomaterials into consumer products. It is of the upmost 
importance that a certain level of care be taken when considering nanomaterials for 
consumer use, especially following documentation of the harm caused by these 
materials at low doses. When trying to establish the risk of such materials, it is 
important to take into account realistic parameters such as concentrationmetrics and 
interaction of nanomaterials with the individual components within living systems when 
designing experiments. This will provided accurate information on the potential hazards 
of nanomaterials towards humans and the environment. This information along with the 
results presented in this study will impact a number of sectors across the area of 
nanotechnology including, food and agricultural, food packaging, medical and cosmetic.  
 
8.2 Future Work 
8.2.1 Effect of AgNP on adaptive immunity 
Furthering the investigation into the innate immune response generated in monocytes by 
AgNP exposure, an experiment designed to determine AgNP effects on the adaptive 
immune response will be investigated. Specifically this experiment seeks to identify the 
allosteric T cell response induced by AgNP exposure. This study would determine the 
ability of AgNP to induce T cell proliferation, important cells in the immune response 
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involved in destruction of infected cells and maturation of other immune cells. 
Following whole blood collection, both monocytes and lymphocytes will be extracted, 
specifically CD3 cells, from donor blood. Monocytes will be pre-treated with AgNP as 
in previous experiments and lymphocytes will be fluorescently labelled. Monocytes will 
then be combined with lymphocytes from another donor in a 96 well plate with cell 
media containing no cytokines and incubated. Following 3, 4, 5 and 6 days cells will be 
stained for CD3 (a marker present on both T helper and T killer cells) CD4 and CD8, 
and analysed on a flow cytometer. A histogram illustrating several peaks indicates cell 
division and would suggest that AgNP exposure can activate monocytes, which leads to 
the activation of T lymphocytes and subsequent cell proliferation, indicative of an 
adaptive immune response. The staining of specific CD markers would also identify the 
type of T cells induced by AgNP exposure. 
 
8.2.2 Innate immune response of AgNP in an in vivo model 
An interesting and important continuation of this work would be to determine if the 
response observed in both the monocyte cell line and in primary human monocytes is 
similar to the response induced in an in vivo model. Galleria mellonella larvae, a type 
of moth, will be used as an in vivo model to determine if a similar innate immune 
response to AgNP exposure is induced. G. mellonella are widely used in research for in 
vivo investigations into immune responses as the innate immune response is similar to 
the human innate immune response. The larvae will be injected with AgNP at a 
concentration of 50µg/ml and the hemolymph extracted for cellular extraction, RNA 
isolation and subsequent molecular analysis. The same endpoints IL-1, IL-6 and TNF-α 
will be analysed to determine cytokine up-regulation induced by AgNP exposure. These 
larvae are a useful in vivo model and can provide an important insight into the 
mammalian innate immune response following AgNP exposure. 
 
8.2.3 Investigation into the toxicity of other metallic nanoparticles following oral 
exposure 
This thesis has demonstrated important results regarding the effects of AgNP on 
biological systems following oral exposure. While there are still further investigations 
remaining to form a complete cytotoxic profile of AgNP exposure, it is important that 
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other nanoparticles are considered for similar investigation. Metallic nanoparticles such 
as titanium dioxide (TiO2) are also applicable in consumer goods making the risk of 
exposure to the public more prevalent. TiO2 is used in powdered foods such as 
powdered milk to prevent caking and is also used as a whitening agent in certain 
foodstuffs (Lomar et al, 2002; Smolkova et al, 2015). TiO2 provides a good example of 
a metallic nanoparticle that should be considered for investigation as they are 
consistently used in consumer products especially food products making the risk of 
exposure a certainty. As such a complete cytotoxic profile of these nanoparticles must 
be performed to determine the potential risks posed following exposure. Similar to the 
work undertaken in this thesis, investigations into the possible interaction with various 
biological entities and their ability to induce a biological response must be considered. 
This work will add to the knowledge available regarding potential hazards of 
nanoparticle use in consumer products, not as a barrier to innovation and growth of the 
industry, but that the decision to use metallic nanoparticles can be approached with 
caution.  
 
8.3 Conclusion 
This thesis has clearly demonstrated that AgNP exposure can induce an innate immune 
response in both a monocyte cell line and primary human monocytes by up-regulation 
of the pro-inflammatory cytokines IL-1, IL-6 and TNF-α. In addition this response was 
found to involve innflammasome activation. This report has also highlighted the 
induced toxicity of AgNP upon oral exposure and the vital role of individual biological 
fluids in modifying toxicity and inflammation. These findings serve to highlight the 
importance of considering the varied and dynamic environment met by AgNP upon oral 
exposure and the effects individual components can have on the biological response 
produced. It also serves to highlight the immunological significance of AgNP following 
entry to the circulation and the generation of an innate immune response. These findings 
demonstrate that there is still a long way to go in fully understanding the toxic potential 
of AgNP following oral exposure and that those responses are varied depending on the 
biological environment and can potentially contribute to disease development or 
exacerbate already existing conditions. 
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Appendix 
 
UV/VIS absorption spectroscopy was performed to identify the features of cell culture 
media RPMI and DMEM and of AgNP dispersed in cell culture media and any 
alterations following the inclusion of the tested biofluid components UDCA, CA, DCA 
and DPPC. This method was employed to explore potential interaction of AgNP with 
cell growth medium and its various constituents. The UV/VIS spectrum of cell culture 
media consists of a number of features at 360, 410 and 560nm. There was also a feature 
at 270nm not illustrated here. The feature at 410nm was attributed to 10% foetal bovine 
serum (FBS) added to culture media which also displays another feature at 270nm, the 
feature at 360nm is riboflavin, a vitamin present in the medium and finally the feature at 
560nm can be attributed to the phenol red indicator. 
 
All features can be seen in the absorbance spectra presented (Fig 4..4.1 (a) and 4.4.1 
(b)). Because AgNP are dispersed in cell culture media for toxicity testing it is 
important to establish if their presence leads to interactions with growth factors present 
in the medium which could play a role in the toxicity of the material. From the data 
presented the presence of AgNP appears to alter the spectra with a slight increase in 
absorbance observed upon the dispersion of AgNP in the media and also in the presence 
of the various biofluid components. Analysis of AgNP alone (dispersed in dH2O) reveal 
a feature between the wavelengths of 300 and 400nm which can be attributed to the 
silver plasmon. There is no evidence of this feature in the preparations of AgNP in cell 
media and with the addition of biofluid components. 
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Figure 4.4.1 (a) Absorption spectra of RPMI only, AgNP (15.6µg/ml) in dH2O, 
dispersed in RPMI, AgNP dispersed in RPMI with UDCA (50µM) and RPMI with 
DPPC (0.25µg/ml) 
 
Figure 4.4.1 (a) compares the absorption spectrum of the cell culture medium RPMI, 
AgNP dispersed in RPMI and AgNP dispersed in RPMI with added DPPC and UDCA. 
The features of cell culture media as detailed previously at 360, 410 and 560nm are 
clearly observed from the spectra presented. From the data there was a slight decrease in 
the peak at 560nm upon the addition of AgNP to RPMI and also with the addition of 
UDCA and DPPC. There was also an apparent decrease in the peaks and increase in 
absorbance at 360 and 410nm upon addition of AgNP and biofluid components. The 
silver plasmon was not apparent upon addition to the different preparations.  
 
 
 
 
 
 
(a) 
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Figure A4.4.1 (b) Absorption spectra of AgNP (15.6µg/ml), DMEM only, and AgNP 
dispersed in DMEM with CA (1mM), DCA (0.125mM) and UDCA (50µM)  
 
Figure 4.4.1 (b) illustrates a similar spectrum to 4.4.1 (a) but with DMEM cell culture 
media used as a dispersant. DMEM displays the features at 360, 410 and 560nm, 
riboflavin, 10% FBS and phenol red respectively. Unlike RPMI these features, 
particularly the phenol red indicator, are more pronounced in DMEM. As with RPMI a 
similar alteration to the spectra is observed. A slight reduction in peaks at 360, 410 and 
560nm were noted, suggestive of a possible interaction of AgNP with the cell media 
components. A change in absorbance spectra was also observed in the presence of the 
biofluid components CA, DCA and UDCA. As before the silver plasmon is not 
visualised following addition of AgNP to DMEM/ biofluid component preparations. 
UV-Vis absorption analysis preparations of AgNP and cell culture media demonstrate 
slight changes in the absorption spectra. Alterations in spectra can indicate an 
interaction of AgNP with the molecular components of the culture media. Any 
interaction could result in a secondary toxicity resulting from depletion of the nutrient 
and growth factors of the media due to the presence of AgNP. The presence of particles 
may cause absorption of the media constituents making them unavailable to cells. This 
has been investigated for other nanomaterials such as carbon nanotubes which resulted 
in significant depletion of cell culture media constituents possibly contributing to a 
secondary toxicity by making the various supplements and growth constituents 
(b) 
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unavailable to cells. This produced a secondary toxicity as opposed to a primary toxicity 
(Casey et al, 2007). The results demonstrated here show only slight changes in peak 
width and absorbance values. Although changes in these features can suggest particle-
media interaction the changes are so small that any possibility of an interaction is 
negligible and may not impact on the any overall toxicity in further studies. 
 
Appendix A5.2 
 
Figure A5.2.1 (a) Cytotoxicity of AgNP in HepG-2 cells after 24, 48, 72 and 96hr 
exposure as determined by the Alamar Blue assay. Data expressed as percentage of 
control mean ± SD of three individual experiments. * denotes a statistically significant 
(p<0.01) difference from the unexposed control 
 
Figure A5.2.1 represents cytotoxic response of HepG-2 cells to AgNP exposure 
determined by the AB assay. In the presence of AgNP cell viability decreases in a 
concentrationand time dependant manner. Loss in cell viability is more apparent in the 
AB assay which assesses the cytosolic integrity of the cell. A reduction in cell viability 
was observed at the lowest exposure concentrations 3.9 and 7.8µg/ml after 24 hours. A 
significant reduction in cell viability compared to the unexposed control was observed 
at a concentration of 15.6µg/ml and upwards following 24, 72 and 96 hour exposures 
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with significant reduction in viability at all exposure time points at concentrations of 
31.25µg/ml and above.  
 
 
Figure A5.2.1 (b) Cytotoxicity of AgNP in HepG-2 cells with added UDCA after 24, 
48, 72 and 96hr exposures as determined by the Alamar Blue assay. Data expressed as 
percentage of control mean ± SD of three independent experiments. * denotes a 
statistically significant (p<0.01) difference from the unexposed control 
 
Figure A5.2.1 (b) illustrates the toxic response of HepG-2 cells following AgNP 
exposure in the presence of UDCA determined by the AB assay. A similar 
concentrationdependant response was noted as seen with the previous assays, following 
exposure to AgNP alone with the response increasing over time. A decline in cell 
viability was observed after 24 hours and upwards at concentrations of 3.91 and 
7.81µg/ml. A significant decrease in cell viability compared to the unexposed control 
occured at all exposure time points at doses of 15.6µg/ml and above. Interestingly the 
presence of UDCA appeared to have no effect on cellular response to AgNP exposure, 
with almost identical patterns of toxicity observed with and without the addition of 
UDCA. This suggests that the presence of UDCA does not modify AgNP toxicity in 
HepG-2 cells. 
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Figure A5.2.1 (c) Cytotoxicity of AgNP in HepG-2 cells with added CA after 24, 48, 
72 and 96hr exposures as determined by the Alamar Blue assay. Data expressed as 
percentage of control mean ± SD of three independent experiments. * denotes a 
statistically significant (p<0.01) difference from the unexposed control 
 
Figure A5.2.1 (c) represents exposure AgNP exposure to HepG-2 cells in the presence 
of CA. A concentrationand time dependant response to AgNP exposure was noted. A 
significant decrease in cell survival after 24 hours at a concentration of 3.91µg/ml was 
observed. At this concentration a significant decline in cell survival was detected after 
48 and 72 hours. The apparent increase in viability after 96 hour exposure may indicate 
cell recovery. At this low concentration any surviving cells may begin to replicate as the 
doubling time for this cell line is 48 hours. A significant decline in cell viability was 
detected at concentrations of 7.81µg/ml and higher compared to the unexposed control 
at all exposure time points.  
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Figure A5.2.1 (d) Cytotoxicity of AgNP in HepG-2 cells with added DCA after 24, 48, 
72 and 96hr exposures as determined by the Alamar Blue assay. Data expressed as 
percentage of control mean ± SD of three independent experiments. * denotes a 
statistically significant (p<0.01) difference from the unexposed control 
 
Figure A5.2.1 (d) illustrates the toxic response of HepG-2 cells to AgNP exposure in the 
presence of DCA. Exposure resulted in a concentrationand time dependant reduction in 
viability. Significant loss in cell viability compared to the unexposed control was 
observed at all time points and at all exposure doses.  
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Figure A5.2.2 (a) Cytotoxicity of AgNP to Hep2 cells after 24, 48, 72 and 96hr 
exposure as determined by the Alamar Blue assay. Data expressed as percentage of 
control mean ± SD of three independent experiments. * denotes a statistically 
significant (p<0.01) difference from the unexposed control 
 
Figure A5.2.2 (a) displays the cytotoxic response of Hep2 cells to AgNP exposure 
determined by the AB assay. As with previous cell lines toxicity occured in a 
concentrationand time dependant pattern. Significant reduction in viability was 
observed at 48 and 72 hours for all exposure concentrations. A significant reduction in 
viability compared to the unexposed control after 24 hours was noted at concentrations 
of 15.6µg/ml and above with a significant reduction observed for all exposure time 
points at concentrations of 62.5µg/ml and upwards. At concentrations of 3.91 to 
62.5μg/ml there appeared to be cell recovery at the 96 hour exposure point. This may be 
due to remaining particles precipitating out of solution giving any remaining cells an 
opportunity to begin replicating. With a rapid doubling time of 23 hours cell viability 
appeared to increase at lower AgNP doses after prolonged exposure.  
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Figure A5.2.2 (b) Cytotoxicity of AgNP to Hep2 cells with added UDCA after 24, 48, 
72 and 96hr exposures as determined by the Alamar Blue assay. Data expressed as 
percentage of control mean ± SD of three independent experiments. * denotes a 
statistically significant (p<0.01) difference from the unexposed control 
Figure A5.2.2 (b) illustrates toxic response of Hep2 cells to AgNP in the presence of 
UDCA. In the presence of UDCA a dramatic reduction in cell viability compared to 
exposure to AgNP alone was noted. Results demonstrated significant reduction in 
viability at 48, 72 and 96 hours at all exposure concentrations with a significant 
reduction at all time points at a concentration of 15.6µg/ml and above. Loss in cell 
viability was more pronounced following 48, 72 and 96 hour exposures suggesting a 
possible delay in toxicity. The data presented illustrate that compared to AgNP exposure 
alone the presence of UDCA does modify toxicity.  
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Appendix 6.2 
 
Figure A6.2.1 Cytotoxicity of AgNP to A549 cells after 24, 48, 72 and 96hr exposures 
as determined by the Alamar Blue assay. Data expressed as percentage of control mean 
± SD of three independent experiments. * denotes a statistically significant (p<0.01) 
difference from the unexposed control 
 
The cytotoxic response of A549 cells to AgNP demonstrated by the AB assay is 
displayed in figure A6.2.1. Decline in cell viability occurred in a concentrationand time 
dependent manner with a significant reduction in cell viability following 48 hour 
exposures at all AgNP doses. After 72 hour exposure a significant reduction in cell 
viability was observed at concentrations of 15.6µg/ml and above with a significant 
decline at 31.25µg/ml and upwards at all exposure time points. At 96 hours and 72 
hours at lower AgNP doses, cell recovery was noted. It is possible that at this time after 
exposure and due to the rapid (22 hour) doubling time of A549 cells, the particles have 
fallen out of solution and with toxic effect having taken place within the first 6-12 hours 
following exposure. It is possible that any surviving cells begin to replicate at lower 
exposure doses and at prolonged exposure times. This was observed at concentrations of 
3.91-62.5μg/ml up to 125µg/ml where a slight recovery was noted. It must also be 
considered that the sensitivity of viability assays can vary with cell type and while one 
assay may be suitable for one type a different assay may be more suited to another type.  
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Figure A6.2.2 Cytotoxicity of AgNP to A549 cells with added DPPC after 24, 48, 72 
and 96hr exposures as determined by the Alamar Blue assay. Data expressed as 
percentage of control mean ± SD of three independent experiments. * denotes a 
statistically significant (p<0.01) difference from the unexposed control 
 
The response of A549 cells to AgNP exposure in the presence of DPPC demonstrated 
by the AB assay (figure A6.2.2). A concentrationand time dependant reduction in 
viability was observed. A significant reduction in cell survival compared to the 
unexposed control was observed at concentrations 7.81µg/ml and above following 24 
hour exposure and at a concentration of 3.9µg/ml and above after 48 and 72 hours. At 
31.25µg/ml and above a significant reduction in cell survival at all exposure time points 
was detected. As previously suggested, at lower AgNP doses following 96 hour 
exposures, the increase in viability may be attributed to cell recovery. 
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Figure A6.2.3 (a) ROS generation in A549 cells after different time points of AgNP 
exposure. Data are expressed as percentage of control mean ± SD of six independent 
experiments.  
 
 
Figure A6.2.3 (b) Confocal image (x40) of A549 cells exposed to 500µg/ml AgNP 
suspended in cell culture media. Image taken on a Zeiss 510 LSM confocal microscope 
with an argon ion laser, excitation 488nm using a band pass filter 505-530nm to detect 
DCF. (a) LSM image demonstrating intracellular ROS, (b) overlay of LSM and bright 
field image. 
 
(a) (b) 
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The generation of ROS in response to AgNP exposure was determined using 2’, 7’ 
Dichlorofluorsecin diacetate which detects intracellular hydroperoxides. Results were 
expressed as a percentage of the unexposed control. A positive control of 10µM H2O2 
was used in this assay. 
Figure A6.2.3 (a) demonstrated little to no intracellular ROS production in response to 
AgNP exposure. The generation of intracellular hydroperoxides was detected only at the 
highest concentration, 500µg/ml with production increasing in a time dependant 
manner. ROS production was detected after 15 minutes at the highest AgNP 
concentrationwith maximum levels detected after 1 hour. In the hourly readings that 
followed ROS production rapidly declined. For this particular cell line it was found that 
AgNP were not potent inducers of ROS. Confirmation of ROS induction by AgNP at a 
concentration of 500µg/ml was verified by confocal microscopy as illustrated in figure 
A6.2.3 (b). 
 
Appendix 7.2 
 
Figure 7.2.1 Fold increase in IL-1, IL-6 and TNF-α gene expression in THP-1 cells 
following 8 hour exposure to AgNP, LPS and combined AgNP + LPS compared to 
unexposed control ± SD of three independent experiments. *denotes a statistically 
significant difference (p<0.05) from the unexposed control 
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Figure 7.2.2 Fold increase in IL-1, IL-6 and TNF-α gene expression in THP-1 cells 
following 8 hour exposure to AgNP, LPS and combined AgNP + LPS compared to 
unexposed control ± SD of three independent experiments. *denotes a statistically 
significant difference (p<0.05) from the unexposed control. Polymyxin B (50µg/ml) 
employed as an endotoxin inhibitor was pre-treated 1 hour before exposure. 
 
In order to ensure that gene expression was due to AgNP and LPS exposure alone, 
polymyxin B an endotoxin inhibitor was pre-treated 1 hour before exposures to ensure 
no endotoxin contamination in the system. Figure 7.2.1 illustrates pro-inflammotory 
cytokine gene expression following exposure to 50µg/ml AgNP, 1µg/ml LPS and a 
combination of AgNP and LPS. A significant up-regulation in gene expression was 
observed for all cytokines IL-1, IL-6 and TNF-α following AgNP and LPS exposures. A 
significant up-regulation in IL-1 and IL-6 was detected following exposure to combined 
AgNP and LPS. With the addition of polymyxin B (figure 7.2.2) no inhibition of gene 
expression was observed following exposure to AgNP and combined AgNP and LPS. A 
significant up-regulation compared to the unexposed control was noted for all cytokine 
targets following exposure to AgNP. LPS induced gene expression was inhibited by 
pre-treatment of cells with polymyxin B, however gene expression was still observed 
following exposure to a combination of AgNP and LPS with significant up-regulation in 
IL-1 and IL-6 compared to the unexposed control detected. These results demonstrate 
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no endotoxin contamination in the system and that gene expression is induced by 
AgNP, LPS and AgNP-LPS exposure alone. 
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